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Characterization of ToxINPa-sensitive bacteriophages 




Abortive infection (Abi) is an anti-phage mechanism in which a bacterium initiates its own death 
upon phage infection. This prevents or decreases the production of phage progeny and protects 
clonal siblings in the bacterial population by an act akin to an “altruistic suicide.” Abortive 
infection can be mediated by a Type III toxin-antitoxin system called ToxINPa, first found in 
Pectobacterium atrosepticum. ToxINPa consists of an endoribonuclease toxin and RNA antitoxin 
and is inactive as a heterohexameric complex until infection by certain phages causes 
destabilization of ToxINPa, leading to bacteriostasis and, eventually, lethality. However, it is still 
unknown why only certain phages are able to activate ToxINPa-mediated Abi and what mechanisms 
are involved.  
 
This study aimed to address this issue by first introducing ToxINPa into the Gram-negative 
enterobacterium, Serratia sp. ATCC 39006 (S39006). A novel environmental S39006 phage, 
ΦCBH8, that is sensitive to ToxINPa-mediated Abi was isolated, characterized, and compared to 
its spontaneous “escape” mutants that were insensitive to ToxINPa. Characterization of ΦCBH8 
led to the discovery of a new genus of T4-family phages that are all ToxINPa-sensitive. Genomic 
comparison of ΦCBH8 with its spontaneous ToxINPa-escape mutants led to the discovery of two 
distinct genetic loci that are candidates for activation of ToxINPa-mediated Abi. 
 
One such locus was a multi-gene region of the phage genome, the deletion of which enabled some 
ΦCBH8 mutants to escape ToxINPa. Different ToxINPa-escape mutants had variable deletions in 
their genomes, but this multi-gene locus was deleted in all of the deletion mutants. Experiments 
showed that at least two genes in this locus must be simultaneously involved in activating ToxINPa-
mediated Abi and one phage gene product within the locus (ORF18) was extremely toxic to the 




Another locus was the asiA gene. This study showed that ΦCBH8 mutants with mutated versions 
of asiA became insensitive to ToxINPa but genetic complementation restored their sensitivity. AsiA 
is involved in σ-appropriation but the mutated AsiA in ΦCBH8 mutants was no longer functional. 
Further experiments showed that AsiA from wild type ΦCBH8 reduced ToxINPa promoter activity 
while mutant AsiA did not, suggesting that AsiA could be involved in activating ToxINPa-mediated 
Abi by perturbing toxINPa transcription. 
 
Finally, an outer membrane protein (OmpW) was defined as the ΦCBH8 receptor in S39006. 
Transfer of the S39006 ompW gene to other bacterial species rendered some of them sensitive to 
the phage thereby enabling expansion of ΦCBH8 host range. Results showed that ΦCBH8 was 
insensitive to ToxINPa in E.coli, suggesting that activation of ToxINPa-mediated Abi is host-
dependent. The function of OmpW was explored to try to link bacterial host physiology with phage 
susceptibility 
 
In conclusion, this work characterized novel phage genes involved in activating ToxINPa-mediated 
Abi. This provided evidence that viral gene lethality and σ-appropriation might be related to the 
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Chapter 1- Introduction 
1. Bacteriophages 
1.1 The discovery of bacteriophages and their abundance 
Bacteriophages (phages) are viruses that infect bacteria. As obligate parasites of bacteria, phages 
are believed to have been first discovered by the English bacteriologist Frederick Twort in 1915 
when he observed the “glassy transformation” of micrococci during cultivation (1). However, at 
that time Twort could not confirm the nature of the glassy transparent material he observed, which 
we now know to be zones of dead bacteria formed after phage propagation. Shortly after, in 1917, 
the French-Canadian biologist Felix d'Herelle observed clear spots speckling the cultures of 
coccobacillus grown on agar and believed that they were caused by obligate parasites of bacteria 
(2). Felix d'Herelle’s arguably independent discovery finally led to the acknowledgement of the 
existence of phages and marked the official beginning of a century’s research on phages. In fact, 
it was d'Herelle who first used the term “bacteriophage”. 
 
Today, phages are considered to be the most abundant biological entity in the world, with an 
estimated number of 1031 viral particles in the biosphere (3). Perhaps what is most impressive is 
the diversity of biology they represent. Phages have been found in every environment where 
bacteria live. At the same time, different phages are distinct from each other both genetically and 
morphologically with genomes varying from 3.4 kb to almost 500 kb and morphologies ranging 
from tailed phages to their non-tailed counterparts (4). However, our knowledge of phages is still 
very limited. In 2008 there were only 500 phage genomes deposited in GenBank (3). That number 
has grown to more than 5,000 today but they still only represent a tiny fraction of the entire phage 
population, most of which are not yet isolated or sequenced. Even for the deposited phage genomes 
in GenBank, little is known about the functions of many phage genes. Indeed, phages contain the 
largest reservoir of unexplored genetic information on earth. 
 
1.2 Phage classification and structure  
1.2.1  Conventional classification of phages based on morphology 
To better characterize phages and address their diversity, classification is necessary. However, no 
universal phage classification method exists, partly because, unlike their bacterial hosts, phages 
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lack universal genes that can be used to identify phylogenetic relationships (5). Therefore, the 
official phage taxonomy published by the International Committee on Taxonomy of Viruses 
(ICTV) lags far behind the discovery of novel phage types (6). So far, the most commonly used 
phage classification method is based on David Bradley’s proposal in 1967 that focuses on the 
morphological characteristics of phages (7). This divides phages into “tailed phages” 
(Caudovirales) and “non-tailed phages” that includes “cubic phages”, “filamentous phages” and 
“pleomorphic phages” (Figure 1.1). 
 
Tailed phages are the most abundant type. More than 96% of phages are tailed phages and all of 
them have a double stranded DNA (dsDNA) genome contained within their icosahedral or 
elongated heads. They have no envelop and adsorb to their bacterial host directly from the outside 
(6). Tailed phages can be further divided into 3 families based on their tail properties: phages in 
the Myoviridae family have long, contractile tails; phages in the Siphoviridae family have long, 
non-contractile tails and represent the largest family of tailed phages; phages in the Podoviridae 
family have short, non-contractile tails (6, 8). The Myoviridae family includes some of the most 
well-studied phages such as T4, the structure of which will be elaborated in Section 1.2.2. 
 
Non-tailed phages are less common but have also been isolated against a wide variety of bacterial 
hosts. “Cubic phages” include families such as Microviridae (ssDNA), Corticoviridae (dsDNA), 
Tectiviridae (dsDNA), Leviviridae (ssRNA)… etc. Some “cubic phages” possess a membrane 
envelop that protects their capsid but all of them lack a permanent phage tail. “Filamentous phages” 
also include several families, the most well-known of which is the Inoviridae (ssDNA) composed 
of long and rod-shaped phages. Some members of the Inoviridae can integrate into the genomes 
of bacterial hosts and contributes to the production of major virulence factors in Vibrio cholerae. 
“Pleomorphic phages” include seven different families all with dsDNA genomes but are less 
commonly found than other phage families. “Pleomorphic phages” include a wide variety of 
irregular morphologies and some families don’t even possess capids (6)  (Figure 1.1). 




Figure 1.1: Classification of phages based on morphology. This figure is reproduced from the 
book chapter published by Ackermann and colleagues (9). Schematic illustrations of phage 
morphology are shown with the names of phage families. Phages are broadly categorized into 
“tailed” and “non-tailed”, with “tailed” phages representing the most abundant and well-studied 
category that includes phages with long, contractile tails (Myoviridae), phages with long, 
noncontractile tail (Siphoviridae) and phages with short, noncontractile tail (Podoviridae) (9). 
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1.2.2  Structure of phage T4: the most well-studied member of the Myoviridae 
Even though phages possess a wide range of morphological structures, past research has been 
focused only on a few model phages, most of them belonging to the Caudovirales order, such as 
phage T4 (Myoviridae), phage lambda (Siphoviridae) and phage T7 (Podoviridae). Among them, 
Escherichia coli (E.coli) phage T4 is the most well-studied and is a good representative of the 
structural complexity of Myoviridae. 
 
The structure of phage T4 has been elucidated using techniques such as complementation assays, 
cross-linking analyses, x-ray crystallography, TEM and cryoEM (10). The main components of 
phage T4 structure are head, tail and long tail fibers, all of which are assembled individually before 
coming together to form a mature virion (Figure 1.2) (10). The prolate head of phage T4 is 1150 
Å-long, 850 Å-wide with hemi-icosahedral ends and made up of 3000 polypeptide chains of at 
least 12 kinds of proteins (11). The phage head contains its 172-kb dsDNA genome and is 
connected to the phage tail. The T4 tail, 1000 Å in length and 210 Å in width, consists of an inner 
cylinder called the tail tube and an outer cylinder called the tail sheath that is wrapped tightly 
around the tail tube. While one end of the tail is connected to the phage head, the other end is 
associated with a hexagonal structure called the baseplate, upon which six long tail fibers are 
attached. Each long tail fiber of phage T4 consists of a rigid proximal part hinged with a distal part. 
The long tail fibers act as antennas that sense the environment and attach to receptors on bacterial 
surfaces. This is followed by unfolding of short tail fibers and irreversible attachment of the star-
shaped baseplate to the bacteria host (10, 11). This initiates the infection process during which the 
tail sheath contracts and genomic DNA from the phage head will pass through the tail tube and 
into the host cell. Details of the infection process can be found in Section 1.3. 





Figure 1.2: Schematic representation of phage T4 structure. The main components of phage 
T4 structure - head, tail, long tail fibers and baseplate are indicated in the diagram. The phage 
genomic DNA is shown as contained within the head capsid and enters the host through the tail 
tube. This figure is reproduced from the review by Yap and colleagues (10). 
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1.2.3  New developments in phage classification 
Whilst conventional phage classification during the 1970s-1990s focused on biological attributes 
of phages, in particular morphological structure, recent assignment of phage taxonomy has seen 
new trends both in the availability of phage sequence information and parameters used to classify 
phages using this information. 
 
The first new trend of phage classification is the increasing reliance on phage genomic sequence 
data, instead of simple phage morphology. In recent years the ICTV has attempted to use predicted 
proteome similarity to define genera and subfamily, as well as EMBOSS Stretcher to calculate 
similarities between phage genomes, yet these methods suffered from limitations. Recent phage 
classification practice has attempted to use alternative methods such as BLASTn to perform 
identification of related phages. BLASTn has been found to be superior to previous programs such 
as EMBOSS Stretcher and some of the newest phylogenetic analysis tools such as CLANS and 
mVISTA are based on BLASTn. As a result of the new genome-based phage taxonomy principle 
and the great increase in the number of sequenced phage genomes, today the order 
Caudovirales includes six subfamilies, 80 genera, and 441 species, compared to only 3 families, 
18 genera and 36 species in 2008 (12). 
 
The second trend of phage classification is the acceptance of metagenomics data to be used for 
phage taxonomy. Historically, the classification of new viruses by the ICTV required substantial 
biological information such as host range, replication cycle, virion structure… etc. However, with 
the availability of high-throughput sequencing and metagenomics data, phage genomes have been 
discovered that are not directly correlated with any biological agent. After several workshops to 
discuss the validity of such metagenomics data, the ICTV has decided to accept, with caution, that 
the detection of phage genome sequence in a sample is sufficient to infer the existence of a 
corresponding phage (5). Using metagenomics data, virologists have uncovered an abundance of 
phages in unexpected sources. For example, a dsDNA phage named crAssphage with a genome 
size of 97 kb was discovered from metagenomics of waste water and is six times more abundant 
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1.3 Phage life cycle 
The process through which phage infection occurs leading to phage reproduction is called the 
phage life cycle. Every second there is an estimated 1025 phage infections occurring in the 
biosphere (14) and the length of a phage life cycle can vary greatly. The most well-defined phage 
life cycles are illustrated in Figure 1.3 and can be categorized into the lytic life cycle and the 
lysogenic life cycle. Phages adopting either life cycle share common initial steps in the infection 
process such as adsorption and DNA injection but adopt different post-injection survival and 
replication strategies. In recent years, this bifurcation of phage lifestyle is challenged by the 
discovery of “pseudolysogeny” – an alternative phage life cycle where phage development inside 
the host cell is stalled without either genome replication and host cell lysis (as in the lytic life cycle) 
or genome replication and stable maintenance synchronized with the host cell cycle (as in the 
lysogenic life cycle). Pseudolysogeny is usually caused by stringent growth conditions for the host, 
such as starvation, and terminated by the availability of nutrients, after which the phage goes into 
either the lytic or lysogenic life cycle (15). However, the following introduction of phage life cycle 
is still focused on the classical lytic/lysogenic categorization, especially the lytic life cycle, because 
of limited understanding of pseudolysogeny and because most phages mentioned in this study 
adopt the lytic life cycle. 
 
1.3.1  Adsorption and DNA injection 
The first step of a phage life cycle is adsorption - the recognition and attachment to the phage 
receptor on the bacterial surface. Adsorption is crucial, not only because it is the first point of 
contact between phage and host, but also because the specificity of receptor recognition is a major 
contributor to determining phage host range. Taking phage T4 as an example, adsorption consists 
of three main steps: initial contact, reversible binding and irreversible attachment (16). Initial 
contact is made by random collision of the phage and host, after which the phage binds reversibly 
to the host surface via its long tail fibers to further its search for specific receptors. After a receptor 
is found, the baseplate is anchored to the receptor with the help of short tail fibers and irreversible 








Figure 1.3: Schematic representation of phage life cycle. Phage infection is initiated with phage 
adsorption to the host surface, followed by injection of phage DNA into the host cytoplasm. After 
DNA injection, the virulent phages enter the lytic cycle while temperate phages could either enter 
the lysogenic cycle or the lytic cycle. In the lytic cycle, phage DNA is replicated, phage genes are 
expressed, and phage components are assembled into mature phage particles. This eventually leads 
to the lysis of the host cell and release of varying numbers of phage progenies. The progenies could 
restart the life cycle by adsorbing to a new host. In contrast, temperate phage entering the lysogenic 
cycle don’t immediate begin DNA replication and gene expression. Instead, genomic DNA is 
circularized and integrated into specific sites in the host chromosome or maintained in the host 
cytoplasm as a circular replicon until exposure to certain signals (such as radiation or mutagenic 
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chemicals), after which the prophage genome can be excised from the host chromosome and the 
phage would enter the lytic cycle (27, 28). 
The identity of bacteria cell surface components that phages recognizes also varies greatly, such 
as wall components (Gram-positive and Gram-negative bacteria), components of bacterial 
capsules, membrane proteins and appendages such as pili and flagella. A summary of different cell 
surface components that have been found to act as receptors and their specific examples are shown 
in Table 1.1. This diversity in receptor identity is reflected by the diversity in phage adsorption 
mechanisms, as reviewed in depth by Silva and colleagues (16). While most phages recognize a 
single receptor, in some cases phages have dual receptors or recognize different cell surface 
components for reversible and irreversible binding. For example, E.coli phage T5 utilizes the O-
antigen of host lipopolysaccharide (LPS) for reversible binding and outer membrane protein FhuA 
for irreversible binding. In such cases, the utilization of more-exposed cell wall components for 
reversible binding creates higher chances of interaction and more stable interaction, which allows 
easier access to receptors for irreversible binding.  
 
For tailed phages, after irreversible binding of the phage tail with host receptor, the tail tube 
penetrates through the bacterial surface. In this process, enzymes associated with the phage tail 
help penetration by digesting the peptidoglycan layer. After the phage tail has penetrated through 
the inner membrane of bacteria, genomic DNA is released from the phage head and injected into 
the host cytoplasm through the tail tube. 
 
1.3.2 DNA replication and gene expression 
Based on post-DNA injection survival strategies, phages can be divided into two categories: 
virulent phages that enter the lytic life cycle and temperate phages that may go through a lytic life 
cycle or can enter the lysogenic life cycle. 
 
In the lytic life cycle, after DNA injection phages immediately embark on the process of making 
large amounts of viral DNA/RNA and proteins that eventually package into mature phage particles. 
Taking the virulent phage T4 as an example, gene expression relies heavily on host transcription 
and translation machineries. T4 genes can be divided into early, middle and late genes depending 
on the order through which they are subsequently expressed. Early genes, such as genes encoding 
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proteins ModA and ModB, usually have strong promoters that compete with host promoters for 
host transcription machineries. Early gene products further reduce host gene transcription and act  
 
 
Table 1.1: Summary of different types of cell surface components known to be utilized by 
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to take control of host machineries to express T4 genes. Middle genes are subsequently transcribed 
1 minute into infection and mainly encode proteins involved in DNA replication, recombination 
and metabolism. Middle gene products also include phage-encoded tRNAs and transcription 
factors that facilitate the switch to late gene transcription (25). Finally, T4 late genes encode 
components of the phage head, tail, tail fiber and proteins involved in their assembly (26). 
 
In contrast, after DNA injection some phages don’t automatically enter the lytic cycle but could, 
under certain host conditions, enter the lysogenic life cycle. In this cycle, genomic DNA is 
circularized and integrated into specific sites in the host chromosome or maintained in the host 
cytoplasm as a circular replicon. In this state, the phage is called a prophage and the host bacterium 
is called a lysogen. The host lives and reproduces normally, and phage DNA is reproduced and 
transmitted to daughter cells during cell division. In some cases, prophages can also change the 
phenotype of the host, for example virulence factors carried on the prophage can turn the host into 
a virulent bacterium in a process called lysogenic conversion or phage conversion. A well-known 
example would be the conversion of the non-toxic Vibrio cholerae into the highly-toxic cholera 
toxin-producing version after infection by phage ΦCTX. The lysogenic life cycle continues until, 
upon exposure to certain conditions such as radiation or mutagenic chemicals, the prophage 
genome can be excised from the host chromosome and the phage would enter the lytic cycle (27, 
28). 
 
1.3.3 Phage assembly and lysis  
For virulent phages or temperate phages that have entered the lytic life cycle, assembly of new 
phage particles occurs after components of the virion are made and genomic DNA is sufficiently 
replicated. In the case of virulent phages such as T4, assisted by chaperones, the phage assembly 
process begins with baseplate and later attachment of tails onto the baseplate. The head capsid is 
assembled separately and packed with genomic DNA before being assembled onto the tails. While 
packing genomic DNA into head capsids, phages could mistakenly package portions of the host 
chromosome into their head and inject this host DNA into the cytoplasm of the subsequent host 
where the DNA from the first host could recombine into the chromosome of the second host. This 
process is called transduction and is responsible for the dissemination of DNA between bacteria, 
sometimes the dissemination of virulence or antibiotic resistance genes. In the case of virulent 
phages, the packaging of host DNA happens randomly, therefore the process is called generalized 
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transduction. In the case of temperate phages, transduction can occur during inefficient prophage 
excision where the prophage is excised alongside portions of the host DNA. Because prophage 
integration happens at specific sites in the host chromosome, the host DNA that is excised and 
packaged into the capsid is also specific. Therefore, this kind of transduction is called specialized 
or restricted transduction (26, 29). 
 
After sufficient numbers of nascent phages are made (e.g. in T4 it could range from 100 to 200 
new phage particles), lysis of the host cell occurs. For example, in the case of Gram-negative 
bacteria, lysis occurs in three main steps where the inner membrane, peptidoglycan layer and outer 
membrane of the host are targeted by phage-encoded holin, endolysin and spanin complex. Holin 
accumulates in the cytoplasmic membrane and eventually triggers the formation of holes in the 
inner membrane. This allows endolysin to escape into the peptidoglycan layer and cause its 
degradation. Finally, the outer membrane is disrupted by a spanin complex that consists of a small 
outer membrane lipoprotein and an integral cytoplasmic membrane protein (30). Defects in any of 
these steps would prevent complete lysis. After lysis of the host cell, phage progenies are released 
into the environment where they can target new hosts and initiate another cycle of infection. 
 
1.4 Applications of phages and their contribution to molecular biology 
Since the discovery of phages a century ago, biologists have studied phages extensively and this 
has led to our current understanding of many basic biological processes. Phage research has also 
translated into many applications within the realm of molecular biology itself as well as in 
biotechnology. 
 
In the early twentieth century, not much was known about genes and their regulation until scientists 
started using phage as model organisms. For example, in the famous Hershey-Chase experiment 
conducted in 1952, T2 phages with either their protein coat labeled with 35S or their DNA labeled 
with 32P were used to infect bacteria. The mixture was agitated to separate phages outside bacteria 
from bacterial cells, followed by centrifugation to pellet the bacteria. The radioactivity of both the 
pellet and the supernatant was measured. 35S was only found in the liquid containing free phages 
that did not infect bacteria or phage parts that did not enter bacterial cells whereas 32P was found 
within the bacteria cells. This indicated that 32P-labeled DNA entered the cells, not 35S-labeled 
protein, suggesting that DNA, instead of protein, acts as genetic material (31, 32). Furthermore, 
phages as model organisms have also contributed to our understanding of gene regulation. For 
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example, in the 1950s François Jacob’s work on λ prophage induction and its genetic circuits led 
to the identification of DNA-binding repressor and activator proteins and transcriptional anti-
terminators (32).  
 
Discoveries in phage biology have also contributed to advancements in molecular cloning and 
DNA sequencing that revolutionized biological research. For example, in the 1950s the 
phenomenon of restriction-modification was discovered in bacteria. Bacteria employ restriction 
endonucleases to cleave foreign DNA, such as invading phage DNA, at specific cut sites as a 
defense mechanism. In concert, bacteria can also use methylation to modify their own DNA to 
protect it from restriction. The recognition of specific DNA sequences by restriction enzymes was 
later used to cleave genes in cloning technology (33, 34). Studies of phages lambda and phage P1 
also contributed to the use of cosmids and artificial chromosomes as cloning vectors. Upon the 
advent of DNA sequencing techniques, phage genomes (e.g. phage ϕX174 in 1977) were the first 
to be sequenced and contributed to the development of different sequencing methods, such as shot-
gun sequencing (4, 32). Studies of the T7 DNA polymerase have also provided a solution for high-
fidelity DNA sequencing (35). 
 
More recently, phages have contributed greatly to the development of biotechnological tools. For 
example, phage display is a method for synthesizing and selecting polypeptides with novel 
characteristics. In phage display, genes encoding polypeptides are fused with phage coat protein 
genes and the peptide fusions expressed on the surface of the phage particles. This creates a library 
of polypeptides that can be screened for desired characteristic such as affinity to target receptors 
or pathogenic agents (36-38). The application of phage display can be further expanded to enable 
phages to carry specific genes for targeted gene delivery or vaccine delivery (37). The specificity 
of phage-host recognition is also used in biotechnology in a technique called phage typing, where 
phages can be used to detect and identify unknown bacterial strains (39). Finally, phages can be 
used as therapeutic agents in phage therapy – the clinical use of phages to treat bacterial infection. 
Phage therapy was first studied in the 1920s by d’Herelle (2, 40), but interest in it waned in the 
West around the 1940s after the discovery of antibiotics. In the last decade, with growing concerns 
of antibiotic resistance, interest in phage therapy has resurfaced. Phage therapy boasts several 
advantages over antibiotics, including the specificity of phages in host recognition that could 
prevent damage to the healthy gut flora, the localized nature of phage proliferation at the site of 
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infection, and the ability of phages to reach required target sites such as by crossing the blood-
brain barrier (41). However, many obstacles still exist for the clinical application of phage therapy, 
such as the lack of rigorous clinical research data, the possibility of human immune response 
against administered phages and, importantly, the threat of anti-phage defense mechanisms 
employed by bacterial hosts. More research is needed on the basics of phage biology and phage-
host interactions.  
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2. Bacterial defense against phage infection 
The infection and killing of bacteria by phages is a very efficient process. This efficiency results 
in a high turnover of phage particles, which imposes great selection pressure on bacteria to evolve 
mechanisms that render them insensitive to phage infection. In response, phage mutations that 
could enable them to infect these insensitive hosts are selected. The perpetual defense and counter-
defense dynamic between phage and host can be described as an evolutionary arms race that has 
helped biologists build an understanding of evolutionary biology. But the possible emergence of 
phage-insensitive bacteria hosts also poses a threat to potential applications of phage, such as 
phage therapy. Therefore, in-depth study of anti-phage mechanisms is essential.  
 
2.1 Overview of anti-phage mechanisms 
Anti-phage mechanisms target different steps in the phage life cycle, as illustrated in Figure 1.4 
(adapted from the review by Seed and colleagues (42)). These include prevention of phage 
adsorption, hindrance to DNA injection, damage of phage DNA before phage genes can replicate 
and express and interference with new phage particle assembly.  
 
Successful phage infection begins with phage recognition of bacteria surface receptors. These 
receptors usually have their own physiological functions but can be utilized by phages for entry. 
Modulation of the expression of these receptors may have the concurrent effect of limiting receptor 
accessibility to phages. Decrease in receptor availability can be achieved through phase variation. 
For example, Bordetella bronchiseptica can vary between the Bvg+ phase and the Bvg- phase. 
Only in the Bvg+ phase can it produce virulence and colonization factors and phage receptors, 
such as pertactin (42, 43). Bacteria can also limit receptor accessibility by blockage of receptors 
using self-made molecules or extracellular matrixes. For example, phage T5 adsorption to its host 
E. coli can be prevented by a lipoprotein (Llp) that E. coli produces to block the receptor, FhuA. 
E. coli F+ strains can also produce the outer membrane protein TraT encoded by the F plasmid to 
modify the conformation of outer membrane protein A (OmpA) that is recognized by many T-
even like phages (44, 45). Some bacteria can also produce an extracellular matrix to create a barrier 
between phages and surface receptors. This strategy can be easily overcome by phages that 
produce polysaccharide-degrading enzymes such as hydrolases and lyases that destroy the 
extracellular matrix (46, 47).  
 




Figure 1.4: Overview of bacterial defense systems against phage. The schematic diagram 
illustrates anti-phage mechanisms and steps in the phage infection process where they interfere: 
attachment inhibition interferes with phage adsorption, DNA entry blocking interferes with DNA 
injection, restriction modification, clustered regularly interspaced short palindromic repeats and 
CRISPR-associated genes (CIRSPR-Cas), BacteRiophageEXclusion (BREX) all target injected 
DNA and prevent DNA replication. Abortive infection is considered the “last line of defence” and 
can target any post-injection steps. Finally, phage particle assembly can also be interfered. The 
schematic diagram is taken and adapted from the review by Seed and colleagues (42) where 
CRISPR-Cas and BREX were missing in the original figure. The name of each phage replication 
step is shown in italics. The name of each anti-phage defense mechanism is highlighted in red 
boxes. 
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If the first line of defense is unsuccessful and phages have adsorbed to receptors, phage DNA 
injection can be prevented by superinfection exclusion (Sie) systems. Interestingly, Sie systems 
are often encoded by prophages, which can be seen as a part of the host in this context, to avoid 
secondary infection by another phage. Our understanding of Sie systems is limited but it is believed 
that these systems encode membrane-associated or membrane-anchored proteins that interact with 
tape measure proteins of other in-coming phages. Tape measure protein is involved in channel 
formation for DNA passage through the cell surface, and therefore Sie systems act to block phage 
DNA from entering the host cytoplasm (42, 48). 
 
 
Once phage DNA is injected into the host cytoplasm, bacteria can also employ systems such as 
restriction and modification (R-M), CRISPR-Cas or BREX to cleave viral DNA before phage 
genes are copied or expressed. R-M systems are usually comprised of a restriction 
endoribonuclease and a methyltransferase. The restriction endoribonuclease recognizes specific 
nucleotide bases and cleaves DNA into fragments. Host DNA is methylated on specific residues 
and thus can be protected from such cleavage. The invading phage DNA is exposed to both the 
endoribonuclease and methyltransferase at the same time, but due to the higher activity of the 
endoribonuclease, phage DNA is usually cleaved (49). Some phages have evolved to overcome R-
M systems by avoiding endoribonuclease-recognized sequence patterns in their genomes or, such 
as in the case of T4, by replacing cytosine in its genome with hydroxymethylcytosine to mimic the 
effect of methylation by a methyltransferase and avoid endoribonuclease recognition (44). In 
bacteria containing the clustered regularly interspaced short palindromic repeats (CRISPRs) and 
the CRISPR-associated (Cas) genes, phage DNA is destroyed in a more targeted manner akin to 
the immune system. The CRISPR locus consists of short DNA repeats separated by short spacer 
sequences of phage origin and flanked by Cas genes that encode immunization and immunity 
machineries including nucleases, helicases, polymerases, and polynucleotide-binding proteins. 
Upon first entry by a phage, a Cas complex recognizes phage DNA and integrates a novel repeat-
spacer unit at the leader end of the CRISPR locus. This immunizes the bacteria against subsequent 
phage infection. If a phage containing identical or similar sequences to any spacer sequence injects 
its DNA, cognate spacers transcribed into RNAs would help Cas RNA-guided nucleases to locate 
and target the complementary sequences in the invading phage genome, resulting in phage DNA 
degradation (50, 51). More recently, a new system called BacteRiophage EXclusion (BREX) was 
found to also confer bacteria resistance against phages by preventing phage DNA replication and 
Chapter 1 Introduction 
 
 18 
integration into the host genome while methylating the host cell for self/non-self-distinction. 
BREX is different from R-M systems because phage DNA is not cleaved or degraded, however 
the exact mechanism of BREX is still under investigation (52-54). 
 
The later stage of phage particle production and assembly can also be disrupted by bacteria 
containing staphylococcal pathogenicity islands (SaPIs). SaPIs are 15-17 kb mobile pathogenicity 
islands in the staphylococcal genome that are also satellite phages. They require helper phages for 
excision and packaging. To ensure their own progeny production, SaPIs are involved in 
complicated mechanisms that block late gene transcription and particle production of the helper 
phage. These mechanisms include interference with full-size helper phage head formation and 
helper phage DNA packaging (55, 56). 
 
Abortive infection (Abi) is another anti-phage mechanism commonly found in a wide range of 
bacteria, especially lactococci that are often exposed to phage infection during dairy fermentation 
(57). Abi differs from other defense mechanism in the following aspects. First, the infected cell 
does not survive but instead dies or is driven into stasis. This greatly reduces or eliminates the 
production of phage progeny. Therefore, while most of the anti-phage mechanisms described 
above protect single bacteria cells, Abi systems arguably protect the entire population of bacteria 
at the expense of the infected cell. Because of this, abortive infection has been considered a form 
of “altruistic suicide” and the last line of defense. Finally, instead of targeting a specific step in the 
phage life cycle, Abi is a collective concept that encompasses a wide range of different defense 
mechanisms that interfere with earlier post-injection steps during phage proliferation (42). The 
next section will focus on reviewing our current understanding of Abi mechanisms. 
 
2.2 Abortive infection 
Different abortive infection systems have been found to target steps such as DNA replication, gene 
transcription, mRNA translation, genome packing and phage particle assembly. The effect of Abi 
is usually manifested by a reduction in Efficiency of Plating (EOP) and decrease in plaque size 
due to decreased burst size (57). Abi systems have been found in a wide range of bacteria such as 
Escherichia coli, Lactococcus lactis (L. lactis), Bacillus subtilis, Bacillus licheniformis, Shigella 
dysenteriae, Streptococcus pyogenes, Vibrio cholerae and Pectobacterium atrosepticum. In 
particular, more than 20 different kinds of Abi systems have been found on plasmids of lactococci. 
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Lactococcus lactis converts lactose to lactic acid and is extensively used in fermentation, e.g. the 
manufacturing of cheese. The fermentation process is often hindered by phage infection of L. lactis 
and therefore anti-phage mechanisms in L. lactis, especially Abi systems, have been extensively 
studied. The majority of Abi systems in L. lactis involve a single gene, and protein homology 
between different systems is usually low. Genetic and biochemical studies in combination with 
characterization of Abi-resistant L. lactis phages have provided insight into the mode of action of 
a few Abi systems, denoted AbiA-Z. For example, AbiA and AbiK systems, albeit having only 
23% protein identity, were found to abort the same family of phages by preventing phage DNA 
replication, possibly through interference with a phage recombinase. The AbiB system was found 
to allow normal phage DNA replication and transcription but cause drastic decay of mRNAs. The 
mechanism of AbiB on mRNA decay is still unclear, the lack of spontaneously resistant phage 
mutants has limited its study to some extent. The AbiD1 system is active against two highly 
virulent L. lactis phages upon the induction of a certain phage protein, ORF1. AbiD1 interferes 
with a RuvC-like protein, which is an essential protein for phage propagation because it facilitates 
the removal of branched DNA generated during replication (58-60). The AbiZ system, found on 
the same plasmid encoding the AbiA system, could induce early lysis of infected bacteria and 
reduce phage burst size by 100-fold. The mode of action of AbiZ is believed to involve interaction 
with holin to induce premature lysis (61). 
 
Many of the characterized Abi systems have been found to be constitutively expressed prior to 
phage infection. This means that their activity is tightly regulated and inactivated until infection 
by certain phages activate their function. Unsurprisingly, recent discoveries of new Abi systems 
have revealed that some of them function as toxin-antitoxin (TA) systems where a toxin “poison” 
is under the control of an antitoxin “antidote”, such as the discovery of ToxINPa in Pectobacterium 
atrosepticum. The discovery that toxin-antitoxin systems could mediate Abi in bacteria have led 
to re-examination of previously known Abi systems in L. lactis, where AbiQ and AbiE were found 
to function as TA systems as well (62-64). 
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3 ToxINPa – a Type III TA system involved in abortive infection 
3.1. Toxin-antitoxin systems 
Toxin-antitoxin systems are genetic modules that encode a proteinaceous toxin and an antitoxin 
that neutralizes the toxicity of the toxin. The antitoxin is more labile than the toxin; its degradation 
therefore leads to the activation of the toxin. TA systems are encoded in the chromosomes or 
plasmids of a wide range of bacteria and archaea and are proposed to have versatile functionality 
important to bacterial growth and survival (65). 
 
TA systems can be categorized into six types based on the nature of the antitoxin and its mode of 
toxin inhibition. A simplified diagram showing the mechanisms of Type I-VI TA systems are 
shown in Figure 1.5, taken from the review by Hall and colleagues (66). While toxins in all six 
types are proteinaceous in nature, antitoxins of different families could be either proteins or RNAs. 
Type I and Type III antitoxins are RNAs. In the Type I TA system the antitoxin is an antisense 
RNA that binds to the mRNA encoding the toxin and causes its degradation by RNase pre-
translationally. In the Type III TA system, the antitoxin RNA forms pseudoknots and binds directly 
to the toxin to keep it inactive. Type II, IV, V and VI antitoxins are proteins. In the Type II TA 
system, the antitoxin binds directly to and inhibits the toxin. In the Type IV TA system, the 
antitoxin prevents toxin activity by competitively binding to the toxin’s target. In the Type V TA 
system, the antitoxin cleaves the toxin’s mRNA directly. In the Type VI TA system, the antitoxin 
triggers another protein to cleave the toxin (65, 67-69). The mechanisms for the toxicity of toxins 
also varies by family. Type I toxins are believed to interfere with membrane integrity. Type II 
toxins are known to interfere with translation by cleaving mRNAs, cleaving initiator tRNAs, 
binding to ribosomal subunits or phosphorylating elongation factors (67). Type III toxins are 
endoribonucleases that cleave mRNA at specific sites (70). So far Type I, II, III TAs are relatively 
well studied while other TA families are represented by one or a few representatives and so require 
further research. 
 




Figure 1.5: Schematic diagram (taken from the review by Hall and colleagues (66) ) 
summarizing the mode of action of Type I-VI TA systems. In the Type I TA system the antitoxin 
is an antisense RNA that binds to the mRNA encoding the toxin and causes its degradation by 
RNase pre-translationally. In the Type II TA system, the antitoxin binds directly to and inhibits 
the toxin. In the Type III TA system, the antitoxin RNA forms pseudoknots and binds directly to 
the toxin to keep it inactive. In the Type IV TA system, the antitoxin prevents toxin activity by 
competitively binding to the toxin’s target. In the Type V TA system, the antitoxin cleaves the 
toxin’s mRNA directly. In the Type VI TA system, the antitoxin triggers another protein to cleave 
the toxin (65, 67-69). Blue color represents genes, mRNA transcripts and proteins of toxins. 
Orange color represents genes, mRNA transcripts and protein/RNA of antitoxins. SD: Shine-
Dalgarno ribosome binding site.  
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The function of TA systems has been studied in depth over the past two decades. When the first 
TA system was reported in the 1980s, they were found to mediate plasmid maintenance (71). Later 
work by Gerdes and colleagues found that the hok/sok (Type I TA) system also mediated plasmid 
stability. It was proposed that plasmid maintenance by TA systems occurs through post-
segregational killing (72). In this model, if a daughter cell fails to inherit a TA-bearing plasmid, 
antitoxin from remnant TA products carried over after cell division will be degraded with time, 
leading to bacteriostasis or cell death caused by the free toxin (72, 73). This “addiction” of plasmid 
also helps the TA-bearing plasmid outcompete another plasmid of the same incompatibility group 
if both were acquired through conjugation (69, 74). However, even though the function of TA 
systems in plasmid maintenance is solidly established, whether or not it functions through post-
segregational killing is still debatable as there was no strong evidence showing that physiologically 
relevant levels of the Hok toxin was lethal (72, 75). 
 
TA systems also promote bacterial survival under unfavorable conditions through the formation 
of persister cells. For example, the Type II hipA/hipB TA module in E.coli was the first to be 
identified as an important determinant for the formation of persister cells (76). Persister cells are 
a small fraction of cells in a clonal population that enters a reversible dormant state under stress 
conditions such as exposure to antibiotics, starvation, oxidative stress, pH and extreme temperature. 
Under antibiotic stress, persister cells maintain minimum metabolic activity. This protects them 
from elimination since antibiotics mainly target metabolically active cells. Because persistence is 
a transient phenotypic change instead of permanent genotypic change, persister cells regain 
activity once antibiotic stress is alleviated. The exact role that TA systems play in inducing 
persistence is not completely understood. Previous work on persistence-related Type II TA in 
E.coli have suggested that (p)ppGpp controls bacterial persistence by stochastic induction of TA 
activity (77, 78). However, this model has been overturned recently by retraction of related 
publications (79).  
 
TA systems are also involved in biofilm formation in both plant and animal pathogens. Biofilms 
are multispecies consortia embedded in an extracellular matrix that can adhere to biotic and abiotic 
surfaces (80). In animal pathogens, biofilms are often present in chronic infections, such as due to 
Pseudomonas aeruginosa and Mycobacterium tuberculosis, and is crucial for their survival against 
host immunity. In plant pathogens, biofilm formation is important for survival in the plant 
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rhizosphere. TA systems are involved in biofilm formation through both the induction of persister 
cells, which are enriched in biofilm populations compared to planktonic populations (81), and 
regulation of biofilm formation and dispersal (82). For example the E.coli Type II antitoxin MqsA 
binds to and represses the promoter of the Rpos sigma factor gene rpos and the quorum sensing 
regulator gene, csgD, leading to reduced biofilm formation. On the other hand, the cognate toxin 
MqsR interacts with MqsA to alleviate repression and induce biofilm formation (82, 83).  
 
Furthermore, TA systems are also involved in host stress response. For example, the Type II 
system relBE caused significant reduction in the level of translation after cells experienced amino 
acid starvation (84), suggesting a role in reducing global translation level during nutritional stress. 
Work by Wood and colleagues also showed in E.coli, MqsA is not only involved in regulation of 
biofilm formation, but also plays a role in regulating cellular tolerance to antibiotics, oxidative 
stress and acid stress through repression of rpoS (83, 85). In addition, Wood and colleagues have 
also demonstrated that toxins and antitoxins from disparate systems can be interconverted when 
they successfully evolved GhoS (an antitoxin from a Type V system) into a novel toxin (ArT) by 
adding two mutations. ArT dramatically decreased growth in E.coli, but mutations introduced to 
MsqA and ToxI converted these antitoxins from other systems to become antitoxins of ArT (86). 
These results, taken together with the observed redundancy of TA systems (87), prompted Wood 
and colleagues to propose that aiding cellular response to a myriad of stresses is the primary 
function of TA systems (86).  
 
Finally, some TA systems can function as anti-phage mechanisms. For example the Type I TA, 
hok/sok found on E.coli plasmid R1, can protect the host from phage T4 infection by forming pores 
in the membrane (88). Type II TA MazE/F in E.coli was found to confer resistance to phage (89). 
However, it was the discovery of Type III TA complex ToxINPa that provided definite evidence 
that TA systems could provide anti-phage protection through Abi. Subsequently, Type IV TA 
AbiE was also found to have Abi function (62). 
 
3.2. The discovery and characterization of ToxINPa 
ToxINPa was first discovered encoded by pECA1039, a cryptic plasmid of the Gram-negative plant 
pathogen Erwinia carotovora subspecies atroseptica 1039 (Eca 1039, later reclassified as 
Pectobacterium atrosepticum, hence the subscript in ToxINPa). Sequencing of the plasmid revealed 
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an orf, denoted toxN, that encodes a protein (ToxN) with 31% amino acid identity to AbiQ, an Abi 
protein in L.lactis. This ORF was found to be preceded by another gene annotated de novo as toxI. 
Cloning of the region containing toxN and toxI (toxIN) into pBR322 conferred on a related host 
(Eca 1043) resistance against 13 of its 25 phages through Abi. The toxIN locus also conferred on 
E. coli DH5α and Serratia marcescens Db11 resistance against some of their cognate phages. 
Individual expression of toxN and toxI revealed that the product of toxN caused bacteriostasis but 
could be rescued with the expression of the toxI locus, therefore indicating its identity as a TA 
system (64, 90). 
 
Further analysis of the toxIN locus revealed its genetic organization (Figure 1.6a). The toxI gene 
and the toxN gene are co-transcribed as an operon, with toxI sitting upstream of toxN and the two 
genes separated by a rho-independent terminator. The toxI gene is composed of 5.5 direct repeats 
of a 36-nucleotide sequence and transcriptional read-through from toxI to toxN is reduced to 10% 
due to a terminator sequence. Experimental data has shown that 2.5 copies of the toxI repeat are 
sufficient, when transcribed from its native promoter, to inhibit ToxN toxicity and function as an 
anti-phage mechanism (64, 90). The toxI gene encodes non-coding RNA that interacts directly 
with ToxN, albeit being more labile that ToxN. Therefore, the discovery of ToxINPa defined a new 
family of TA systems, designated Type III TA. 
 
Structural studies of ToxINPa revealed that three ToxN proteins, each 19.7-kDa, and three ToxI 
RNA oligomers, each 36-nt, form a heterohexameric, triangular assembly with ToxN proteins 
sitting at the vertices of the triangle and ToxI oligomers forming the sides. The three ToxI RNAs 
are pseudo-continuous and each ToxN protein interacts with two ToxI RNAs, the 3’ terminus of 
one and 5’ terminus of the other. In this complex, each ToxN adopts a globular fold while each 
ToxI forms a hairpin-type pseudoknot (Figure 1.6b) (70). 
 
Biochemical studies of ToxINPa has shown that ToxN is a sequence-specific endoribonuclease and 
cleaves RNAs at AA↓AU sites (70). The full-length precursor ToxI transcript with 5.5 repeats is 
also cleaved by ToxN and experimental data suggests that the ToxINPa complex is dynamic. Fresh, 
unprocessed precursor ToxI is constantly cleaved and displaces the mature ToxI already in the 
ToxINPa complex. This cleavage and assembly is likely associated with the inhibition of ToxN 
toxicity. The dynamic nature of the structure may also give the complex more plasticity in 
responding to external signals (91, 92). 





Figure 1.6: Genetic organization of the toxINPa locus (a) and crystal structure of the ToxINPa 
complex (b). The toxI gene and the toxN gene are co-transcribed as an operon, with toxI sitting 
upstream of toxN and the two genes separated by a rho-independent terminator. The toxI gene is 
composed of 5.5 direct repeats of a 36-nucleotide sequence and transcriptional read-through from 
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toxI to toxN is reduced to 10% due to a terminator sequence. After assembly, the ToxINPa complex 
contains three ToxN proteins, each 19.7-kDa, and three ToxI RNA oligomers, each 36-nt. They 
form a heterohexameric, triangular assembly with ToxN proteins sitting at the vertices of the 
triangle and ToxI oligomers forming the sides. The three ToxI RNAs are pseudo-continuous and 
each ToxN protein interacts with two ToxI RNAs, the 3’ terminus of one and 5’ terminus of the 
other. In this complex, each ToxN adopts a globular fold while each ToxI forms a hairpin-type 
pseudoknot. This figure is reproduced from the research article by Blower and colleagues (70). 
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3.3. Other members of Type III TA 
After characterization of the paradigmatic ToxINPa, attempts were made to find examples of other 
Type III TA systems using structure-based homology searches with ToxN as the model as well as 
using the presence of a transcriptional terminator and tandem array of nucleotide repeats as 
filtering conditions. Hits from the search were further subjected to BLASTp comparison that 
resulted in separation of the hits into three different families which share low amino acid identity 
with each other. Based on a representative from each family, the three Type III TA families were 
named ToxIN (contains the toxINPa locus), CptIN (contains a locus found in Coprococcus 
catus GD/7) and TenpIN (contains a locus found in Photorhabdus luminescens subsp. 
laumondii TT01) where the “I” and “N” represent the antitoxin and toxin components respectively 
(87). Among the total of 125 putative Type III TA systems found in the bioinformatics search, 67 
members belong to the ToxIN family, 33 members belong to the CptIN family and 25 members 
belong to the TenpIN family. In particular, aside from including the TA loci from which they were 
named, the ToxIN family also includes ToxINBt from Bacillus thuringiensis and AbiQ from L. 
lactis. The CptIN family also includes CptINEr from Eubacterium rectale. These Type III TA 
systems are found either on plasmids or chromosomes across a wide range of bacteria (87). Apart 
from differences in their toxin secondary and tertiary structures, cognate antitoxin genes also differ 
in length, number of repeats and sequences both within and between families. So far, the structures 
of ToxINBt and CptINEr have been solved and the structure of AbiQ partially elucidated. Both 
ToxINBt and AbiQ from the ToxIN family adopt a heterohexameric, triangular assembly highly 
similar to that of ToxINPa. In contrast, CptINEr from the CptIN family adopts a heterotetrameric 
conformation where two toxin monomers are joined by two antitoxin RNAs (91, 93). The structure 
of TenpINPl from Photorhabdus luminescens is yet to be reported. 
 
Most of the Type III toxins tested so far, namely toxins of ToxINPa, ToxINBt, AbiQ and TenpIN, 
have been found to act as endoRNases that each recognizes different RNA sequences (91, 94, 95). 
However, the function of these systems is not uniform. While ToxINPa, ToxINBt and CptINEr are 
found to facilitate plasmid addiction, only ToxINPa is thus far able to function as an Abi system in 
the hosts tested (64, 87, 91, 93, 96). AbiQ and TenpINPl have also been found to confer phage-
resistance on the hosts (87, 97). This has led to the debate of whether phage resistance is the main 
function of Type III TA or an evolutionary by-product. At the same time, the structural similarity 
between the ToxIN family members and their different responses to phage infection also presents 
the mystery as to how Abi-mediating Type III TA modules are activated. 
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3.4. Phage interactions with Type III TA 
Members of Type III TA family, especially ToxINPa, AbiQ and TenpIN, have been found to 
facilitate Abi against phages of different families and in different host backgrounds. It is unclear 
why some phages are aborted by Type III TA while others are not and, for those aborted, no 
obvious common features have been found between these phage families. Furthermore, it has been 
observed that phage-aborting Type III TA systems are constitutively expressed, but Abi is only 
activated upon phage assault, through unknown mechanisms. To better define the selectivity and 
specificity of Type III TA-mediated Abi, it is important to study the mechanisms of Abi-activation 
by phages.  
 
Past research on components of the paradigmatic ToxINPa have provided hints as to how this 
complex may be activated by phages. First of all, tracking of ToxNPa has shown that the toxin level 
does not increase during phage infection (90, 98), therefore it is unlikely that phages could activate 
ToxINPa-mediated Abi by increasing ToxNPa transcription or translation. Secondly, phage M1 that 
activates ToxINPa was shown to cause a decrease in cellular ToxIPa by direct or indirect means 
(98). Thirdly, a mutant ToxNPa with decreased ToxNPa-ToxIPa binding was shown to have 
increased Abi capability (92). Therefore, we could hypothesize several ways in which ToxINPa-
mediated Abi activation may occur: 1) a phage product(s) could perturb toxINPa transcription, the 
decrease of which could cause the more labile ToxIPa to be degraded and ToxNPa freed; 2) a phage 
product(s) could interact with ToxIPa to decrease or sequester ToxIPa and lead to ToxNPa activation; 
3) a phage product(s) could also interact with ToxNPa to prevent neutralization by ToxIPa or guide 
ToxNPa towards its targets. In addition, phage infection could also trigger the production of a host 
product(s) or pathway(s) that activates ToxINPa-mediated Abi in ways similar to the three 
described above. Due to its dynamic nature, it is likely that ToxINPa-mediated Abi could be 
activated in any of these ways with different phages and host background. It is also probable that 
ToxINPa-mediated Abi is activated later in the phage infection cycle because normal phage DNA 
accumulation could still be detected after it takes effect (90). 
 
Direct investigation of ToxINPa interaction with phage multiplication steps could only provide 
limited insight into its activation because it is difficult to distinguish between direct targets of 
ToxINPa and downstream effects. To circumvent this limitation, mutant phages have been used to 
reveal candidate phage product involved in Abi activation. If a ToxINPa-sensitive phage is 
propagated in the presence of ToxINPa, spontaneous mutants of the phage that are insensitive to 
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ToxINPa could be selected. Comparison of the wild type and mutant phage could then point to 
product(s) potentially involved in the activation of ToxINPa-mediated Abi.  
 
Past research on ToxINPa-insensitive mutant phages have provided insight into the nature of the 
potential phage product(s) involved. That a phage protein(s) is involved in Abi-activation was 
shown because phage genes whose mutation could cause ToxINPa-insensitivity were predicted or 
proven to be protein-coding. For example ΦM1 of P.atrosepticum was sensitive to ToxINPa but its 
mutants could escape ToxINPa by acquiring mutations in a gene encoding a conserved, highly toxic 
protein (M1-23) of unknown function (98). In the similar AbiQ system, several AbiQ-sensitive 
L.lactis phages could overcome Abi also by mutating different protein-coding genes (99). For 
example, the gene in phage bIL170 encodes a conserved hypothetical protein of unknown function; 
the early gene e19 in phage c2 also produces a conserved protein of unknown function; the gene 
in coliphage 2 produces a protein similar to DNA polymerases; the gene in phage P008 produces 
an essential phage protein. Furthermore, phage protein products are involved in activation of other 
types of TA systems (99). However, none of the phage proteins mentioned above share obvious 
homology with each other, suggesting that the mode of phage interaction with ToxIN systems is 
diverse. 
 
ToxINPa-insensitive mutant phages and their mechanisms of escape have also provided insight into 
phage-host co-evolution. Characterization of the ToxINPa-sensitive phage ΦTE has shown that 
mutants could circumvent the ToxINPa system by duplicating a DNA sequence highly similar to 
that of ToxIPa, allowing it to neutralize ToxNPa and escape. This DNA sequence is present in the 
ToxINPa-sensitive wild type phage genome but expanded in the ToxINPa -insensitive mutant likely 
through strand slippage (100). The expansion enabled the production of full-length pseudo-
antitoxin to neutralize ToxNPa. This example shows that pressure from host anti-phage 
mechanisms could select for expansion in the phage’s genomic content. Aside from ΦTE, some 
insight have also been gained from studying ΦM1 of P.atrosepticum and its M1-23 protein 
involved in activating ToxINPa-mediated Abi. M1-23 was highly toxic, suggesting that activation 
of ToxINPa-mediated Abi may be related to toxicity from phage protein(s). Furthermore, mutated 
M1-23 also co-purified with the host UvrA protein, which is involved in SOS response in bacteria. 
This may imply that SOS response is related to Abi activation. However, in a urvA mutant 
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background, ΦM1 was still aborted by ToxINPa, making the mechanism of Abi activation even 
more elusive (98). 
No other ToxINPa phages and their escape mechanisms have been completely elucidated. 
Therefore, it would be interesting to isolate more phages and their corresponding escape mutants 
to investigate how certain phage product(s) could activate ToxINPa-mediated Abi, how ToxINPa 
insensitivity could be achieved through mutation, and at what cost. 
 
3.5. ToxINPa-sensitive phages of Serratia sp. ATCC 39006 
Serratia sp. ATCC 39006 (S39006) is a Gram-negative, rod-shaped bacterium of the genus 
Serratia. It was first isolated in Salicornia alterniflora from a salt marsh in Cheesequake, New 
Jersey (101) and found to be an opportunistic pathogen of a wide range of plant and animal hosts. 
Recently S39006 has attracted growing research interest because of its ability to secrete secondary 
metabolites such as a carbapenem (102) that could be exploited for future antibiotic development, 
and prodigiosin, a red pigment and member of the prodiginine class of molecules with 
antimicrobial, anticancer, and immunosuppressant properties (103). Furthermore, S39006 has been 
found to adopt different modes of mobility beneficial to nutrition acquisition and virulence, such 
as swimming, swarming and flotation. Because of these characteristics of S39006, extensive 
research has been carried out on regulatory networks in S39006. Recently, the genome of S39006 
has also been fully sequenced and annotated (104).  
 
As a model organism in laboratory where this study was carried out, S39006 is devoid of its own 
Type III TA system and previous isolation of phages infecting S39006 resulted in interesting 
discovery of highly-efficient generalized transducers such as ΦOT8, therefore S39006 was chosen 
as the non-native host to isolate novel phages sensitive to Type III TA systems. S39006 was 
transformed with plasmid-encoded Type III TA systems to test whether these systems have anti-
phage activity. Prior to this study, two highly similar phages of S39006 had been isolated that 
could be aborted by ToxINPa. One of these phages, ΦCHI14, could escape ToxINPa via three 
different routes: mutation of a gene encoding a hypothetical phage protein ORF84; mutation of the 
phage gene asiA encoding the AsiA protein, and deletion of a large genomic region (105). The 
other phage, ΦX20, isolated a year apart from ΦCHI14, could also escape ToxINPa by deleting a 
large genomic region similar to ΦCHI14 (106). The discovery of ΦCHI14 was the first case in 
which three different genetic loci could be independently involved the activation of ToxINPa-
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mediated Abi. Furthermore, the high similarity between ΦCHI14 and ΦX20 and their interaction 
with ToxINPa, (albeit their independent isolation) hints that common themes exist in S39006 
phages’ response to ToxINPa. This could be interesting for further exploration to add new members 
to the diverse repertoire of phage loci involved in ToxINPa sensitivity. However, prior to this study, 
the aforementioned escape loci of S39006 phages had not been studied in depth. 
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4 Aims of this study 
Based on the interesting interactions between ToxINPa and S39006 phages observed in previous 
studies, one aim of this study was to continue using S39006 as the host to isolate new phages from 
the natural environment. Type III TA systems sub-cloned onto plasmids would be introduced into 
S39006 and phages would be tested for sensitivity to Abi. Type III TA-sensitive phages would be 
characterized morphologically, genotypically and biologically. This would test the hypothesis that 
Type III TA-sensitive phages of S39006 all belonged to a small clade of highly similar phages, 
which had already been observed in the case of ΦCHI14 and ΦX20. 
 
After acquiring Type III TA-sensitive S39006 phages, another aim of this study was to identify 
genetic loci involved in their sensitivity by comparing, through whole genome sequencing, wild 
type phages and their “escape” mutants that are no longer aborted by Type III TA systems. This 
would test the hypothesis that common themes exist in S39006 phages’ interaction with Type III 
TA systems, if similar loci from ΦCHI14 and ΦX20 could be found in newly isolated phages. All 
of the Abi-activating loci found in S39006 phages would be characterized in depth to reveal their 
biological function and interaction with Type III TA systems.  
 
Previous work had shown that it was easy to isolate Type III TA-sensitive phages for some hosts 
but difficult for others (Nathalie Goeders, unpublished data; Xinzhe Fang, unpublished data). 
Therefore, the last aim of this study was to test the hypothesis that Type III TA-mediated Abi is 
host dependent. The bacterial surface component that S39006 phages utilize as receptor would be 
investigated. Heterologous expression of this receptor in other bacteria would be attempted to 
expand the host range of these phages and examine their response to Type III TA in new hosts. 
This would provide insight on the role that the host background plays in Type III TA-mediated 
Abi. 
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Chapter 2 - Materials and Methods 
 
1. Media, reagents and solutions 
Media used for bacterial growth are listed in Table 2.1. Antibiotics and other supplements used 
are listed in Table 2.2. Chemical solutions are listed in Table 2.3. Solutions were sterilized by 
autoclaving at 121°C for 20 minutes or were filter sterilized using 0.22 μm filters. 
 
Table 2.1 Media used in this study 
Medium Components per liter 
Luria-broth (LB) 
10 g Bacto tryptone 
5 g Bacto yeast extract 
5 g NaCl 
2×LB 
20 g Bacto tryptone 
10 g Bacto yeast extract 
10 g NaCl 
Luria-broth agar (LBA) LB + 15 g agar 
0.35% top agar/agarose LB + 3.5 g agar/agarose 
0.75% top agar LB + 7.5 g agar 
Tryptone Swarm Agar (TSA) 
10 g Bacto tryptone 
5 g NaCl 
3 g Bacto agar 
Eiken agar 
10 g Tryptone 
8 g NaCl 
2 g Eiken agar 
6 g Sodium citrate 
0.75% Mueller Hinton top agar 
21 g Muller Hinton Broth (Oxoid) + 7.5 g agar 
1 L of Muller Hinton Broth gives: 
2.0 g Beef extract 
17.5 g Casein hydrolysate 
1.5 g Starch 
(pH 7.3 ± 0.1) 
1.7% Mueller Hinton agar 1 g Muller Hinton Broth (Oxoid) + 17 g agar 




Table 2.2 Antibiotics and supplements used in this study 
 
Chemical Abbr. Stock concentration Working concentration  
Antibiotics 
Ampicillin Ap 100 mg/mL in dH2O, store at -20°C 100 μg/mL 
Chloramphenicol Cm 50 mg/mL in EtOH, store at -20°C 50 μg/mL 
Kanamycin Kn 50 mg/mL in dH2O, store at -20°C 50 μg/mL 
Tetracycline Tc 10 mg/mL in EtOH, store at -20°C 10 μg/mL 
Supplements 
2,6-Diaminopimelic acid DAPA 30 mM in dH2O, stored at 4°C 300 μM 
L-arabinose L-ara 20% in dH2O, store at 4°C 0.05% or higher 
D-Glucose Glu 20% in dH2O, store at 4°C 0.2% or higher 
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10 mM Tris-HCL pH 7.4 
10 mM MgSO4 
0.01% Gelatin 
Solution A (per L) 
9.9 mL 1M MnCl2 
49.5 mL 1M CaCl2 
198 mL 50 mM MES 
742.6 mL dH2O 
Solution B (per L) 
9.9 mL 1M MnCl2 
49.5 mL 1M CaCl2 
198 mL 50 mM MES 
300 mL 50% Glycerol 
442.6 mL dH2O 
50× TAE buffer (per L) 
242 g Tris base 
57.1 mL Glacial acetic acid 
100 mL 0.5 M EDTA 
pH 8.0 
Agarose gel (1%) 
1 g Agarose in 100 mL TAE buffer 
4 μl Ethidium Bromide 
Phosphate buffered saline (PBS) 
1 PBS tablets (Oxoid) dissolved in 100 mL dH2O to provide: 
0.8 g NaCl 
0.02 g KCl 
0.115 g Na2HPO4 
0.02 g KH2PO4 
pH 7.3 
MUG assay reaction mix 
In 100 mL PBS: 
400 μg/mL Lysozyme from chicken egg white 
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2. Bacterial strains and culture conditions 
Bacterial strains used in this study and their growth conditions are summarized in Table 2.4. Strains 
were grown either in liquid culture shaking at 215 rpm or on LBA plates. Bacterial growth was 
monitored by measuring optical density at 600 nm (OD600) using a Thermo Scientific Helios Zeta 
spectrophotometer. Overnight cultures were set by inoculating a single colony into 25 mL 
universal tubes containing 10 mL LB and the appropriate antibiotic where required. Overnight 
cultures were grown at the appropriate temperature on a rotating wheel. Stocks of bacterial strains 
were made by mixing 1 mL of overnight culture with 1 mL of 50% glycerol in a CryoTubeTM 
(NUNC) and stored in a -80 °C freezer. 
 
Table 2.4 Bacteria strains used in this study 
 
Strain name Temp. Relevant characteristics Source  
Escherichia coli strains 
DH5α 37 °C 
F– endA1 glnV44 thi-1 recA1 relA1  
gyrA96 deoR nupG purB20 φ80dlacZΔM15  
Δ(lacZYA-argF)U169, hsdR17(rK–mK+), λ– 
Gibco 
CC118 λpir 37 °C 
araD, Δ(ara, leu), ΔlacZ74, phoA20, galK, thi1, 
rspE, rpoB, argE, recA1, λpir 
(107) 
ESS 37 °C β-lactam sensitive indicator strain (108)  
β2163 37 °C (F−) RP4-2-Tc::Mu ΔdapA::(ermpir) KnR EmR (109) 
Serratia strains 




Laboratory strain, referred to as wild type (wt) in text, 
Lac-derivative of ATCC S39006, carbapenem+, 
prodigiosin+ 
(110) 
S39006-R1 30 °C 
ompW mutant of S39006 with Tn-KRCPN1 transposon 
insertion (genotype of Tn-KRCPN1 detailed in Table 2.7) 
This study 
S39006-R4 30 °C 
Spontaneous ompW mutant of S39006 where the peptide 
product is truncated to only 47 amino acid remaining at 




30 °C Wild type (111) 





30 °C Wild type (112) 
Dickeya strains 
Dickeya solani MK10 25 °C Wild type (113) 
Dickeya zeae NCPPB 
3532 
25 °C Wild type (113) 
Dickeya chrysanthemi 
NCPPB 402 
25 °C Wild type (113) 
Dickeya dadantii 3937 25 °C Wild type (114) 
Dickeya dianthicola 
NCPPB 453 
25 °C Wild type (113) 
Dickeya paradisiaca 
NCPPB 2511 
25 °C Wild type (113) 
Dickeya sp. NCPPB 
3274 









25 °C Wild type (117) 
Citrobacter rodentium 
DBS100 
37 °C Wild type (118) 
Pseudomonas 
aeuroginosa PAO1 
37 °C Wild type (119) 
Pantoea agglomerans 
9rz4 




25 °C Wild type (120) 
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3. Phages, phage techniques and assays 
Phages used in this study are summarized in Table 2.5.  
 
 
Table 2.5 Phage strains used in this study 
 
Phage name Relevant characteristics Source  
ΦOT8 Transducing phage infecting S39006 (120) 
ΦCBH8  Wild type This study 
ΦCBH189 Wild type This study 
ΦCHI14 Wild type This study 
ΦX20 Wild type (106) 
ΦCBH8f, i, m, o, p, t, u, x 
“Large deletion” mutants of ΦCBH8, details 
included in Table 3.3 
This study 
ΦCBH8a, l, r 
asiA mutants of ΦCBH8, details included in 
Table 3.3 
This study 
ΦCHI14w asiA mutant of ΦCHI14 with V13G mutation (105) 
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3.1 Isolation and purification of phages from the environment 
Phages ΦCBH8 and ΦCBH189 were isolated from treated sewage effluent collected from the 
sewage treatment plant at Milton, Cambridge. A 5-mL sample of effluent was filter sterilized using 
0.22 μm filters (Millipore) and mixed with 5 mL of 2×LB and 500 μl of S39006 overnight culture. 
After overnight incubation, 1 mL of the enriched culture was treated with 50 μl chloroform and 
subjected to centrifugation at 1,500×g for 5 min. The supernatant was serially diluted, and each 
diluted lysate mixed with 150 μl of S39006 overnight culture and 5 mL of top agarose, and then 
poured as an overlay onto LBA plates. After overnight incubation, any resulting phage plaques 
were examined and further purified by picking with a sterile toothpick into 150 μl of phage buffer. 
The mixture was treated with 20 μl chloroform, centrifuged and the supernatant was serially 
diluted and plated out again. This process was repeated at least 3 times until all the phage plaques 
appeared homogeneous. 
 
3.2 Phage titer determination and lysate preparation 
To prepare a high titer phage lysate, top agarose samples containing near-confluent phage plaques 
were scraped off into glass universal tubes containing 2 mL phage buffer and 500 μl chloroform. 
The mixture was vigorously vortexed and centrifuged at 2,200×g for 20 min at 4 °C. The 
supernatant was then filter sterilized using 0.22 μm filters (Millipore) and stored at 4 °C. To 
measure the titer of the phage lysate, the lysate was serially diluted and 10 μl each dilution was 
mixed with 150 μl of bacterial overnight culture and 5 mL of top agarose, then poured as an overlay 
onto LBA plates. After overnight incubation at the appropriate temperature, the resulting plaques 
were counted to determine the plaque forming units per mL (pfu/mL). 
 
3.3 Efficiency of plating (EOP) assay 
Phage titer on the test and the control strain was measured separately as described in Section 3.2. 
The EOP was calculated by [titer on test strain ÷ titer on control strain]. 
 
3.4 Phage spot test 
An overnight culture of the bacterial host (150 μl) was mixed with 5 mL of top agarose and poured 
onto LBA plates as a seeded top lawn. The top lawn was left on the bench to set, after which the 
phage lysate to be tested was serially diluted and 4 μl of each dilution was spotted on the top lawn 
in order. After the spots had dried, plates were incubated overnight at the appropriate temperature. 
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If the phage could infect the host, completely clear spots could be observed at high concentration 
whereas individual plaques could be observed at low concentration. In contrast, if the phage could 
not infect host, no individual plaques could be observed at lower concentration, but sometimes 
turbid spots were seen at extremely high concentration (neat samples) due to the effect of “lysis 
from without” instead of true replicative infection. 
 
3.5 Phage host range assay 
Colonies of bacteria to be tested was inoculated in 10 mL cultures with appropriate supplements 
if needed and grown overnight at the appropriate temperature. The susceptibility of these bacteria 
to the phage was tested in a standard spot test as described in Section 3.4.  
 
3.6 Phage sensitivity to Type III TA systems 
S39006 was transformed with a plasmid encoding one of the Type III TA systems (ToxINPa, 
ToxINBt, CptINEr or TenpINPl) or one of the frameshifted mutant systems (ToxINPa-FS, ToxINBt-
FS, CptINEr-FS or TenpINPl-FS). The infection of these strains by phages was examined by spot 
tests as described above. If the phage did not form clear spots on the test strain but formed clear 
spots on the cognate control strain, then the phage was considered potentially sensitive to the Type 
III TA system. Sensitivity was further confirmed by testing the EOP of the phage infecting the test 
and control strains. Testing of ΦCBH8 sensitivity to ToxINPa in E.coli DH5a followed the same 
procedure, except for addition of 0.05% L-ara and the appropriate antibiotic to the bacterial 
overnight culture or LBA plates to induce receptor expression and phage adsorption. 
 
3.7 Isolation of ToxINPa escape mutants of ΦCBH8 
A high titer lysate of wild type ΦCBH8 was serially diluted and each dilution was plated out with 
an overnight culture of wild type S39006 as top lawn. After overnight incubation, the plate with 
near-confluent phage plaques was chosen to prepare another sample of a high titer ΦCBH8 lysate. 
This was repeated several times to ensure that spontaneous mutants had enough opportunity to 
arise in the ΦCBH8 lysate. After several wild type ΦCBH8 lysates had been prepared, each lysate 
was serially diluted again, and each dilution plated out again, this time with S39006 containing 
ToxINPa as the host. After overnight incubation, one plaque from each plate containing visible 
plaques was picked and prepared as potential escape mutant lysates. To verify that they were true 
escape mutants, the EOP of these mutants was assessed by plating on S39006 containing ToxINPa 
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or ToxINPa-FS. The EOP of true escape mutants should be close to 1. 
 
3.8 Phage transduction 
Overnight cultures of the donor strain with appropriate chromosomal or plasmid selection marker 
were infected in a top lawn with serial dilutions of the phages to be tested for transduction 
capability. After overnight incubation, phage lysate from the top lawn was harvested as described 
in Section 3.2. To test the transduction ability of a phage, an overnight culture of the recipient 
strain was infected with different MOIs of the phage. The phage-host mixture was kept static at 
room temperature for 20 minutes, followed by 20-minute incubation on the roller wheel at the 
appropriate temperature. The phage-host mixture was then centrifuged, and the cell pellets were 
washed twice with LB. After the second wash, cell pellets were resuspended in 200 µl of LB, 100 
µl of which was then plated onto LBA plates with appropriate antibiotics. Transduction efficiency 
was calculated as [the number of transductants that grew on selection plates ÷ the number of cells 
infected]. If the goal was to use a known transducing phage to transduce chromosomal markers or 
transfer plasmids, then overnight cultures of the recipient strain were infected with the optimal 
MOI of the phage to achieve maximum transduction efficiency. After similar washing and plating 
steps as described above, colonies that arose on selection plates were re-streaked twice. In both 
cases, recipient-only or phage-only controls were also plated out. 
 
3.9 Adsorption assay 
An overnight culture of bacteria was adjusted to OD600 = 1 with LB in a 250 mL flask and infected 
with phages at a MOI of 0.01. The 10 mL phage-bacteria mixture was quickly mixed by vortexing 
and placed in a water bath at the appropriate temperature with shaking at 150 rpm One hundred 
microliters samples were taken at different time points and added to 900 μl of chilled LB to reduce 
re-adsorption. The samples were treated with 50 μl of chloroform and phage titer in the samples 
was determined. Adsorption curves was drawn by plotting the percentage of free phages in the 
culture against time. Where needed, an LB-only sample was infected with phages as a negative 
control. 
 
3.10 One-step burst size assay 
Phage burst size assays were modified from the method described by Petty and colleagues (121). 
In brief, an overnight bacterial culture was used to inoculate fresh LB in a 250 mL conical flask 
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and incubated at the appropriate temperature to mid-exponential phase. Phage samples were then 
added at a MOI of 0.1 and the culture incubated with shaking at 150 rpm at the appropriate 
temperature. One hundred microliter samples were taken at different time points and added to 900 
μl of chilled LB to reduce readsorption. Samples were treated with 50 μl of chloroform and phage 
titer in the samples was determined. The one-step growth curve was drawn by plotting the number 
of phages per initial infection center against time. 
 
3.11 Phage genome extraction 
Phage DNA extraction was modified from the phenol-chloroform protocol described by Sambrook 
and colleagues (122). In a phase-lock gel (PLG) tube (5’ Prime), 450 µl of high titer phage lysate 
was added with 4.5 µl of 1 mg/mL DNase I and 2.5 µl of 10 mg/mL RNase A and incubated at 
37°C for 30 minutes. After incubation, 11.5 µl of 20% SDS and 4.5 µl of 10 mg/mL Proteinase K 
was added into the tube and the mixture was incubated for 30 minutes. DNA in the mixture was 
extracted by adding 500 µl of a Phenol-Chloroform-Isoamyl Alcohol (25:24:1) solution and 
centrifuged at 1500×g for 5 minutes. The supernatant was transferred to a new PLG tube and the 
previous step repeated. In a new PLG tube, the supernatant was added with 500 µl of Chloroform-
Isoamyl Alcohol (24:1) and centrifuged at 1,500×g for 5 minutes. The aqueous phase at the top of 
the PLG tube was transferred into an Eppendorf tube and incubated with 45 µl sodium acetate (3 
mol/L, pH 5.2) and 500 µl of 100% Isopropanol at room temperature for 15 minutes. The mixture 
was then centrifuged at 12,000×g for 20 minutes. The pelleted DNA was washed at least twice 
with 70% ethanol and re-suspended in deionized H2O. 
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4. Recombinant DNA techniques 
All DNA techniques were performed based on standard protocols provided by commercial kit 
manufacturers, unless stated otherwise. Oligonucleotide primers were obtained from Sigma- 
Aldrich (now part of Merck KGaA) and are listed in Table 2.6.  
 
4.1. DNA purification and visualization 
4.1.1. Bacterial plasmid and genomic DNA extractions 
Plasmids used in this study are listed in Table 2.7. Plasmid DNA was purified using the GeneJET 
Plasmid Miniprep Kit and genomic DNA was purified using the Genomic DNA Purification 
Kit, all according to the manufacturers’ instructions. The concentration and purity of extracted 
DNA was measured using the NanoDrop™ 1000 Spectrophotometer. All the above kits and 
instruments were from Thermo Scientific. 
 
4.1.2. Visualization and extraction of DNA from agarose gel 
Agarose gels were prepared as described in Table 2.3. A 6× loading buffer (New England Biolabs) 
was mixed with DNA samples and standard ladders (Bioline) were included for size reference. 
Gels were run in TAE buffer in an electrophoresis gel tank (Bio-Rad) for 1.5 hours at no higher 
than 80V. Gels were visualized using a Gene Genius Bio-Imaging System (Syngene, Synoptics 
Ltd.). To extract DNA from the agarose gel, bands were excised using a scalpel and purified using 
a GeneJET Gel Extraction Kit (Thermo Scientific) according to the manufacturer’s instructions. 
 
 
Table 2.6 Primers used in this study 
 
Primer Sequence (5’-3’) Description 
Restriction 
site 
pBAD33-F CTGTTTCTCCATACCCGTT Forward primer of pBAD33 MCS* - 
pBAD33-R CTCATCCGCCAAAACAG Reverse primer of pBAD33 MCS - 
oMAMV1 GGAATTGATCCGGTGGATG  Sequencing primer of pKRCPN1  - 
oMAMV2 GCATAAAGCTTGCTCAATCAATCAC  Sequencing primer of pKRCPN1  - 




Primer flanking the largest deleted 
region in all of ΦCBH8/ ΦCHI14/ 
ΦX20 mutants combined 
- 
oBH2 TGGATGCGGTGGTGGATATC 
Primer flanking the largest deleted 
region in all of ΦCBH8/ ΦCHI14/ 





Forward cloning primer of LD-ORF8 
into pBAD33 MCS 
Sac I 
oBH51 CCCCAAGCTTTTATCTACACTCTTTA 
Reverse cloning primer of LD-ORF8 





Forward cloning primer of LD-ORF9 





Reverse cloning primer of LD-ORF9 





Forward cloning primer of LD-ORF10 





Reverse cloning primer of LD-ORF10 





Forward cloning primer of LD-ORF11 





Reverse cloning primer of LD-ORF11 





Forward cloning primer of LD-ORF12 





Reverse cloning primer of LD-ORF12 





Forward cloning primer of LD-ORF13 





Reverse cloning primer of LD-ORF13 





Forward cloning primer of LD-ORF14 





Reverse cloning primer of LD-ORF14 





Forward cloning primer of LD-ORF15 
into pBAD33 MCS 
Sac I 






Reverse cloning primer of LD-ORF15 





Forward cloning primer of LD-ORF16 





Reverse cloning primer of LD-ORF16 





Forward cloning primer of LD-ORF17 





Reverse cloning primer of LD-ORF17 





Forward cloning primer of LD-ORF18 





Reverse cloning primer of LD-ORF18 





Forward cloning primer of LD-ORF19 





Reverse cloning primer of LD-ORF19 





Forward cloning primer of LD-ORF20 





Reverse cloning primer of LD-ORF20 
into pBAD33 MCS 
Pst I 
oBH3 CTGTGACTTCGAGCTTAAATCTCC 
Forward primer for asiA gene in 
ΦCBH8/ ΦCHI14 genome 
- 
oBH4 CGCTATATGTCAACAGGCCG 
Reverse primer for asiA gene in 

















Forward cloning primer of tRNA-Leu 





Reverse cloning primer of tRNA-Leu 





Forward cloning primer of tRNA-Arg 
into pBAD33 MCS 
Kpn I 






Reverse cloning primer of tRNA-Arg 





Forward cloning primer of tRNA-Met 





Reverse cloning primer of tRNA-Met 





Forward cloning primer of tRNA-Gly 





Reverse cloning primer of tRNA-Gly 






Forward cloning primer of ompWS39006 





Reverse cloning primer of ompWS39006 
into pBAD33 MCS 
Hind III 
 
*MCS: multiple cloning site 
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Table 2.7 Plasmids used in this study 
 
Plasmid Characteristics Source 
pBAD33 Expression vector, repressed by Glu, induced by L-ara, CmR (123) 
pBR322 Cloning vector, ApR, TcR (124) 
pKRCPN1 Vector used for transposon mutagenesis, tetA, tnp, ‘lacZ, oriR6K, KnR (33) 
pTRB30 Kn resistance cassette cloned into pQE-80L NcoI sites (125) 
pTA46 toxINPa with native promoter in pBR322, ApR (64) 
pTA47 toxINPa-frameshift with native promoter in pBR322, ApR (64) 
pTA114 toxINBt with native promoter in pBR322, ApR (64) 
pFLS63 toxINBt-frameshift with native promoter in pBR322, ApR (126) 
pFLS116 cptINEr with native promoter in pBR322, ApR (126) 
pTW03 cptINEr-frameshift with native promoter in pBR322, ApR (105) 
pFR2 tenpINPl with native promoter in pBR322, ApR (95) 
pFR2 tenpINPl-frameshift with native promoter in pBR322, ApR (95) 
pBAD33::orf8 LD-orf8 with native RBS in pBAD33, CmR This study 
pBAD33::orf9 LD- orf9 with native RBS in pBAD33, CmR This study 
pBAD33::orf10 LD- orf10 with native RBS in pBAD33, CmR This study 
pBAD33::orf11 LD- orf11 with native RBS in pBAD33, CmR This study 
pBAD33::orf12 LD- orf12 with native RBS in pBAD33, CmR This study 
pBAD33::orf13 LD- orf13 with native RBS in pBAD33, CmR This study 
pBAD33::orf14 LD- orf14 with native RBS in pBAD33, CmR This study 
pBAD33::orf15 LD- orf15 with native RBS in pBAD33, CmR This study 
pBAD33::orf16 LD- orf16 with native RBS in pBAD33, CmR This study 
pBAD33::orf17 LD- orf17 with native RBS in pBAD33, CmR This study 
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pBAD33::orf19 LD- orf19 with native RBS in pBAD33, CmR This study 
pBAD33::orf20 LD- orf20 with native RBS in pBAD33, CmR This study 
pBAD33::tRNALeu tRNA-Leu with native RBS in pBAD33, CmR This study 
pBAD33::tRNAArg tRNA-Arg with native RBS in pBAD33, CmR This study 
pBAD33::tRNAMet tRNA-Met with native RBS in pBAD33, CmR This study 
pBAD33::tRNAGly tRNA-Gly with native RBS in pBAD33, CmR This study 
pBAD33::asiA-wt asiA from wild type ΦCBH8 with native RBS in pBAD33, CmR This study 
pBAD33::asiA-CBH8a asiA from ΦCBH8a with native RBS in pBAD33, CmR This study 
pBAD33::asiA-CHI14w asiA from ΦCHI14 with native RBS in pBAD33, CmR This study 
pBAD33::ompW Wild type ompWS39006 with native RBS in pBAD33, CmR This study 
pTA104 toxINPa promoter-lacZ fusion, pRW50 based, TcR (64) 
 
Notes: ApR - ampicillin resistance; TcR – tetracycline resistance; CmR – chloramphenicol resistance; KnR – kanamycin 
resistance; RBS - Ribosome-binding site 
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4.1.3. Purification of DNA from enzymatic reactions 
After enzymatic reactions such as PCR and restriction digestion, DNA was purified and extracted 
using the GeneJET PCR Purification Kit (Thermo Scientific) according to the manufacturer’s 
instructions. 
 
4.2. DNA manipulation 
4.2.1. Polymerase chain reaction (PCR) 
PCR reactions were performed using Phusion® High-Fidelity DNA Polymerase (New England 
Biolabs). Reactions were carried out in an Applied Biosystems Veriti Thermal Cycler, according 
to the manufacturer’s instructions. Annealing temperatures were adjusted according to specific 
primer pairs and extension times were calculated by the estimated extension speed of 15-30 
seconds per kb. PCR could be carried out using bacterial colonies (“colony PCR”) where colonies 
were picked using a sterile toothpick and added directly to the reaction mixture. An example 
reaction set-up is shown below: 
 
Reaction mixture: 
Component 20 µl Reaction Final Concentration 
Nuclease-free water to 20 µl  
5× Phusion HF or GC Buffer 4 µl 1× 
10 mM dNTPs 0.4 µl 200 µM 
10 µM Forward Primer 1 µl 0.5 µM 
10 µM Reverse Primer 1 µl 0.5 µM 
Template DNA variable < 250 ng 
Phusion DNA Polymerase 0.2 µl 1.0 units/50 µl PCR 
 
Program set-up: (Initial denaturation could be extended to 10 min if used for colony PCR) 
Step Temp Time 







15-30 seconds per kb 
Final Extension 72°C 5-10 minutes 
Hold 4-10°C  
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4.2.2. Restriction digestion 
Digestion of DNA using restriction enzymes (New England Biolabs) was carried out according to 
the manufacturer’s instructions. An example reaction set-up is shown below. Additional enzymes 
could be used if digesting phage or bacteria genomic DNA. 
 
 
 Component  Volume (μl) 
DNA <1μg 
Enzyme 1-2 





Ligation of digested DNA was performed using T4 DNA ligase (New England Biolabs or Thermo 
Scientific), according to the manufacturers’ instructions. The amount of insert and vector DNA to 




Sequencing of plasmid and amplicon DNA was performed using the LightRun Sanger Sequencing 
service at GATC Biotech (now a Eurofins Genomics Company).  
 
4.2.5. Random transposon mutagenesis to select for phage resistant S39006 
An overnight culture of the donor strain (E. coli β2163) was grown at 37°C in LB supplemented 
with Diaminopimelic acid (DAPA) and appropriate antibiotics. The overnight of the donor strain 
containing the transposon pKRCPN1 (33) was mixed with the overnight of the recipient strain 
(S39006) in a 1:3 ratio and 30 μl of the mixture was spotted onto LBA plates supplemented with 
DAPA, but no antibiotic. The mixture was incubated overnight at an appropriate temperature for 
the recipient strain. The spot containing the mixed culture was then scraped off LBA and re-
suspended in sterile LB and spread out onto LBA plates without DAPA but with kanamycin and 
high titer phage lysate to select for recipient strains that had simultaneously obtained the 
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transposon and became phage resistant. 
 
4.2.6. Replicon cloning 
Replicon cloning was carried as described by Monson and colleagues (33) to identify the insertion 
position of the transposon Tn-KRCPN1. Genomic DNA of phage-resistant transposon mutants 
was extracted and digested with the restriction enzyme EcoR V that does not cut within the 
transposon. Digested DNA was purified and subjected to self-ligation. The ligation mixture was 
used to transform E.coli CC118λpir and plated onto LBA containing kanamycin. Replicon DNA 
from successful transformants was extracted and the location of Tn-KRCPN1 was identified by 
sequencing using oMAMV1 or oMAMV2 primers. 
 
4.3. Bacterial cell transformation 
4.3.1. Preparation of competent cells for heat shock transformation 
Overnight cultures of bacterial cells were used to inoculate 25 mL of LB medium containing 15 
mM MgCl2 for an OD600 of 0.05. Cells were grown at appropriate temperature to mid-exponential 
phase and then chilled on ice for 60 minutes. Cells were harvested by centrifugation at 4500×g for 
10 minutes at 4°C and re-suspended in 10 mL of chilled Solution A. Cell were left on ice for 
another 20 minutes before being harvested by centrifugation as previously. Finally, cells were re-
suspended in 1 mL of chilled Solution B and can be used for transformation or storage at -80 °C. 
 
4.3.2. Preparation of competent cells for electroporation  
Overnight cultures of bacterial cells were used to inoculate 25 mL of LB medium for an OD600 of 
0.05. Cells were grown to mid-exponential phase, chilled on ice for 30 min and then pelleted by 
centrifugation at 4500×g for 10 minutes at 4°C and washed in 10 mL sterile H2O pre-chilled on 
ice. The centrifugation and wash step was repeated, after which the cells were pelleted again and 
resuspended in chilled 10% glycerol. This wash and centrifugation step was repeated once and 
cells were finally re-suspended in 1 mL of chilled 10% glycerol, ready for transformation or 
storage at -80 °C. 
 
4.3.3. Transformation of competent cells by heat shock  
Approximately 100 ng of DNA were added to 50 μl of competent cells in an Eppendorf tube and 
incubated on ice for 20-30 minutes. The bottom 1/2 to 2/3 of the tube was then placed in a heat 
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block for 2 minutes at 42 °C for heat shock. The tube was then put back on ice for 2 minutes and 
900 μl of LB was added. The cells were allowed to recover at appropriate temperature for 1 hour 
before plating out onto LBA plates with the appropriate antibiotic and incubated overnight. 
 
4.3.4. Transformation of competent cells by electroporation  
Fifty microliters of competent cells were added to approximately 50 ng of DNA in an 
electroporation cuvette on ice. Electroporation was carried out using a Bio-Rad Gene Pulser at 200 
Ω, 2.5 kV and 25 μFd. Immediately after pulsing, the cells were supplemented with 1 mL of LB 
and allowed to recover at the appropriate temperature before plating out onto LBA plates with the 
appropriate antibiotic, then incubated overnight. 
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5. Protein expression and toxicity assays 
5.1. Protein expression and toxicity assays 
Genes to be tested were cloned into the multiple cloning site of the L-ara inducible pBAD33 vector 
using a standard restriction digestion method described in Section 4.2. Primers used for 
amplification of the genes are listed in Table 2.6. After successful cloning, recombinant plasmids 
were introduced into S39006 or other hosts by chemical or heat shock transformation. Growth 
curves were carried out to measure the effect of the cloned gene products in bacteria. In brief, 
overnight cultures of bacterial cells were used to inoculate 25 mL of LB medium supplemented 
with the appropriate antibiotic for an OD600 of 0.05. Cells were grown in a water bath with shaking 
at the appropriate temperature to early-exponential phase and gene expression was induced by 
adding 0.05% or 0.1% L-ara (or higher if needed). Samples were taken at regular intervals and the 
OD600 of samples was measured until the culture reached stationary phase. Where required, the 
viable count (colony forming units; cfu) of samples was also measured by plating serially diluted 
cultures on LBA plates supplemented with the appropriate antibiotics. The morphology of cells in 
the cultures was also monitored, if necessary, by phase-contrast microscopy described in Section 
6.2. 
 
5.2. Measurement of ToxINPa promoter activity in the presence of AsiA 
E.coli DH5a cells transformed with plasmids pTA104 (ToxINPa promoter-lacZ fusion cloned into 
pRW50 (64)) or pBAD33::asiA were used to inoculate 25 mL of LB medium supplemented with 
tetracycline and chloramphenicol to an OD600 of 0.05. Cells were grown in a water bath with 
shaking at 37°C until early-exponential phase. AsiA expression was induced by adding 0.05% L-
ara and samples were taken every 2 hours, the OD600 was recorded and β-galactosidase activity 
measured in a MUG assay. MUG is the fluorogenic substrate 4-Methylumbelliferyl beta-D-
galactoside, which emits fluorescence upon cleavage by β-galactosidase. In brief, 10 μl of culture 
was transferred to a 96-well plate and frozen immediately at -80°C. Samples were thawed at room 
temperature and freeze-thawed again to thoroughly lyse the cells. After the final thaw, 100 μl of 
MUG reaction mix (Table 2.3) was added to each well and samples mixed quickly. Fluorescence 
was detected in a SpectraMax Gemini XPS fluorescence microplate reader (Molecular Devices) 
as relative light units per second (RLU/s) using the following settings: excitation 360 nm, emission 
450 nm, read intervals 30 seconds/min for 20 min, temperature 37°C. β-galactosidase activity was 
arbitrarily expressed as RLU/s/mL/OD600. 
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6. Imaging techniques 
6.1. Transmission Electron Microscopy (TEM) 
Transmission Electron Microscopy (TEM) images of phages were taken on a Tecnai G2 TEM 
(Thermo Scientific) at the Multi-Imaging Center, University of Cambridge. Sample grids were 
prepared by adding 10 μl of high titer phage lysate onto a charged copper grid for 10 min. The 
grids were then washed with dH2O twice before being stained with 2% phosphotungstic acid (PTA) 
neutralized with potassium hydroxide (KOH). The accelerating voltage was 120.0 kV and the 
direct magnification used to image phages was 25,000×. Measurement of phage dimensions was 
carried out in ImageJ (NIH). 
 
6.2. Phase contrast microscopy 
Phase contrast microscopy images were obtained from 1 μl of bacterial samples from liquid culture 
taken during a growth curve. Imaging was carried out using an Olympus BX-51 microscope with 
a 100× oil-immersion lens. 
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7. OmpW phenotypic assays 
7.1. Isolation of spontaneous phage-resistant mutant strains of S39006  
Isolation of spontaneous phage-resistant mutants was carried out as described previously (127). In 
brief, an overnight culture of wild type S39006 was used to inoculate 5 mL of LB and the culture 
was grown until OD600=0.5. Following this, the phage lysate was added to achieve a MOI of 1. 
The phage-host culture was incubated for a further 24 h before 100 µl of the original or diluted 
culture was plated onto LBA and incubated for 48 h. Five colonies were picked from each sample, 
re-streaked twice onto fresh LBA plates before being tested for phage resistance in a spot test. 
 
7.2. Secondary metabolite secretion 
Prodigiosin 
Prodigiosin production was measured as described previously (116). Cells in 1 mL of bacterial 
culture were pelleted by centrifugation at 13,000 rpm for 10 min. The pellets were re-suspended 
in 1 mL of acidified ethanol and then vortexed for 5 sec. The cells were pelleted again by 
centrifugation and 900 μl of supernatant was transferred to a 1 mL cuvette. Prodigiosin was 
measured by absorbance at 534 nm using a Helios Zeta spectrophotometer (Thermo Scientific). 




Carbapenem production was measured by comparing the zone of inhibition formed on a top lawn 
of the carbapenem-sensitive E. coli strain ESS. In brief, overnight cultures of the control and test 
strains of S39006 were adjusted to OD600=1 and 3 μl of each strain was spotted on a 0.75% top 
agar lawn of ESS on the same LBA plate. After overnight incubation at 30°C, the sizes of the halos 
due to the carbapenem inhibition were compared. 
 
N-butanoyl-L-homoserine lactone (BHL) 
BHL production was measured by spotting 3 μl of OD600=1 adjusted overnight cultures of control 
and test strains of S39006 onto an indicator plate. To prepare a BHL indicator plate, 100 μl of the 
Serratia biosensor strain SP19 was made in a 0.75% top agar lawn on an LBA plate. BHL was 
detected by the production of a red-orange halo by SP19 around the control and test strain colonies 
(128). 
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7.3. Swimming and swarming motility assays 
Overnight cultures of test and control strains of S39006 were adjusted to OD600=0.2 for swimming 
motility and OD600=1 for swarming motility assays. Three microliters of the cultures were spotted 
onto test plates. For swimming motility, tryptone swarm agar (TSA) plates were used and 
incubated at 30°C for 16 hours. For swarming motility, Eiken agar plates were used and incubated 
at 30°C for 36 hours. Halo sizes were examined to compare the level of motility. 
 
7.4. Stress tolerance assays 
Overnight cultures of test and control strains of S39006 were adjusted to OD600=1 and serially 
diluted to 10-6. Ten microliters of each dilution were spotted sequentially on LBA plates 
supplemented with 2.5% NaCl, 2.5% EtOH or 0.1% SDS (129). After incubation at 30°C for 48 
hours, the numbers of colonies were compared for each strain. For susceptibility to H2O2, test and 
control strains of S39006 were each made in a seeded top lawn over LBA plates. Fifteen microliters 
of 3% H2O2 was spotted onto a paper disk and placed on the top lawns. After incubation at 30°C 
for 24 hours, the diameter of inhibition for each strain was measured to compare susceptibility 
(130). 
 
7.5. Antibiotic susceptibility assays 
Antibiotic susceptibility of test or control strains of S39006 was tested using the disk-diffusion 
agar method. In brief, overnight cultures of test or control strains of S39006 were made into top 
lawns with 0.75% Muller Hinton top agar on 1.7% Mueller Hinton agar plates. Commercially 
available antimicrobial susceptibility disks (Bio-Rad) with standard minimal inhibition 
concentration (MIC) were placed on the top lawns and plates were incubated at 30°C for 24 hours. 
The diameter of clearing zone formed by antibiotic inhibition was measured and the inhibition 
ratio of an antibiotic was calculated as [diameter formed on wild type S39006 ÷ diameter formed 
on mutant S39006]. 
 
7.6. Virulence assays 
Potato infection assay 
S39006 virulence in potatoes was assessed as described previously (131). Maris Piper potatoes 
were inoculated with 1×106 cfu of wild type or mutant S39006 using a clean pipette tip and the 
point of inoculation was sealed with vacuum grease. The inoculated potatoes were wrapped in wet 
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tissue paper and cling film before incubation at 30°C. At day 2,3 and 4 of incubation, rotted potato 
tissue was extracted, weighed and compared. 
 
Caenorhabditis elegans (C. elegans) infection assay 
S39006 strains to be tested or the control strain E.coli OP50 were spotted (10 μl ) onto NGM agar 
in a small Petri dish. After overnight incubation at the appropriate temperature, 50 C. elegans 
DH26 worms synchronized to the L4 stage were picked and added to each bacterial spot. Following 
overnight incubation at 25°C, the worms were observed under a Stereo Microscope (Leica) and 
live worms counted. Worms were considered dead if they were no longer responsive to touch. 
Incubation and counting were repeated daily until all worms had died.  
  




8.1. Phage whole genome sequencing 
The genomes of phages were sequenced using the Illumina MiSeq and HiSeq 2500 platforms at 
MicrobesNG. Contigs were assembled using Genomic Sequencer de novo assembler (Roche) or 
SPAdes. The wild type sequences had coverage ranging from 57× to 100× of the full genome while 
the escape phage sequences had coverage ranging from 45× to 150×. 
 
8.2. Phage genome annotation 
Phage genome open reading frames (ORFs) were identified using the gene prediction tools 
GeneMark.hmm (132) and Glimmer (133) with default setting for prokaryotic genomes. ORFs 
were annotated by searching for homologs using BLASTp (NCBI) searches or i-TASSER (134). 
The program tRNAScan-SE (135) was used to identify phage tRNA genes and ARAGORN (136) 
was used to predict host tRNA genes. The GC content of phage genomes was calculated using 
Artemis (Wellcome Sanger Institute). 
 
8.3. DNA alignment and homology search 
Alignment of phage whole genomes was carried out using ACT (Wellcome Sanger Institute) and 
BLASTn (NCBI). Circular representation of phage genomes was drawn using DNAPlotter 
(Wellcome Sanger Institute). Pairwise alignment of shorter DNA fragments was carried out using 
EMBOSS Water at default settings. Search for homologous genes was carried out using BLASTn 
at default settings.  
 
8.4. Protein alignment and homology search 
Alignment of protein sequences was carried out using BLASTp and EMBOSS Needle at default 
settings. Protein structure and function prediction was also carried out using i-TASSER at default 
settings. Protein structure visualization was carried out using Swiss-PdbViewer. 
 
8.5. Promoter prediction 
Promoter and potential binding sites for regulatory proteins of the ompW gene was predicted using 
the online prokaryotic promoter prediction software BPROM (Softberry) at default settings. 
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8.6. Codon usage analysis 
The codon usage of the phages was analyzed using Artemis by combining all of the ORFs into one 
entity. The codon usage of bacterial hosts was analyzed by the online tool Codon Usage 
(http://www.bioinformatics.org/) at default settings. 
 
8.7. Phylogenetic analysis 
Phylogenetic analysis of phages was based on similarities of the major capsid protein (MCP). The 
phylogenetic tree was constructed using Phylogeny.fr (137, 138) at default settings. 
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Chapter 3 - S39006 phages ΦCBH8 and 




In the natural environment, bacteria are under constant threat of infection from phages. This drives 
them into an “evolutionary arms race” with phages where both parties involved have come up with 
mechanisms to ensure continued defense or attack. From the bacterial side (Figure 1.4), 
mechanisms such as prevention of adsorption, blocking of DNA injection, cleavage of injected 
DNA via CRISPR-Cas/BREX/restriction modification, and finally, abortive infection (Abi) have 
been found in evolutionarily distinct bacteria species (44, 54).  
 
Abi, the anti-phage mechanism that causes “altruistic suicide” by bacteria, thereby reducing or 
eliminating the number of phage progeny produced, occurs via distinct mechanisms in different 
bacteria. Recently, Abi has been found to be mediated by Type III TA members ToxINPa and 
TenpINPl (64, 87, 139). Despite increasing knowledge of Type III TA structures and biochemistry 
(especially for ToxINPa) over the years, limited understanding has been gained regarding the 
interaction of Type III TA systems with phages. Isolation of novel phages from the environment 
and examination of their interaction with Type III TA systems has shown that only a small 
proportion of phages could activate Abi mediated by ToxINPa and TenpINPl. Some of these phages 
also produced “escape mutants” that are insensitive to ToxINPa, and studies of these mutants have 
revealed interesting information on how they could activate or escape from ToxINPa-mediated Abi. 
For example, two ToxINPa-sensitive phages, ΦM1 and ΦTE, were isolated against P. atrosepticum, 
the native host in which ToxINPa was discovered. ΦM1 encodes a hypothetical protein M1-23 that 
is believed to be involved in the activation of Abi because different ToxINPa-insensitive mutants 
of ΦM1 were found to have mutations in the orf encoding the M1-23 protein (98). However, 
attempts to express and purify M1-23 were unsuccessful due to its high level of toxicity, therefore 
the exact mechanism of how ΦM1 activates ToxINPa-mediated Abi through M1-23 is unclear. 
ΦTE also evolved to produce ToxINPa-insensitive mutants, which contained several copies of a 
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DNA sequence highly similar to that of ToxIPa, allowing it to neutralize ToxNPa and escape (140). 
However how ΦTE directly activated Abi is also unclear. 
 
Isolation of ToxINPa-sensitive phages using the native host P. atrosepticum provided limited 
insight into phage interaction with Type III TA systems, therefore other hosts were employed to 
test whether Type III TA systems are active in non-native bacteria hosts, and to find novel phages 
that are sensitive. S39006 is devoid of its own Type III TA system and previous isolation of phages 
infecting S39006 resulted in interesting discovery of highly-efficient generalized transducers such 
as ΦOT8, therefore S39006 was chosen as the non-native host to study Type III TA systems. 
Between 2013 and 2014, two M.Phil. students have independently introduced plasmid-encoded 
Type III TA systems into S39006 and isolated two ToxINPa and TenpINPl-sensitive phages. This 
serves as proof of principle that Type III TA systems can function to abort phages in the non-native 
host S39006.These phages, isolated two years apart, shared extremely high genome sequence 
identity and shared the same genetic loci that were mutated in their cognate escape mutants (105, 
106). However, these escape loci have not been characterized in detail, and no other ToxINPa-
sensitive S39006 phages have been isolated since then. Therefore, it is important to try to isolate 
novel S39006 phages from the natural environment.  
 
The study described in this chapter aims at isolating and characterizing novel S39006 phages that 
are sensitive to Type III TA systems. S39006 phages will be tested for their EOP when infecting 
strains containing Type III TA systems and those that are aborted will be chosen for further 
characterization mainly through whole genome sequencing. Characterization of these Abi-
activating phages would enable us to test the hypothesis that these phages are constrained to a 
small clade of highly similar phages or demonstrate that more distinct phages could be found. 
Identification of loci altered in “escape mutants” of these phages would also enable us to determine 
whether similar loci would repeatedly occur, or novel loci could be discovered. This information 
might point us towards target(s) to focus on for in-depth studies of how these phage loci are 
involved in Abi-activation. 
 
2. ΦCBH8 and ΦCBH189 activate Abi mediated by ToxINPa and TenpINPl 
From October 2014 to May 2015, a total of 175 phages were isolated from the natural environment 
by enrichment methods using wild type S39006 as the host. These phages were tested for their 
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ability to activate Abi mediated by Type III TA members – ToxINPa, ToxINBt, CptINEr and 
TenpINPl. For example, to test phage sensitivity to ToxINPa, the wild type S39006 was transformed 
with a plasmid (pTA46) encoding ToxINPa (64). As control, the wild type S39006 was also 
transformed with a plasmid (pTA47) encoding an inactive version of ToxINPa caused by a toxN 
frameshift mutation, denoted ToxINPa-FS. Phages to be tested were spotted or plated out in full on 
a top lawn of S39006 containing either ToxINPa or ToxINPa-FS. The efficiency of plating (EOP) 
was calculated as the titer of the phage grown on the ToxINPa-containing strain divided by the titer 
of the phage grown on the ToxINPa-FS-containing strain. Where the EOP was less than 10-2, the 
phage was considered to activate Abi mediated by ToxINPa; in other words, “aborted” by ToxINPa. 
In a similar way, phage sensitivity to other Type III systems were tested, using wild type and 
frameshift mutants of the corresponding TA systems. 
 
In the initial assays, two phages, named ΦCBH8 and ΦCBH189, both showed sensitivity to 
ToxINPa and TenpINPl. As shown in Figure 3.1a, when ΦCBH8 and ΦCBH189 were serially diluted 
and spotted on ToxINPa-FS or TenpINPl-FS, the phages were able to form clear spots, indicating 
complete lysis. This is expected as the frameshifted versions of these toxins have lost their activity. 
In contrast, when ΦCBH8 and ΦCBH189 were serially diluted and spotted on ToxINPa or TenpINPl, 
no clear spots were observed. The turbid spots observed at low dilution factor (high phage titer) is 
a result of “lysis from without” caused by high concentration of phages outside bacterial cells 
instead of lysis caused by productive phage lytic infection. This result indicates that ΦCBH8 and 
ΦCBH189 are unable to propagate in the presence of ToxINPa or TenpINPl because they have been 
aborted. In addition to spot tests, plating serially diluted ΦCBH8 and ΦCBH189 in full on an entire 
top lawn and calculation of their EOP also confirmed that these phages were aborted by ToxINPa 
and TenpINPl. The EOP of ΦCBH8 and ΦCBH189 is shown in Table 3.1. Consistent with 
previously characterized ΦCHI14 and ΦX20, ΦCBH8 was aborted by ToxINPa to a similar degree 
and produced spontaneous “escape mutants” that became insensitive to ToxINPa. ΦCBH8 was also 
strongly aborted by TenpINPl but did not produce any detectable spontaneous escape mutants. On 
the contrary, ΦCBH189 was strongly aborted by both ToxINPa and TenpINPl but failed to produce 
any escape mutants with either system Figure 3.1b. No phages tested have shown sensitivity to 
ToxINBt or CptINEr.  
 
 














Table 3.1 EOPa of S39006 phages with ToxINPa and TenpINPl 
 
Phage name EOP with ToxINPa EOP with TenpINPl 
ΦCBH8 8.0 × 10−6 < 1.0 ×10-9 
ΦCBH189 < 1.0 ×10-9 < 1.0× 10-9 
ΦCHI14 2.0 ×10-7 < 1.0 ×10-9 
ΦX20 2.8 × 10-8 < 1.0 ×10-9 
 
aEOP = phage titer on test strain / phage titer on control strain.  
Test strain: S39006 expressing ToxINPa or TenpINPl.  
Control strain: S39006 expressing ToxINPa-FS or TenpINPl –FS.  
EOP is represented as < 1.0 ×10-9 when the phage is strongly aborted and fails to produce any 
observable escape mutants. 
 





Figure 3.1 (figure legend provided overleaf): ΦCBH8 and ΦCBH189 infecting S39006 
containing ToxINPa or TenpINPl.  
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Figure 3.1: ΦCBH8 and ΦCBH189 infecting S39006 containing ToxINPa or TenpINPl.  
(a) Spot tests of ΦCBH8 and ΦCBH189: when ΦCBH8 and ΦCBH189 were serially diluted and 
spotted on ToxINPa-FS and TenpINPl-FS (top row), the phages were able to form clear spots, 
indicating complete lysis. When ΦCBH8 and ΦCBH189 were serially diluted and spotted on 
ToxINPa or TenpINPl (bottom row), no clear spots were observed. The turbid spots observed at low 
dilution factor (high phage titer) are due to “lysis from without” instead of productive phage lytic 
infection. (b) Plaque formation of ΦCBH8 and ΦCBH189: when ΦCBH8 and ΦCBH189 were 
serially diluted and plated as entire top lawns, both could form clear, round plaques on ToxINPa-
FS and TenpINPl-FS when the phage lysates were sufficiently diluted (10-6). However only 
ΦCBH8 was able to produce plaques of “spontaneous escape” mutants in the presence of ToxINPa 
when high titer non-diluted phage lysate was used. No mutants were observed when high titer 
ΦCBH8 was plated on TenpINPl, or when high titer ΦCBH189 was plated on either ToxINPa or 
TenpINPl. Scale bars represent 2 mm. For both ΦCBH8 and ΦCBH189, the non-diluted phage 
lysate used in (a) and (b) had a titer of ~1010 pfu/mL. 
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3 ΦCBH8 and ΦCBH189 define a new genus of T4-like phages 
The fact that ΦCBH8 and ΦCBH189 are both sensitive to ToxINPa and TenpINPl, but demonstrated 
differences in their ability to circumvent the systems made them interesting subjects for further 
characterization and comparison. For both ΦCBH8 and ΦCBH189, their morphology, genomic 
content and similarity with other phages were investigated. 
 
3.1 ΦCBH8 and ΦCBH189 are phages of the Myoviridae Family 
In order to obtain high resolution Transmission Electron Microscopy (TEM) images of ΦCBH8 
and ΦCBH189, high titer phages were stained with PTA (see Section 6.1, Chapter 2). As shown 
in Figure 3.2, both phages have polyhedron heads, tails and tail fibers. Furthermore, the tails of 
both phages have also been captured in a contracted state. This provides clear evidence that 
ΦCBH8 and ΦCBH189 belong to the Myoviridae family of the order Caudovirales, as seen with 
ΦCHI14 and ΦX20. 
 
Detailed measurement of ΦCBH8 showed that ΦCBH8 has a head width of 84 nm, head length of 
108 nm, extended tail length of 113 nm, extended tail width of 18 nm, while ΦCBH189 has a head 
width of 78 nm, head length of 110 nm, extended tail length of 110 nm, extended tail width of 24 
nm. These measurements indicate that ΦCBH8 and ΦCBH189 are similar in size to ΦCHI14 and 
ΦX20, also phage T4. The large size of the phage particles can be an indication of large genome 
size, but since phage morphology could only provide limited information, ΦCBH8 and ΦCBH189 
were then subjected to whole genome sequencing. 
 
3.2 Whole genome sequencing of ΦCBH8 and ΦCBH189 
Results from whole genome sequencing showed that ΦCBH8 has a genome size of 171,151 bp, 
with a GC content of 38.74%, much lower than the host GC content of 49.24%. ΦCBH8 has 275 
predicted open reading frames (ORFs) that are predicted to encode proteins and 17 tRNA genes. 
A full list of all ORFs, tRNAs and their predicted function can be found in Appendix I. Of the 275 
protein-coding ORFs, 18% are predicted to encode structural proteins or proteins involved in 
phage assembly while 56% encode hypothetical proteins with no known function. Compared to 
ΦCBH8, ΦCBH189 has a slightly larger genome size of 172,248 b.p., with a GC content of 38.72%. 
ΦCBH189 has 276 ORFs that are predicted to encode proteins and encodes for 15 tRNAs. A full 
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list of all ORFs and their predicted function can be found in Appendix II. Of the 276 protein-





Figure 3.2: (a) TEM images of ΦCBH8 with extended tail (left) and contracted tail (right). 
(b)TEM images of ΦCBH189 with extended tail (left) and contracted tail (right). 
Recognizable phage structures are pointed out with arrows. Scale bars represent 100 nm. 
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assembly while 54% encode hypothetical proteins with no known function. For both phages, the 
remaining ORFs with known function encode for proteins predicted to be involved in DNA 
replication, metabolism and other regulatory aspects of phage propagation. 
 
The genomic composition and arrangement of ΦCBH8 and ΦCBH189 were further analyzed by 
plotting ORFs in a circular representation. As shown in Figure 3.3, ΦCBH8 and ΦCBH189 have 
ORFs located on both strands, with the forward strand (arbitrarily assigned) carrying all of the 
tRNA genes, the majority of hypothetical proteins, proteins involved in DNA/RNA 
replication/metabolism, other regulatory proteins, and a small fraction of structural proteins. These 
ORFs are interspersed on the forward strand except for the region positioned between 
approximately 50 kb to 75 kb where ORFs encoding hypothetical proteins are more concentrated. 
The reverse strand encodes the majority of structural proteins clustered together in three different 
regions of the genome. The above genomic organization is shared in ΦCBH8 and ΦCBH189. 
 
3.3 ΦCBH8 and ΦCBH189 represent a new species and genus of T4-like phages 
To investigate the relationship between ΦCBH8, ΦCBH189 and other phages whose genomes 
have been sequenced, a nucleotide BLAST search was conducted to look for phages with high 
whole-genome identity with ΦCBH8 and ΦCBH189. Unsurprisingly, ΦCHI14 and ΦX20 were 
top hits and an E.coli phage EcS1 came in third. As expected, ΦCBH8 and ΦCBH189 also share 
a high degree of nucleotide identity with each other. Some of the most significant hits from the 
BLASTn search are shown in Table 3.2. Based on percentage identity and coverage, it seems that 
ΦCBH8, ΦCBH189, ΦCHI14 and ΦX20 all belong to a new group of phages that share >95% 
sequence identity with each other over >95% of the genome. This meets the ICTV’s requirement 
for new species classification (141). Furthermore, Escherichia virus EcS1 shares >75% sequence 
identity over >85% coverage of the genome with these S39006 phages. On the contrary, other 
phages in Table 3.2 share a moderately high level of identity with S39006 phages but only in 
limited regions of the genome (overall identity <50% after adjusting for coverage). These phages 
include the unclassified Edwardsiella phages and some classified phages belonging to different 
genera of the Tevenvirinae subfamily, such as phage T4. All of the phage mentioned above belong 
to the T4-like superfamily due to their genomic similarity of varying degrees to phage T4. This 
suggests that ΦCBH8, ΦCBH189, ΦCHI14 and ΦX20 belong to the T4-like phage superfamily 
but could, at the same time, define a new genus that also includes EcS1, based on the ICTV’s 
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criteria that viruses within a genus must share >50% overall nucleotide similarity and be distinct 
from viruses of other genera (141). 
 
 




Figure 3.3 (figure legend provided overleaf): Circular representation of ΦCBH8 and 
ΦCBH189 genomes.  
Figure 3.3: Circular representation of ΦCBH8 and ΦCBH189 genomes. The outer ring 
represents ORFs on the forward strand while the inner ring represents ORFs on the reverse strand. 
ORFs are color-coded based on their categorized function. tRNA genes are located on the reverse 
strand but are represented here between the inner and outer strand for easier visualization. The 
figures are plotted using DNAPlotter (Wellcome Sanger Institute). The “LD region” labeled in the 
circular map of ΦCBH8 is mentioned later in Section 2.1, Chapter 4. 
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Table 3.2: Whole genome alignment of ΦCBH8, ΦCBH189 and T4 with related phages 
using BLASTn 
Phage name Subfamily : Genus 
Percentage 
identity with 
ΦCBH8 (%) and 
coverage (%) 
Percentage identity 
with ΦCBH189 (%) 
and coverage (%) 
Percentage identity 
with T4 (%) and 
coverage (%) 
Identity Coverage Identity Coverage Identity Coverage 
ΦCBH8 Unassigned 100 100 98 97 74 49 
ΦCBH189 Unassigned 98 97 100 100 74 49 
ΦCHI14 Unassigned 99 100 98 97 74 49 
ΦX20 Unassigned 99 97 97 97 73 49 
Escherichia virus EcS1 Unassigned 78 86 78 85 71 50 
Edwardsiella virus PEi20 Unassigned 72 67 71 67 72 47 
Edwardsiella virus PEi26 Unassigned 72 67 71 67 72 47 
Escherichia virus CC31 Tevenvirinae : Cc31virus 70 58 70 58 72 52 
Enterobacter virus PG7 Tevenvirinae : Cc31virus 73 58 73 57 72 54 
Escherichia virus JS10 Tevenvirinae : Js98virus 75 53 75 53 76 56 
Escherichia virus VR5 Tevenvirinae : Js98virus 75 54 75 54 76 58 
Escherichia virus JS98 Tevenvirinae : Js98virus 75 54 75 55 76 58 
Escherichia virus IME08 Tevenvirinae : Js98virus 68 54 68 54 76 60 
Escherichia virus T4 Tevenvirinae : T4virus 74 49 74 49 100 100 
 
 
To further substantiate the relationship between these S39006 phages and other related phages, 
phylogenetic analysis was conducted using the amino acid sequences of major capsid protein 
(MCP) of S39006 phages and other phages with homologous MCP to them according to BLASTp 
(142). As seen in Figure 3.4, all the S39006 phages belong to the same clade, consistent with 
BLASTn comparison of their whole genomes. Phage EcS1 is phylogenetically closest to S39006 
phages and might share a common ancestor. On the contrary, S39006 phages are more distant to 
other phages of the T4-like superfamily.  
 
As gp23 encoding MCP is a signature protein in T4-family phages, the phylogenetic analysis 
provides further proof these S39006 phages represent a new species and even possibly a new genus 
of T4-family phages (141). Recently, the name of the new genus has been proposed to the ICTV 
Chapter 3 S39006 phages ΦCBH8 and ΦCBH189 activate Type III TA-mediated Abi  
 
 72 
(pending approval) as Winklervirus and falls under the subfamily of Tevenvirinae (Andrew 




Figure 3.4: The phylogenetic relationship of S39006 phages with other phages based on the 
amino acid sequences of major capsid protein. The evolutionary distance between any two 
leaves in the tree is proportional to the sums of the branch lengths connecting them. The scale bar 
(0.08) shows the approximate percentage difference in amino acid sequences associated with that 
particular length. The tree is unrooted and bootstrap values are shown in red. 
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4. ΦCBH8 and ΦCBH189 have narrow host range 
The host ranges of ΦCBH8 and ΦCBH189 were investigated in order to determine whether these 
phages infect bacteria other than S39006 and potentially to explore their activation of Type III TA 
systems in another host background. ΦCBH8 and ΦCBH189 were used in spot tests on top lawns 
containing different bacteria. The bacterial hosts to be tested were chosen depending on their 
availability in the lab collection as well as their Gram-negative nature. Different species of Serratia, 
Citrobacter, Dickeya, Escherichia, Pectobacterium and Pseudomonas were tested for their 
susceptibility to ΦCBH8 and ΦCBH189. However, no bacteria could be infected by these S39006 
phages, similar to the host range assays carried out previously with ΦCHI14 and ΦX20. The results 
indicate that this new genus of S39006 phages exhibits high host specificity; thus far they only 
infect the host from which they were isolated.  
 
5. ΦCBH8 could escape ToxINPa via distinct routes 
Infection assays shown in Figure 3.1 indicated that while ΦCBH8 infection was aborted by 
ToxINPa, a tiny proportion of its progeny were able to escape ToxINPa. Based on an EOP of ~10-6, 
roughly 1 in a million phages in the ΦCBH8 phage stock were ToxINPa-insensitive mutants, 
observed in Figure 3.1b. These mutants would have arisen during the propagation of wild type 
ΦCBH8 and presumably should contain mutated versions of orf(s) involved in the activation of 
ToxINPa-mediate Abi. Therefore, attempts were made to isolate these escape mutants and identify 
their mutated gene(s). 
 
To ensure that each mutant isolated was independent and that the mutant bank created has the 
greatest diversity, wild type ΦCBH8 was serially diluted and plated out on top lawn of S39006 
containing ToxINPa-FS. As shown in the schematic diagram in Figure 3.5, individual plaques of 
wild type ΦCBH8 progenies were individually picked and “bulked up” again on S39006 (ToxINPa-
FS) to give ample opportunities for mutants to arise. These wild type ΦCBH8 progenies were 
named ΦCBH8wt1, ΦCBH8wt2, ΦCBH8wt3,…,ΦCBH8wtn. Each wild type ΦCBH8 progeny 
phage stock was then serially diluted and plated out separately on S39006 (ToxINPa) to select for 
escape mutants. One mutant from each wild type stock was selected, purified and named ΦCBH8a, 
ΦCBH8b, ΦCBH8c,…, ΦCBH8n. These mutants were plated out on S39006 (ToxINPa) and 
S39006 (ToxINPa-FS) again to calculate their EOP, all of which were restored to ~1, indicating 
that they were phages that became true escape mutants. 





Figure 3.5: Schematic diagram showing the isolation and purification of ΦCBH8 mutants.  
(a) Plaques of wild type ΦCBH8 progenies were individually picked and bulked up again on 
S39006 (ToxINPa-FS). These wild type ΦCBH8 progenies were named ΦCBH8wt1, ΦCBH8wt2, 
ΦCBH8wt3,…,ΦCBH8wtn. (b) Each wild type ΦCBH8 progeny phage stock was then serially 
diluted and plated out separately on S39006 (ToxINPa) to select for mutants. One mutant from each 
wild type stock was selected, purified and named ΦCBH8a, ΦCBH8b, ΦCBH8c,…,ΦCBH8n. 
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A total of 11 independent ΦCBH8 mutants were subjected to whole genome sequencing. Mutant 
genomes were compared with the wild type genome to identify the mutated gene(s) involved in 
escaping ToxINPa (Table 3.3). Interestingly, the mutations did not all map to the same location in 
the corresponding genomes. Instead, 8 of the mutants harbored a large deletion (size ranging from 
6.5 kb to 10 kb) in their genomes while 3 mutants carried a nonsense mutation in the asiA gene. 
Similar mutations have been found previously in ΦCHI14 and ΦX20 mutants, which is 
unsurprising given their high DNA identity with each other. However, the details of each mutated 
locus differ between mutants of ΦCBH8, ΦCHI14 and ΦX20, as shown in Table 3.3. What is 
worth noting is that the large deletion regions in some phage mutants, albeit having different start 
and end positions, all overlapped with each other, as shown in detail in Figure 4.1, Chapter 4.  
 
Taken together, the repeated appearance of similar escape loci in these phages suggest variations 
on a common theme for S39006 phages that activate ToxINPa-mediate Abi. More detailed 
characterization of these escape loci will be the focus of Chapter 4 and Chapter 5. 
 
 
Table 3.3. Summary of mutations in ToxINPa-escape mutants of ΦCBH8, ΦCHI14 and 
ΦX20. 
Escape phage Mutation type Gene(s) affected Effect of mutation 
FCBH8 mutants 
FCBH8f large deletion (10040 bp) 19 orfs, 11 tRNAs 
elimination of affected genes  
(64343 bp – 74382 bp) 
FCBH8i large deletion (7802 bp) 15 orfs, 11 tRNAs 
elimination of affected genes 
(66568 bp – 74369 bp) 
FCBH8m large deletion (8575 bp) 17 orfs, 6 tRNAs 
elimination of affected genes 
(64427 bp – 73001 bp) 
FCBH8o large deletion (6521 bp) 13 orfs, 11 tRNAs 
elimination of affected genes 
(67248 bp – 73768 bp) 
FCBH8p large deletion (8368 bp) 16 orfs, 10 tRNAs elimination of affected genes 
Chapter 3 S39006 phages ΦCBH8 and ΦCBH189 activate Type III TA-mediated Abi  
 
 76 
(65513 bp – 73880 bp) 
FCBH8t large deletion (7328 bp) 15 orfs, 9 tRNAs 
elimination of affected genes 
(65310 bp – 73637 bp) 
FCBH8u large deletion (8158 bp) 17 orfs, 4 tRNAs 
elimination of affected genes 
(64543 bp – 72700 bp) 
FCBH8x large deletion (7731 bp) 14 orfs, 10 tRNAs 
elimination of affected genes 
(65959 bp – 73689 bp) 
FCBH8a nonsense mutation asiA E71 à stop codon 
FCBH8l nonsense mutation asiA E72 à stop codon 
FCBH8r nonsense mutation asiA E72 à stop codon 
FCHI14 mutants 
FCHI14a large deletion (7647bp) 14 orfs, 12 tRNAs 
elimination of affected genes  
(66821 bp – 74468 bp) 
FCHI14b nonsense mutation asiA E71 à stop codon 
FCHI14c large deletion (10094bp) 19 orfs, 13 tRNAs 
elimination of affected genes 
(64429 bp – 74524 bp) 
FCHI14e missense mutation orf84 E66D 
FCHI14f deletion (10bp) asiA extends protein by 17 residues 
FX20 mutants 
ΦX20b large deletion (9533 bp) 19 orfs, 11 tRNAs 
elimination of affected genes 
(64664 bp – 74196 bp) 
ΦX20d large deletion (9479 bp) 19 orfs, 8 tRNAs 
elimination of affected genes 
(64093 bp – 73572 bp) 
ΦX20f large deletion (9473 bp) 19 orfs, 8 tRNAs 
elimination of affected genes 
(64110 bp – 73583 bp) 
ΦX20g large deletion (9533 bp) 19 orfs, 11 tRNAs 
elimination of affected genes 
(64664 bp – 74196 bp) 
ΦX20h large deletion (9533 bp) 19 orfs, 11 tRNAs 
elimination of affected genes 
(64664 bp – 74196 bp) 
ΦX20j large deletion (9533 bp) 19 orfs, 11 tRNAs 
elimination of affected genes 
(64664 bp – 74196 bp) 





ΦX20k large deletion (9533 bp) 19 orfs, 11 tRNAs 
elimination of affected genes 
(64664 bp – 74196 bp) 
ΦX20l large deletion (9533 bp) 19 orfs, 11 tRNAs 
elimination of affected genes 
(64664 bp – 74196 bp) 
ΦX20m large deletion (9533 bp) 19 orfs, 11 tRNAs 
elimination of affected genes 
(64664 bp – 74196 bp) 
ΦX20n large deletion (9533 bp) 19 orfs, 11 tRNAs 
elimination of affected genes 
(64664 bp – 74196 bp) 
ΦX20o large deletion (9533 bp) 19 orfs, 11 tRNAs 
elimination of affected genes 
(64664 bp – 74196 bp) 
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6. ΦCBH189 cannot escape ToxINPa 
Despite having extremely high overall genome identity with ΦCBH8, ΦCHI14 and ΦX20, 
ΦCBH189 did not produce any detectable escape mutants (Figure 3.1b, Table 3.1). This is 
surprising given that at least 3 different escape loci were found among the other S39006 phages. 
Therefore, bioinformatic analysis was carried out to verify whether the ToxINPa escape loci found 
in ΦCBH8 are present in ΦCBH189. 
 
Alignment of asiA sequences showed that ΦCBH189 only differs in the 144th and 176th nucleotide 
of asiA compared to ΦCBH8 and ΦCHI14. However, these mutations do not alter the cognate 
amino acids encoded, and these nucleotides are not the same as those mutated in the escape mutants. 
Therefore, it is intriguing why the asiA mutation has not been observed in ΦCBH189. Comparison 
with the deleted region in ΦCBH8o (denoted “CBH8o-LD”, the smallest deleted region among all 
mutants) showed that ΦCBH189 also contains this region, with 82% nucleotide identity. Therefore, 
it is also intriguing why the large deletion mutation failed to arise in ΦCBH189. Further analysis 
showed that each orf and tRNA within CBH8o-LD shares high level of similarity with the orf or 
tRNA in ΦCBH189, with two exceptions. In one case, a predicted hypothetical protein is only 
present in the cognate region in ΦCBH189 but not in ΦCBH8. In another case, a hypothetical 
protein in CBH8o-LD is missing in ΦCBH189. It is possible that this orf (named orf12) was 
involved in the activation of Abi by ΦCBH8, therefore deletion of the region encompassing orf12 
produced escape mutants while the absence of orf12 explained the lack of escape mutants of 
ΦCBH189.  
 
Aside from having differences with escape loci found in ΦCBH8, it could also be that ΦCBH189 
lacks certain proteins required for the genesis of asiA mutation or large deletions. A detailed 
comparison was made between ΦCBH8 and ΦCBH189 to identify protein-coding regions with 
known function that differ between the two phages. Table 3.4 summarizes ORFs with significant 
differences between ΦCBH8 and ΦCBH189 (ORFs with minor alterations between ΦCBH8 and 
ΦCBH189, and ORFs with significant differences in ΦCBH8 and ΦCBH189 but without known 
function are omitted). ΦCBH8 and ΦCBH189 possess different types of homing endonucleases, 
and the Endonuclease IV they possess have different amino acid sequence in the C-terminal 
domain. However whether these proteins are involved in facilitating asiA and large deletion 
mutation in ΦCBH8 mutants is not clear. 






Table 3.4: ORFs of known function that differ in ΦCBH8 and ΦCBH189 
 
aCTD: C-terminal domain 
bNTD: N-terminal domain 
 
 
Since ΦCBH189 did not produce mutants escaping ToxINPa, the next 2 chapters will focus on 
characterization of escape loci found in ΦCBH8 and exploration of their relationship with ToxINPa.  
 
7. Discussion 
Over the course of 3 years, > 300 phages of S39006 were isolated and tested for their sensitivity 
to Type III TA systems. However, so far only 1% of the phages screened were aborted by ToxINPa 
and TenpINPl. This rarity may be unsurprising, since wild type S39006 does not contain any Type 
III TA systems in its genome, and in this study, all of the Type III TA systems were introduced 
artificially into S39006 on a plasmid. Despite the artificial introduction, it was still possible to find 
rare phages that were sensitive to ToxINPa and TenpINPl. It could be a coincidence that these 
phages carried ORF(s) that made them susceptible to ToxINPa and TenpINPl. It is also possible that 
Gene name Source Difference 
segA homing endonuclease Present only in ΦCBH8 Entire orf missing in ΦCBH189 
tRNA-Lys (TTT) Present only in ΦCBH8 Entire orf missing in ΦCBH189 
tRNA-Glu (TTC) Present only in ΦCBH8 Entire orf missing in ΦCBH189 
segB homing endonuclease Present only in ΦCBH189 Entire orf  missing in ΦCBH8 
segD homing endonuclease Present only in ΦCBH8 Entire orf missing in ΦCBH189 
Long tail fiber, distal subunit Present in both ΦCBH8 and ΦCBH189 
82% amino acid identity, 
similar length protein but CTDa 
did not align 
Endonuclease IV Present in both ΦCBH8 and ΦCBH189 
82% amino acid identity, 
similar length protein but CTDa 
did not align 
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these phages infect other unknown host(s) that naturally possess a similar Type III TA system. 
However, screening of a large number of bacteria strains available in the lab yielded no positive 
result and more research needs to be done to determine whether these ToxINPa/TenpINPl-sensitive 
S39006 phages infect other hosts. 
 
None of the >300 phages screened were aborted by ToxINBt or CptINEr. This resonates with earlier 
studies and supports the hypothesis that ToxINBt and CptINEr might not abort phages, and that the 
original function of Type III TA system could be something other than Abi, such as plasmid 
addiction (96).  
 
Two of the S39006 phages isolated in this study were able to activate Abi mediated by both 
ToxINPa and TenpINPl. Characterization of the two phages alongside previously isolated ΦCHI14 
and ΦX20 showed that while they share some level of similarity with phages of the T4-like 
superfamily, they are more similar with each other than with these T4-like phages. Whole genome 
alignment and phylogenetic studies using major capsid protein suggested that these S39006 phages 
represent a new genus of phages. As an increasing number of phage genomes are added to Genbank 
in recent years, the identification of this new genus of phages will contribute to better 
understanding of the diversity of T4-family phages (26, 143-145). Characterization of certain 
known/unknown ORFs of these phages described in later chapters will also add to our 
understanding of basic phage biology. 
 
Three out of the four S39006 phages in this study were not only aborted by ToxINPa but also 
produced spontaneous escape mutants that became insensitive to ToxINPa. Identification of the 
escape loci showed that ΦCHI14, ΦCBH8 and ΦX20 could escape ToxINPa via three, two and one 
different route(s), respectively. Of the phage mutants analyzed, the “large deletion” escape route 
is shared by all three phages while the asiA escape route is unique to ΦCHI14 and ΦCBH8. 
Mutation of ORF84 was only seen in ΦCHI14 and in only one of its mutants. The repeated 
appearance of similar escape loci of the three S39006 phages, and the absence of a “new” escape 
locus suggests that common themes may exist in terms of how these phages interact with the 
ToxINPa system. This highlights the “large deletion” region and asiA gene as important candidates 
for direct activation of ToxINPa-mediated Abi that are in need of further investigation. 
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In contrast, ΦCBH189 was unable to escape ToxINPa. It is more likely that ΦCBH189 lacks certain 
proteins required for the genesis of escape mutants, since both asiA and the “large deletion” region 
are almost identical to those found ΦCBH8. Analysis of differences between ORFs of ΦCBH189 
and other phages provided little clue since many of the ORFs involved have unknown function. 
This further complicates the nature of phages that could activate ToxINPa-mediated Abi, since 
ΦCBH189 is very closely related to the other three phages but fails to exhibit similar behavior 
regarding its interaction with ToxINPa. Future work could involve chemically mutating ΦCBH189, 
such as using hydroxylamine, to artificially generate escape mutants of ΦCBH189 and analyze 
their escape loci. 
 
Finally, even though S39006 phages in this study were aborted by TenpINPl, none of them could 
produce any spontaneous mutants that escaped the system. This might be because the TenpNPl 
toxin was overexpressed on a high copy number plasmid, or that the phage gene(s) involved in 
TenpINPl -sensitivity is essential, therefore mutants were unable to survive.  
 
In summary, three closely related phages, ΦCHI14, ΦCBH8 and ΦX20, were identified from 
current and previous studies that contain interesting loci presumed to be involved in activating 
ToxINPa-mediated Abi. The following two chapters will focus on two of those loci, the asiA gene 
and the “large deletion” region, to investigate whether they are directly involved in activating Abi 
and gather information on their possible biological function(s)
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Chapter 4 - T4-family phages escape 




As obligate parasites for their bacterial hosts, phages have a high level of genetic plasticity to adapt 
to changing host physiology. As phage genome replicates rapidly during the infection process, 
they can produce missense mutations, nonsense mutations, insertions, inversions, deletions or 
duplications. Under certain conditions, these spontaneous mutations are selected for and allow 
phages to quickly adapt to changes, especially to avoid host defense mechanisms. In the case of 
Type III TA systems, mutants escaping ToxINPa and AbiQ have been found where insertion, 
deletion or missense mutations have enabled them to escape these Abi systems (98, 99). Among 
ToxINPa-escape mutants of S39006 phages ΦCBH8, ΦCHI14 and ΦX20, deletion of a large 
genomic region (> 6.5 kb) was observed. Deletions of this extent has not been observed previously 
for any mutants of Type III TA-sensitive phages. BLAST searches showed that no known function 
can be assigned to any of the orfs deleted in these mutants (Appendix I), making it mysterious as 
to how these “large deletion” regions are related to ToxINPa-sensitivity.  
 
This chapter aims at carrying out biological characterization of these “large deletion” regions to 
answer the following questions: 1) What facilitates the deletion event of regions so large? 2) Are 
the deleted regions as a whole important for Abi-activation or just single genetic element(s) within 
the locus? 3) What is the biological relevance of the deleted regions and how are they related to 
ToxINPa-sensitivity?  
 
2. “Large deletion” (LD) is the most prevalent mutational route through which S39006 
phages escape ToxINPa 
Of the 27 sequenced ToxINPa-escape mutants of ΦCBH8, ΦCHI14 and ΦX20 combined, 21 of 
them have lost a large region of their genomic DNA (shown in Table 3.3 in the previous chapter). 
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In particular, all 11 of ΦX20 mutants isolated arose through this “large deletion” (LD) 
mutation. These “LD mutants” arose for all three phages, therefore making LD the prevalent 
escape route and the only route through which all these T4-family phages can escape ToxINPa 
(asiA mutants were not found for ΦX20). To understand how the deletion of the LD region 
facilitates escape from ToxINPa, the locus was characterized in detail. 
 
2.1 The LD region varies between phage mutants but share a common core 
Comparison of the sizes of the LD regions in different phage mutants showed that the LD regions 
range from 6,521 bp (ΦCBH8o) to 10,094 bp (ΦCHI14c). The largest deleted region covers 19 
orfs and 13 tRNA genes, whereas the smallest covers 13 orfs and 11 tRNA genes. The variation in 
the size of the LD region prompted investigation into whether the LD region could still be smaller 
so that we could home in on fewer genetic elements to investigate. To look for smaller LD regions, 
11 more ToxINPa-escaping spontaneous mutants of ΦCBH8 were isolated and their genomes 
extracted. Primers oBH1 and oBH2 designed to flank the LD region in ΦCBH8f (the largest LD 
region among ΦCBH8 mutants) were used to amplify the cognate regions in these 11 new mutants. 
The sizes of the amplicons were compared to the size of the amplicon from ΦCBH8o. If any of 
these 11 mutants had deleted a smaller region than ΦCBH8o, then its amplicon size should be 
bigger than that of ΦCBH8o. However, visualization of the amplicons on an agarose gel showed 
that no other mutants have a smaller LD size (data not shown), making ΦCBH8o the mutant with 
the smallest LD so far. 
 
The exact positions of the deleted region in each mutant were then mapped onto the wild type 
phage genome to compare similarities and differences. As shown in the schematic diagram in 
Figure 4.1a-b, no mutation has the exact same 5’ or 3’ border of deletion as another. The 5’ borders 
of LD mutants seem to be dispersed in a region consisting mostly of tRNA genes, while the 3’ 
borders of LD regions lie in a region full of orfs encoding hypothetical proteins. Despite the 
variability in the borders of the deleted regions, all of the LD regions share a common core that 
consists of 11 orfs and 3 tRNA genes. The location of the LD regions relative to the whole genome 
was also analyzed by mapping the furthest 5’ and 3’ borders of all ΦCBH8 and ΦCHI14 mutants 
combined (64343 bp and 74523 bp). As shown in Figure 3.3, the LD region lies on the forward 
strand of the phage genome, in a region consisting mostly hypothetical proteins without known 
function. 










Figure 4.1: Mapping of the deleted regions in different LD. (a) Mapping of the deleted regions 
in ΦCBH8 and ΦCHI14 LD mutants onto the wild type genome. Due to the 99% similarity 
between ΦCBH8 and ΦCHI14 wild type genomes, the two are represented as one in the schematic 
diagram. The numbers mark orfs mentioned later in Section 4.4, 4.5 and 4.6 (b) Mapping of the 
deleted regions in ΦX20 LD mutants onto the wild type genome. The direction of arrows 
represents the direction of transcription of genes. (c) Schematic diagram showing the existence of 
direct repeats in the wild type ΦCBH8 genome immediately upstream and downstream of the 
region deleted in ΦCBH8o, and the cognate region in ΦCBH8o after deletion occurred where only 
one copy of the repeat sequence is left. 
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LD size (bp) 
Direct repeat 
sequence 
Frequency of repeat in 





ΦCBH8f 10040 GAACTGC 22 3 
ΦCBH8i 7802 TTGAGTAG 7 0 
ΦCBH8m 8575 GTCCCTG 11 0 
ΦCBH8o 6521 CCGAAGC 15 1 
ΦCBH8p 8368 GTTCAC 94 4 
ΦCBH8t 7328 AGCCATCC 5 0 
ΦCBH8u 8158 GGAAGCC 22 1 
ΦCBH8x 7731 ATCTG >100 11 
 
 
Investigation of the sequences directly upstream or downstream of the deleted regions showed the 
presence of direct repeats immediately adjacent to the 5’ and 3’ borders of the cognate LD regions. 
These direct repeats, varying from 6 bp to 8 bp in size, are different in each LD mutant (Table 4.1). 
As exemplified by the case of ΦCBH8o in Figure 4.1c, even though the wild type genome contains 
2 copies of the direct repeat sequences adjacent to the region to be deleted, only one copy of the 
repeat sequence is left after the deletion occurred. This is characteristic of recombination or strand 
slippage as the mechanism for such deletion (146, 147). Further analysis was also carried out to 
count the number of times the direct repeats appeared in the ΦCBH8 genome, especially within 
the deleted regions of mutants. Interestingly, for ΦCBH8o, the mutant with the smallest LD region, 
the direct repeat also appeared once within the deleted region (Table 4.1). This means that, 
theoretically, the LD region in ΦCBH8o could have been even smaller than 6.5 kb. However 
previous screening of more LD mutants showed that 6.5 kb is the smallest deleted region found so 
far. This could be due to the limited sample size or could imply that a smaller deleted region would 
not remove orf(s) or tRNA(s) that are involved in Abi-activation, therefore such a mutant could 
not arise as a viable escape mutant during the positive selection. 
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2.2 The LD region is highly specific to T4-family S39006 phages 
Alignment of the LD region with the genomes of other related phages was carried out to evaluate 
whether the region is conserved among T4-family phages. Phages T4, CC31, PEi20, Esc1, 
ΦCBH189 and ΦX20 were chosen to compare with the LD region deleted in ΦCBH8o in their 
ascending order of similarity with wild type ΦCBH8 (ΦCBH8wt). As shown in Figure 4.2, 
alignment of the ΦCBH8o LD region with T4 and CC31 genomes resulted in very low level of 
identity, and no corresponding LD region exists in these 2 phages. In contrast, ΦCBH8o LD 
alignment with PEi20 and Esc1 genomes showed moderate levels of identity. The homologous 
regions in PEi20 and Esc1 are concentrated in one area of the genome, indicating the existence of 
a cognate LD region (albeit moderate levels of identity) in their genomes. Finally, ΦCBH8o LD 
alignment with ΦCBH189 and ΦX20 genomes resulted in high level of identity. This is 
unsurprising since ΦCBH189 and ΦX20 have very high overall genome similarity with ΦCBH8. 
The corresponding LD regions in ΦCBH189 and ΦX20 are almost identical to ΦCBH8 except for 
a few gaps. The level of similarity far exceeds the similarity between ΦCBH8o LD and cognate 
LD regions in PEi20 and Esc1, even though the latter two also have moderately high level of 
overall genome similarity with ΦCBH8 (Table 3.2, Chapter 3). This shows that as a whole, the LD 
region presumed to be involved in Abi-activation is highly specific to the S39006 phages 
characterized so far and absent (to different extents) in other related T4-family phages. This result 
is not surprising since previous results have shown that phage T4, which lacks this LD region, is 
not able to activate ToxINPa-mediated Abi in E.coli K-12. 
 
 




Figure 4.2: ACT alignment of the deleted region in ΦCBH8o (LD) with genomes of highly 
similar or well-studied phages of the T4 family. (a) phage T4; (b) phage CC31; (c) phage PEi20; 
(d) phage Esc1; (e) ΦCBH189; (f) ΦX20. While the top panel in each alignment represents the 
entirety of ΦCBH8o LD, the bottom panel only represents an incomplete portion of the 
corresponding phage genome that is most similar with ΦCBH8o LD. The red color represents 
corresponding regions in the alignment that are at least 20 bp in length and exceed 70% sequence 
identity with each other. Schematic representation of orfs in the LD region is imposed on top of 
the alignments. A clear, detailed version of the annotation can be found in Figure 4.1a. 
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2.3 The LD region has negligible influence on phage fitness 
The apparent specificity of the LD region to S39006 phages, and the fact that ToxINPa-insensitive 
mutants could afford to lose such a large portion of their genomes to escape yet remain viable, 
prompted investigation into the importance of the LD region for the fitness of phages such as 
ΦCBH8. TEM imaging of ΦCBH8o showed that the LD mutant still retained the same morphology 
as its wild type parent (Figure 4.3a). Measurement of ΦCBH8o showed that ΦCBH8o has a head 
width of 95 nm (±7 nm), head length of 105 nm (±10 nm), extended tail length of 113 nm (±7 nm), 
and extended tail width of 19 nm. Accounting for errors, this measurement is in the same range as 
the measurements for ΦCBH8wt, indicating that the loss of the LD region did not cause observable 
changes to phage morphology, and implying that the LD region does not contain ORFs involved 
in phage structure or assembly. The importance of the LD region to plaque morphology was also 
investigated. As shown in Figure 4.3b, ΦCBH8o plaques formed on a top lawn of S39006 are 
round, clear and with smooth edges, identical to ΦCBH8wt plaques. This suggests that the lytic 
efficiency of ΦCBH8o is not significantly reduced. The sizes of the plaques are also similar to 
ΦCBH8wt, corroborating TEM measurements where the size of the ΦCBH8o particle is similar to 
ΦCBH8wt, since differential plaque size correlates with diffusion speed through agar, stemming 
from differential phage head size (148).  
 
The fitness of ΦCBH8o was furthered quantified by measuring adsorption efficiency in overnight 
cultures of S39006 at an M.O.I. of 0.01. As shown in Figure 4.4a, in the adsorption assay, the ratio 
of free (i.e. unadsorbed) phage was measured. The lower the ratio of free phage in the culture, the 
higher the ratio of adsorbed phages. ΦCBH8wt and ΦCBH8o only had minor differences in the 
ratio of free phage. Both adsorbed to S39006 efficiently, achieving more than 80% phage 
adsorption by 20 min. This shows that with stationary phase hosts in abundance, ΦCBH8o does 
not exhibit significantly reduced adsorption efficiency despite lacking the LD region. The burst 
size of ΦCBH8wt and ΦCBH8o was measured next during one-step growth on exponential-phase 
S39006 (Figure 4.4b). Both ΦCBH8wt and ΦCBH8o have a latent period of 25 min and a rise 
period of about 20 min. The average burst size was approximately 30 phage particles (pfu; plaque 
forming units) per initial infection center for ΦCBH8wt and 29 for ΦCBH8o; similar when 
accounting for errors. Therefore, the above assays indicate that ΦCBH8o does not exhibit obvious 
reduction in fitness compared to ΦCBH8wt. This implies that the LD region has no fitness impact 
on phage survival and propagation under these conditions. 






Figure 4.3: The effect of the large deletion (LD) on phage morphology and plaque 
morphology. (a) TEM images of ΦCBH8o with extended tail (left) and contracted tail (right). 
Scale bars represent 100 nm. (b) Plaque morphology comparison of ΦCBH8wt (left) and ΦCBH8o 
(right) grown on top lawn of S39006. Scale bars represent 2 mm. 
  




Figure 4.4: Adsorption and burst size comparison of ΦCBH8wt and ΦCBH8o. (a) The 
adsorption of ΦCBH8wt and ΦCBH8o to S39006. Detailed methods of the adsorption assay can 
be found in Section 3.9, Chapter 2. The percentage of free phage is calculated by dividing the titer 
of the phage taken from the sample at any given time point by the titer of the phage in the sample 
at time point 0. The lower the ratio of free phage in the culture, the higher the ratio of adsorbed 
phages. Error bars represent standard deviation from triplicates. (b) Burst size comparison of 
ΦCBH8wt and ΦCBH8o infecting S39006. Detailed methods of the burst size assay can be found 
in Section 3.10, Chapter 2. Burst size is calculated by dividing the pfu of phage at any given point 
by the initial phage titer at time point 0. Error bars represent standard deviation from triplicates. 
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3. No ORF in the LD region activates ToxINPa-mediated Abi on its own 
The major components of the LD regions are orfs encoding hypothetical proteins with no known 
function. Even in ΦCBH8o, where the deleted region is the smallest, 13 orfs were completely 
eliminated. Similarly, in the overlapping core of all LD regions found in different mutants, there 
were still 11 orfs affected. All the genetic loci identified to be Abi-activating in previous research 
were shown to be protein-encoding orfs, so it is presumed that the orf(s) in the LD regions are 
involved in direct or indirect activation of ToxINPa-mediated Abi. 
 
To pinpoint which orf(s) activates Abi, each one of the 13 orfs(denoted orf8 to orf20) deleted in 
ΦCBH8o were cloned into pBAD33 and introduced into S39006 containing pTA46 (ToxINPa) for 
attempts at complementation. The sequence of each cloned orf was checked to confirm that none 
of them have mutated in the cloning process. ΦCBH8o was then serially diluted and spotted on 
top lawn of S39006 expressing both ToxINPa and an individual orf from the LD region. If any orf-
encoded product could activate Abi on its own, then ΦCBH8o would be aborted again. As shown 
in Figure 4.5, with the positive control where ΦCBH8wt was spotted on S39006 containing 
pBAD33 and pTA46, no clear spots were observed, indicating activation of Abi. In contrast, in the 
negative control (where ΦCBH8o was spotted on S39006 containing pBAD33 and pTA46), clear 
spots were observed. This was expected since ΦCBH8o escaped from ToxINPa-mediated Abi. 
However, when orf8-orf20 (excluding orf18) were expressed individually alongside ToxINPa, none 
of them caused ΦCBH8o to be aborted again to the extent of the positive control, indicating that 
none of the orf products (excluding ORF18) in the smallest LD region could activate Abi on its 
own. Expression of orf16, orf17 and orf19 caused minor reduction of phage titer (~10 fold) 
compared to the negative control, implying that they contribute to Abi to some extent, but must 








Figure 4.5 (figure legend provided overleaf): Complementation assay of ORFs in ΦCBH8o 
LD region in the presence of ToxINPa. 
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Figure 4.5: Complementation assay of ORFs in ΦCBH8o LD region in the presence of 
ToxINPa. All the top lawns contain S39006 transformed with ToxINPa and an ORF cloned into 
pBAD33. In positive and negative controls, the empty vector pBAD33 was used. In all the spot 
tests, 0.05% L-ara was used to induce ORF expression. The undiluted phage stock (100 dilution) 
used had a titer of 1010 pfu/mL. Dilution of the ΦCBH8o spots are as follows –  
Top row left: 10-1; middle: 10-2; right: 10-3.  
Bottom row left: 10-4; middle: 10-5; right: 10-6. 
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4. ORF18 might be toxic 
Attempts to clone orfs of the ΦCBH8o LD region into pBAD33 were successful except for orf 18 
(gene# 146 in Appendix I). This orf encodes a hypothetical protein (ORF18) with 114 amino acids. 
After transformation of DH5α with the ligation mixture of the orf18 insert in the pBAD33 vector, 
either no transformants were obtained on the chloramphenicol selection plate or only 1-2 
transformants appeared. Sequencing of the recombinant plasmid in these rare colonies showed that 
orf18 has suffered a missense mutation. The cloning process was repeated several times and even 
in the presence of 0.4% Glucose for repression, orf18 could only be cloned after acquiring 
missense mutations, suggesting two possibilities: either the cloned portion of the orf contains 
endogenous promoter, or ORF18 is extremely toxic. Search for endogenous promoter of orf18 
based on consensus promoter sequences of T4 genes yielded no result, indicating that either the 
cloned portion of orf18 does not have endogenous promoter, or that the promoter is does not 
conform to the T4 consensus. Whichever scenario applies, the failure in cloning and expression 
orf18 explains the failure in attempts to clone and complement the entire LD region of ΦCBH8o 
(data not shown), within which orf18 is contained. Since wild type orf18 cannot be cloned and 
expressed, it is not known if orf18 can activate Abi on its own. However, given its location on the 
5’ end of the common core of all LD regions (Figure 4.1a) and its toxicity, it is theoretically 
possible that its product ORF18 could be involved in Abi-activation. 
 
5. ORF10 causes filamentation in S39006 
In the absence of direct evidence that any orf deleted in ΦCBH8o could activate ToxINPa-mediated 
Abi on its own, bioinformatic prediction of the function of the orfs was carried out in the hope that 
some hints could be gained regarding their possible interaction with ToxINPa. BLASTn and 
BLASTp searches were carried out to annotate orfs in the ΦCBH8o LD region but those orfs had 
either no homologues or only had homologues with no known function. In addition to using 
sequence information, structural information of these orf products was also predicted using i-
TASSER (134, 149) to search for potential structural homologues with known function. However 
only homologues with low Z-scores were returned in the search. Finally, Phagonaute (150) was 
used to look at the neighboring genes of the homologues of these orfs in other phages. Even though 
some of the ORFs in the ΦCBH8o LD region have high scoring homologues in other phages, those 
homologues have no known function assigned and were surrounded by hypothetical proteins 
without known function.  




The exhaustive search for functional information of orfs8-20 yielded little information, therefore 
attempts were made to express these orfs in S39006 to gain some first-hand information on their 
biological function. Given the fact that these orfs were shown to be non-essential for the phage 
lytic cycle, attempts were made to assess their effect on host fitness. orfs8-20 (excluding orf18) 
were cloned into pBAD33 and introduced into wild type S39006, individually. A growth curve of 
S39006 expressing each orf was plotted where orf expression was induced with 0.1% L-ara at the 
start of exponential phase. The OD600 of S39006 expressing each orf was compared to the control 
where S39006 was transformed with the empty pBAD33 vector. Among the 12 orfs assessed, only 
orf10 product ORF10 caused reduction of OD600 in cells (Figure 4.6a) whereas the growth curve 
of cells expressing the rest of the orfs was indistinguishable from control (data not shown). 
Therefore, orf10 was singled out and a more refined growth curve was carried out where the colony 
forming units (cfu) of strains expressing orf10 were also counted and the morphology of S39006 
cells expressing orf10 was imaged using phase contrast microscopy. As shown in Figure 4.6b, 
immediately after induction, cells expressing orf10 entered into a bacteriostasis state. The peak cfu 
of cells expressing orf10 after reaching stationary phase was 20-fold lower than cells with the 
empty vector control. The reason for such reduction could be attributed to stalled cellular division 
as orf10 was shown to cause filamentation of the cells (Figure 4.6c). This could also explain the 
continued increase in OD600 despite the lack of increase in cfu. Compared to control, cells 
expressing orf10 seem to be elongating but not dividing. Some of the elongated cells (Figure 4.6c, 
pBAD33::orf10 at 15h) exceeded the length of 10 normal cells, but only 1-2 septa could be 
observed. This implies that ORF10 does not significantly affect cellular elongation but obstructs 
septation. This could be due to the innate functionality of ORF10 or could simply be the result of 
overexpression of an exogenous protein. 
 
 




Figure 4.6 (continued overleaf): Growth curve of S39006 expressing orf10. 
 




Figure 4.6 (continued from previous page): Growth assay of S39006 expressing orf10. 
Detailed method of the growth assay is described in Section 5.1, Chapter 2. The starting culture 
had an OD600 of 0.05 and was grown to early-exponential phase (5h) when 0.1% L-ara was added. 
(a) Optical density at 600 nm of S39006 expressing orf10 versus S39006 with the empty vector 
pBAD33. (b) Colony forming units of S39006 expressing orf10 versus S39006 with the empty 
vector pBAD33. (b) Phase contrast microscopy of S39006 expressing orf10 versus S39006 with 
the empty vector pBAD33 at hours 5, 9, and 15. Scale bar represents 3μm. 
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6. No tRNA in the LD region activates Abi on its own 
In the LD regions deleted in ToxINPa-escape mutants of ΦCBH8, there are numerous tRNAs genes. 
Attempts were made to first investigated whether the tRNAs deleted were responsible for directly 
activating Abi. ΦCBH8u was chosen as the target mutant because it has the least number of tRNAs 
contained in its LD region, namely tRNA genes encoding Leu (anticodon TAA), Arg (anticodon 
TCT), Met (anticodon CAT) and Gly (anticodon TCC) (Figure 4.1). These tRNA genes and 
surrounding sequences were cloned into pBAD33 individually and introduced into S39006 
containing ToxINPa. In a complementation assay, similar to that described in Section 3 of this 
chapter, induction of tRNA gene transcription with 0.05% L-ara in the presence of ToxINPa did 
not restore Abi of ΦCBH8u (data not shown). This suggests that tRNAs in the LD regions are not 
directly activating ToxINPa-mediated Abi, at least individually. 
 
Analysis was also carried out to assess whether the deleted tRNAs could be indirectly activating 
ToxINPa-mediated Abi by assisting the translation of orf products in the deleted region. Previous 
research suggested that even though phages could hijack host tRNAs for their own translation, 
some can still carry tRNA genes in their genomes to complement the different codon usage bias 
between phage and host (151). Therefore, it is possible that the tRNAs deleted in the escape 
mutants were important for translation of an Abi-activating phage protein that could not be 
translated adequately with only host tRNAs. Investigation of the tRNA genes in the S39006 
genome showed that it contains 1 copy of Leu (TAA), Arg (TCT) and Gly (TCC) genes and 5 
copies of Met (CAT). This shows that the host is not completely devoid of the tRNAs deleted in 
ΦCBH8u. Despite this, the phage may still have a different codon usage profile compared to the 
host, and a single copy of the above tRNA genes in the host may not have been adequate for 
efficient translation. Therefore, the codon usage of orfs contained in the LD region in ΦCBH8u 
was analyzed to identify if any ORFs has frequent usage of Leu (TAA), Arg (TCT) and Gly (TCC). 
As seen in Figure 4.7, the codon usage frequency of all three tRNAs in the phage is higher than in 
the host, but the difference is minimal. Focusing on orfs8-18 within the common core of all deleted 
regions in different mutants, orf10, orf16 and orf17 have higher codon usage of Leu (TAA) and 
Gly (TCC) compared to the host or the average of the ΦCBH8 genome, whereas orf18 has higher 
codon usage of Gly (TCC). Despite the relatively higher frequency, the difference in codon  
 
 




Figure 4.7: Codon usage frequency of Leu (anticodon TAA), Arg (anticodon TCT) and Gly 
(anticodon TCC). “% frequency” is calculated from the number of times the said codon is used 
divided by the total number of times that any codon is used for the specific amino acid. “Host” 
represents the codon usage in S39006, “phage” represents the codon usage in ΦCBH8wt, ORF3-
ORF18 represent the codon usage of orfs deleted in ΦCBH8u. 
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usages mentioned above are only marginal. Therefore, from the crude bioinformatics analysis, 
there is no evidence that that deletion of the tRNA genes in ΦCBH8u would affect ORF translation 
in deleted regions.  
 
7. Discussion 
Whole genome sequencing of ToxINPa-escape mutants of ΦCBH8, ΦCHI14 and ΦX20 revealed 
that the most frequently found escape locus was the deletion of a substantial region of the phage 
genome, presumably indicating that elements within these regions activate ToxINPa-mediated Abi. 
The deletions may have occurred through recombination or strand slippage, as suggested by the 
existence of direct repeats bordering the deleted regions. The size of the deletion represented 3.8–
5.8% of the total genome size, yet no obvious fitness defects were observed for the mutants, 
confirming that the deleted regions are dispensable for phage propagation under lab conditions. 
This is consistent with previous research showing that some phage genomes carry genes that are 
not necessary for propagation, at least in the growth conditions tested (152, 153). However, this 
does not mean that the deleted regions are completely redundant, they may have functions under 
unfavorable conditions to improve phage fitness, such as in the natural environment, or perhaps to 
trigger host defense. This is intriguing in that a “redundant” part of the phage genome acts against 
the phage itself to activate an Abi system. One explanation for this would be that these S39006 
phages are not usually exposed to ToxINPa in nature, and the LD regions’ involvement in Abi 
activation is mere coincidence or side effect. Another explanation would be that the entire LD 
region is acquired by wild type phages through recombinogenic lateral gene transfer (154) in the 
natural environment (perhaps during mixed viral infections). This is supported by two pieces of 
evidence: (1) the LD region is unique to these ToxINPa-sensitive S39006 phages and has limited 
degree of identity with other related phages; and (2) most of the 5' borders of the deleted regions 
lie within tRNA genes, whose conserved sequences are readily recombinogenic. It could be argued 
that this has echoes of the descriptions of Pathogenicity Islands in bacteria (155, 156) and therefore 
could even suggest that the large deletion region is a potentially mobile viral genome unit.  
 
Further investigation into the genetic elements contained in the deleted regions showed the 
presence of protein-coding orfs and several tRNA genes. It is more likely that the orfs, instead of 
tRNAs, are responsible for Abi-activation for 4 reasons: (1) genetic loci involved in Type III-TA 
activation in other systems were all found to be protein-coding orfs; (2) the 4 tRNAs deleted in 
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ΦCBH8u were present in the host genome; (3) for the 4 tRNAs deleted in ΦCBH8u, no significant 
codon usage bias difference was observed between the host and phage, or between orfs in the LD 
region and host and (4) complementation of the deleted tRNA genes did not “re-activate” Abi 
during ΦCBH8u infection. orfs in ΦCBH8o, the mutant that contains the least number of orfs 
deleted, were investigated one by one. Complementation assays showed that none of the orfs could 
individually activate ToxINPa, suggesting that at least 2 orfs are simultaneously involved in the 
process. These orfs could be located some distance apart from each other, so that it could be easier 
to delete the entire region of non-essential genes containing these orfs rather than mutating each 
of them simultaneously. Evidence corroborating this hypothesis comes from the toxicity of the 
orf18 product and obstruction of cell division from the orf10 product. At the same time, orf18 and 
orf10 are located at two extremes of the common core shared by all LD regions (Figure 4.1). 
Therefore, orf10 and orf18 are two candidates that may be involved in activating ToxINPa-
mediated Abi in concert. Given the possible toxic nature of orf18, future research could focus on 
deleting orf10 and orf18 from ΦCBH8wt and assessing the resulting ToxINPa-sensitivity. In 
addition, ORF16, ORF17 and ORF19 were found to cause partial reduction of ΦCBH8o titer in 
the complementation assay, implying that they could also be involved in activating Abi. Therefore 
future attempts could also involve investigation of any direct interactions between these ORFs and 
the ToxINPa complex using biochemical techniques. 
 
In conclusion, characterization of the “large deletion” mutants in this chapter have presented a 
frustrating and complicated scenario where more than two orfs are likely to be simultaneously 
involved in Abi-activation. This is different from previous examples of ToxINPa or AbiQ escape 
mutants where only a single orf was mutated (98, 99). If indeed orf10 and orf18 are involved in 
activating ToxINPa-mediated Abi, then a similar feature with orf23 in ΦM1 is that both encode a 
toxic, but unrelated, hypothetical protein. These orfs could be triggering some host stress-response 
pathway that, in turn, could cause Abi activation. Future work could test this hypothesis by looking 
at ToxINPa-mediated Abi activation in hosts with defective stress-response systems. 
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Chapter 5 - T4-family phages escape 
ToxINPa via mutation of the asiA gene 
 
1. Introduction 
For virulent phages such as T4, transcription of its own genes happens rapidly after DNA injection. 
In the absence of its own RNA polymerase (RNAP), T4 must hijack the host transcription 
machinery. The key process in hijacking involves redirecting the σ70 subunit of host RNAP away 
from host promoters and towards phage promoters. While promoters of early T4 genes have 
naturally high affinity for host σ70, the mechanism for phage middle gene transcription is much 
more complicated (26). The transcription of some middle genes occurs through a process called σ-
appropriation where RNAP is redirected towards phage middle promoters through the concerted 
effort of a phage-encoded transcription activator MotA and a co-activator AsiA. As reviewed 
extensively by Hinton and colleagues and illustrated in the simplified diagram in Figure 5.1, AsiA 
re-models σ70 through its multiple contacts with Region 4 of σ70 and β-flap of the RNAP β-subunit 
(25, 157). This remodeling retards RNAP’s ability to recognize -35 elements of host promoters 
and phage early promoters and frees the C-terminal domain (CTD) of σ70 so that it can form contact 
with the CTD of MotA. In the meantime, the N-terminal domain (NTD) of MotA recognizes and 
binds to the MotA box, a phage middle gene-specific element located at -30. This enables host 
RNAP to recognize phage middle gene promoters and initiate transcription. In this complicated 
process, AsiA can be seen as a bridge that connects σ70, the β-flap and MotA (25, 158). 
 
As briefly introduced in Chapter 3, S39006 phages ΦCBH8 and ΦCHI14 could escape ToxINPa-
mediated Abi through mutation of the asiA gene. In contrast to the situation with hypothetical 
proteins in the LD regions of other S39006 phages or protein M1-23 in ΦM1 (98), this is the first 
case where an ORF associated with ToxINPa-mediated Abi has known function. However, given 
the important yet complicated role that AsiA plays in σ-appropriation, it is not immediately clear 
how AsiA is connected to the activation of Abi.  
 
Therefore, this chapter aims to characterize the effect of the asiA mutations on the phage, the host, 
and ToxINPa. Phage fitness in the presence of wild type asiA gene and mutant asiA gene will be 
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tested. The effect of producing the wild type AsiA protein and mutant AsiA protein on S39006 
growth will also be assessed. Finally, the effect of expressing the wild type and mutant asiA gene 
on the activity of the toxINPa locus will be investigated using a reporter system. These assays will 
provide an answer to whether the asiA gene’s involvement in ToxINPa activation occurs through 























Figure 5.1: The process of σ-appropriation in T4. (a) Without AsiA, RNAP transcribes host 
genes by recognizing promoter -35 elements through Region 4 of σ70. (b) After the AsiA protein, 
produced by T4 early gene asiA, contacts σ70 Region 4 and β-flap, σ70 undergoes conformational 
change and is no longer able to recognize the promoter -35 element, and is thus unable to transcribe 
phage early genes or host genes. (c) The conformational change caused by AsiA also enables σ70 
to form contact with MotA, which recognizes and binds to the MotA box at phage middle 
promoters. This enables RNAP to start transcribing phage middle genes. In all the figures, α-
subunits of RNAP are not shown for simplicity. Figures are adapted from the research article by 
Minakhin and colleagues (159). 
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2. AsiA is involved in the activation of ToxINPa-mediated Abi 
ToxINPa-escape mutants of ΦCBH8 and ΦCHI14 (FCBH8a, FCBH8l, FCBH8r, ΦCHI14b and 
ΦCHI14f), were found to have mutations in the asiA gene based on whole genome sequencing 
data. To validate the mutations, the asiA genes in these mutants were PCR amplified and subjected 
to Sanger sequencing. Furthermore, additional ToxINPa-escape mutants of ΦCBH8 and ΦCHI14 
were isolated in an attempt to find more mutants with asiA mutations. This resulted in the isolation 
of three more mutants (FCHI14q, FCHI14s and FCHI14w) (105). In total, 8 asiA mutants of 
ΦCBH8 and ΦCHI14 were sequenced and the nature of the mutations shown in Figure 5.2. Most 
of the mutations cause changes at the CTD of AsiA except for FCHI14w where the Valine to 
Glycine mutation is near the NTD. At the CTD, the mutated AsiA is either truncated after the 70th 
or 71st amino acid or undergoes amino acid substitution followed by extension after the 80th or 81st 
amino acid.  
 
To further confirm that AsiA plays an important role in enabling ΦCBH8 and ΦCHI14 to activate 
ToxINPa-mediated Abi, complementation of AsiA was carried out. The asiA gene from wild type 
ΦCBH8 was PCR amplified and cloned into the L-ara inducible pBAD33 vector. ΦCBH8a (CTD 
truncated AsiA) was used to infect S39006 transformed with both ToxINPa and pBAD33::asiA. As 
shown in Figure 5.3, when expression of wild type AsiA was not induced, ΦCBH8a formed clear 
spots on the bacterial top lawn, indicating no activation of Abi. In contrast, when expression of 
wild type AsiA was induced with 0.05% L-ara, ΦCBH8a was not able to lyse the bacterial lawn, 
indicating Abi. The complementation assay confirms that the presence of wild type AsiA is indeed 












Figure 5.2: Alignment of the AsiA protein sequence in wild type ΦCBH8 (CBH8wt) and 
ΦCHI14 (CHI14wt) with mutated AsiA protein in ToxINPa-escaping mutants (CHI14b, 
CHI14f, CHI14q, CHI14s, CHI14w, CBH8a, CBH8l, CBH8r). Note that AsiA sequences from 
wild type ΦCBH8 and ΦCHI14 are identical. Blue highlight indicates conserved residues in 
mutants compared to wild type while yellow highlight represents mutated residues, including 
single amino acid substitution (CHI14w) or frameshift mutation causing truncation (CHI14b, 
CBH8a, CBH8l, CBH8r) or substitution followed by extension (CHI14f, CHI14q, CHI14s). 
  





Figure 5.3: Complementation of AsiA. ΦCBH8a was serially diluted and plated on a top lawn 
containing S39006 transformed with ToxINPa and pBAD33::asiA. When asiA expression was not 
induced (left), ΦCBH8a formed clear spots and plaques on the bacterial lawn, indicating escape 
from ToxINPa. When asiA expression was induced with 0.05% L-ara (right), ΦCBH8a did not 
cause lysis of the bacteria even at high phage titer, indicating Abi. In the experiments above, the 
undiluted phage stock (100 dilution) used had a titer of 1010 pfu/mL. 
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3. AsiA in ToxINPa-escape mutants exhibit loss of functionality 
To provide more context for AsiA mutations found in ToxINPa-escape mutants of ΦCBH8 and 
ΦCHI14, the AsiA primary sequences from different T4-family phages mentioned in Table 3.2 
(Chapter 3) were aligned with each other. As shown in Figure 5.4, ΦCBH8 and ΦCHI14 have 
identical AsiA consisting of 89 amino acids whereas AsiA sequences from other T4-family phages 
are 1-7 amino acids longer. Amino acid residues that are fully conserved or have conservative 
replacements (highlighted in red in Figure 5.4) are evenly distributed throughout the lengths of the 
peptides. In particular, the NTD and CTD showed greater continuity of sequence conservation, as 
well as the 33rd -39th residue region (in reference to T4 AsiA). The mutated Valine in FCHI14w 
is positioned in a fully conserved region in the NTD and the truncated or substituted and extended 
regions in the CTD of other mutants also contain conserved residues. Since sequence conservation 
is often correlated with functional conservation, it is possible that the mutated protein product of 
asiA in ToxINPa-escape mutants have compromised functionality.  
 
To investigate whether the mutated AsiA protein from ToxINPa-escape mutants was still functional, 
a two-pronged approached was used where the effect of asiA mutations on both the host and phage 
fitness was investigated. On the host side, a growth assay of S39006 transformed with the pBAD33 
vector carrying different versions of asiA was conducted. As shown in Figure 5.5a, S39006 
carrying the empty pBAD33 vector (negative control) was grown in LB, and culture OD600 
exhibited the conventional S-shaped curve and reached ~4.5 after entering stationary phase. Cells 
also became smaller and shorter upon reaching stationary phase (Figure 5.5b), which is 
characteristic of reductive division and dwarfing for stationary phase cells (160).  In contrast, 
where S39006 was transformed with the wild type AsiA (positive control), expression of asiA 
caused a reduced growth rate in culture OD600, and when cells entered stationary phase, culture 
OD600 was less than half of the negative control. Cell morphology did not exhibit any obvious 
changes after entering stationary phase. This suggests that expression of wild type asiA of ΦCBH8 
slowed down S39006 cell division and eventually caused growth arrest. This is expected since the 
function of AsiA in T4 is prevention of host gene transcription, leading to diminished growth and 
growth arrest. Interestingly, in the test cultures where S39006 expressed the mutated AsiA protein 
from FCHI14w (V13G) or FCBH8a (CTD truncation), cells did not exhibit any growth arrest and 
behaved almost identical to the negative control. This implies that mutated AsiA can no longer 
inhibit host  





Figure 5.4: Alignment of AsiA protein in T4-family phages. “*” (asterisk): positions that have 
a single, fully conserved residue. “:” (colon): conservation between groups of strongly similar 
properties. “.” (period): conservation between groups of weakly similar properties. Positions that 



















Figure 5.5: S39006 expressing wild type or mutant AsiA. In the negative control, S39006 was 
transformed with the empty pBAD33. In the positive control, S39006 was transformed with the 
wild type asiA cloned into pBAD33 (pBAD33::asiA-wt). In the test samples, S39006 was 
transformed with asiA from FCHI14w or FCBH8a cloned into pBAD33 (pBAD33::asiA-CHI14w 
or pBAD33::asiA-CBH8a). Cells were grown from a starting OD600 of 0.05. Induction of asiA 
expression was achieved by adding 0.05% L-ara at 2h. (a) OD600 of the cultures, taken every two 
hours until stationary phase. Error bars represent standard deviation from triplicates. (b) Phase-
contrast microscopy showing cellular morphologies at 8h (exponential phase) and 12h (early 
stationary phase). Scale bars represent 2 µm. 
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gene expression, consistent with the mutations causing loss of function. The different positions of 
the mutations also suggest that both V13 and the C-terminus residues are important for a functional 
AsiA. 
 
On the phage side, if mutated AsiA protein lost its function in inhibiting host cell growth, it is 
likely that phages with mutant AsiA protein would also have fitness defects because successful 
phage replication is dependent on the function of AsiA in σ-appropriation. The plaque size and 
morphology of asiA mutant FCBH8a was first investigated in comparison to FCBH8wt. As shown 
in Figure 5.6a, when grown on a top lawn of wild type S39006, FCBH8a formed pinpoint plaques. 
Since plaque size is considered to be positively correlated with burst size for some phages (161), 
this could imply that FCBH8a has a decreased burst size when infecting wild type S39006. Indeed, 
investigation of FCBH8a burst size showed that FCBH8a has significantly decreased burst size 
(~10 phage particles per center of infection), in comparison to the FCBH8wt burst size of 30 
(Figure 5.6b). Furthermore, FCBH8a also had a significantly longer latent period. This means that 
mutation of AsiA in ToxINPa-escape mutants seriously compromises the efficiency of phage 
propagation. 
 





Figure 5.6: Fitness of AsiA mutant FCBH8a. (a) Plaque morphology comparison of FCBH8a 
and FCBH8wt grown on a top lawn of S39006. Scale bars represent 2 mm. (b) Burst size 
comparison of FCBH8a and FCBH8wt. Phages were added to exponential phase S39006 culture 
at a MOI of 0.1, and phage titer was measured every 10 minutes. Burst size was calculated by 
dividing the number of phages in the culture by the number of phages at time point 0. Details of 
the burst size assay is described in Section 3.10, Chapter 2. Error bars represent standard deviation 
from triplicates. 
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4. The effect of AsiA on ToxINPa promoter activity 
Considering the effect of asiA mutation on both host growth and phage fitness, the above results 
suggest that the involvement of the AsiA protein in ToxINPa-mediated Abi might be related to its 
function in σ-appropriation. Previous studies suggested that ToxINPa is a highly dynamic complex 
with newly transcribed antitoxin RNA constantly being cleaved by the toxin, thereby inhibiting 
ToxNPa toxicity (91, 92). Therefore, perturbation of toxINPa transcription could affect the 
continuous supply of ToxIPa, lead to the release of ToxNPa and activation of ToxNPa-mediated Abi. 
Since AsiA in T4 was known to decrease host gene transcription and AsiA in FCBH8wt was 
shown to cause S39006 cell arrest, it is possible that AsiA could be involved in activating ToxNPa-
mediated Abi by perturbing transcription from the ToxINPa promoter. To investigate this 
hypothesis, plasmid pTA104 (64) that contains the ToxINPa promoter (transcriptional positions -
200 to +3)-lacZ fusion was first introduced into E.coli DH5α (Figure 5.7a). At the same time, 
pBAD33 (control), the wild type asiA cloned into pBAD33 (pBAD33::asiA-wt) or asiA from 
FCBH8a cloned into pBAD33 (pBAD33::asiA-CBH8a) was also introduced into E.coli DH5α 
carrying pTA104. E.coli DH5α, instead of S39006, was used in this experiment because of the 
difficulty in transforming S39006 with pTA104. The growth of each strain was assessed with asiA 
expression induced at 2h with 0.05% L-ara. As shown in Figure 5.7b, wild type asiA expression 
inhibited DH5α culture growth to an extent even greater than observed in S39006. Consistent with 
the results in S39006, expression of mutant asiA showed no inhibition of cell division and behaved 
like the control culture. To determine the level of ToxINPa promoter activity (reflected as β-
galactosidase production), the β-galactosidase activity (normalized to cell density) in each culture 
was measured in a MUG assay. As shown in Figure 5.7c, β-galactosidase activity after induction 
of wild type AsiA was significantly lower compared to that of the control, with the greatest 
difference of 3-fold observed at 8h. In contrast, β-galactosidase activity of cells expressing the 
mutant AsiA was essentially identical to that of the control. This suggests that asiA expression 
could reduce ToxINPa promoter activity by as much as 3-fold in DH5α, whereas expression pf the 
mutant asiA had no such effect. These results are consistent with the hypothesis that the AsiA 











Figure 5.7: The effect of AsiA on ToxINPa promoter activity. (a) Schematic representation of 
the ToxINPa promoter-lacZ fusion in pTA104, using pRW50 as backbone (90). (b) Growth curve 
of E.coli DH5α transformed with pTA104 and pBAD33 (control), pBAD33::asiA-wt or 
pBAD33::asiA-CBH8a. asiA expression was induced at 2h with 0.05% L-ara and the OD600 of the 
cultures was measured every 2h until stationary phase. (c) MUG assay of cultures measuring β-
Chapter 5 T4-family phages escape ToxINPa via mutation of the asiA gene 
 
 116 
galactosidase activity. Detailed method can be found in Section 5.2, Chapter 2. In both (b) and (c), 
error bars represent standard deviation from triplicates. 
5. Discussion 
S39006 phages sensitive to ToxINPa-mediated Abi could escape the system via mutation of the 
phage gene encoding the AsiA protein involved in σ-appropriation. Complementation of AsiA 
restored the Abi phenotype to escape phages, confirming that AsiA plays a role in phage sensitivity 
to ToxINPa-mediated Abi. This is the first example where an orf associated with ToxINPa 
functionality has a defined function.  
 
The majority of ΦCBH8 and ΦCHI14 mutants with an asiA mutation have the CTD of the protein 
extended or truncated while only one mutant had a NTD missense mutation. Both the NTD and 
CTD mutants lost their ability to inhibit host cell division. The results involving the V13G mutant 
are consistent with previous research showing that this residue is conserved in T4 and is important 
in σ-appropriation by contacting Region 4 of σ70 (162). In contrast, the results involving the CTD 
mutants of AsiA in this study differ from previous research. According to previous work on T4, 
the CTD of AsiA is not essential for its function because mutants with a 17-residue truncation still 
showed moderate level of toxicity, a 28-residue truncation still showed low level of toxicity and 
only when 34-residues in the CTD were truncated did AsiA show no toxicity at all (162). However, 
in the work described here, expression of asiA from ΦCBH8a with a 19-residue truncation at the 
CTD showed no toxicity to S39006, suggesting that the CTD residues are required for AsiA 
function. This could mean that the functionality of the AsiA CTD differs in different phages. 
Nevertheless, these results show that, at least in ΦCBH8, the CTD residues of AsiA are important 
for σ-appropriation. This view is further corroborated by results from the burst size assay where 
the CTD truncation of AsiA reduced phage burst size by 60% and extended the latent period. 
Similar fitness defect was also observed in T4 where a mutant with AsiA truncated after the 22nd 
residue (from the N-terminus) had a significantly longer latent period (163). Taken together, these 
results suggest that the mutated AsiA in ToxINPa-escaping mutants of ΦCBH8 and ΦCHI14 have 
completely lost their ability to inhibit host cell growth, whereas they are still able to facilitate phage 
propagation, albeit with significantly decreased efficiency (as seen in the case of ΦCBH8a). 
 
The compromised functionality of AsiA in ToxINPa-escape mutants of ΦCBH8 and ΦCHI14 
suggest that the mechanism for AsiA activation of ToxINPa-mediated Abi may be closely related 
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to its function in σ-appropriation. Three possible mechanisms can be proposed: (1) AsiA perturbs 
toxINPa transcription, causes imbalance of ToxNPa: ToxIPa ratio which leads to ToxINPa 
disassembly; (2) The toxicity of AsiA in S39006 triggers some host response pathway that 
subsequently activates ToxINPa-mediated Abi; (3) ToxINPa-mediated Abi is directly activated by 
another phage middle gene product(s) but AsiA is essential for its transcription. This study has 
revealed evidence for the first mechanism because the effect of AsiA on ToxINPa promoter activity 
showed that wild type AsiA caused a significant reduction in ToxINPa promoter activity, whereas 
mutant AsiA had no such effect, suggesting that ΦCBH8 and ΦCHI14 mutants may escape 
ToxINPa because their AsiA no longer perturbs toxINPa transcription. Future work could focus on 
directly measuring the ratio of ToxNPa and ToxIPa in the presence of AsiA, as well as testing Abi 
of previously insensitive S39006 phages in the presence of AsiA from ΦCBH8 or ΦCHI14. 
Mechanism 2 is also possible because of the significant host growth arrest caused by AsiA, similar 
to that observed for some LD orfs in Chapter 4. While mechanism 3 is also plausible, ΦCBH8a 
fitness assays suggest that the mutant phages could still produce progeny and it is therefore 
unlikely that transcription of the putative middle gene products are obliterated.   
 
In summary, the discovery that AsiA is involved in activating ToxINPa-mediated Abi shows that 
σ-appropriation, a mechanism benefiting phage proliferation, could also be involved in phage 
demise. This further complicates the story of whether activation of ToxINPa-mediated Abi is 
caused by targeted phage product(s) per se or is just the indirect effect of normal phage processes, 
or perhaps both, depending on the specific phage and host. 
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Chapter 6 - Host dependency of ToxINPa 




During the interaction between phages and Type III TA systems such as ToxINPa, a phage 
product(s) might directly activate ToxINPa-mediated Abi but might also indirectly activate Abi 
through triggering certain response pathway(s) in the host. If the latter turns out to be true, then 
ToxINPa-sensitivity could be host dependent. However, no data supports a host-dependency of 
ToxINPa-sensitivity so far. While it has been observed that it is relatively easier to isolate ToxINPa-
sensitive phages for some hosts (such as P.atrosepticum and E.coli K-12) (64) and difficult for 
others (such as D. solani MK10, where no ToxINPa-sensitive phage has been isolated, so far), this 
is not proof that ToxINPa-sensitivity is host dependent, because ToxINPa might not be adequately 
expressed and correctly assembled in some hosts (Xinzhe Fang, unpublished data). Therefore, it is 
important to test the same phage for ToxINPa-sensitivity in different hosts where ToxINPa is known 
to be active for Abi.  
 
The first step during phage infection is receptor recognition and adsorption. Phages have been 
found to utilize a wide range of cell surface components as receptors, including membrane proteins 
that function as porins or flagella that function as motility nanomachines (16). The host range of 
phages differ with some phages able to only infect very specific species of bacteria while others 
are able to infect a broader range of hosts. Both ΦM1 and ΦTE, the only well-studied ToxINPa-
sensitive phages so far, are very sub-species specific (164), therefore limited information is 
available on their susceptibility to ToxINPa in more distant hosts. S39006 phages isolated in this 
study were also found to have a narrow host range (Section 4, Chapter 3). Since receptor specificity 
is the first limiting step to successful infection (32), it may be possible to artificially expand the 
host range of certain phages by modifying their tail structure (165, 166). It is also possible to render 
a host susceptible to phage by artificially introducing the appropriate receptor.  
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The aim of this chapter is to identify the receptor(s) used by S39006 phages and express the 
receptor in a different host to try to expand the host range of these phages. This would enable us 
to test the hypothesis of whether Abi by ToxINPa depends on the host background, and whether 
relevant ΦCBH8 loci involved in Abi-activation in a new host is the same as in S39006. Expansion 
of the host range of S39006 phages would also enable exploitation of these phages as 
biotechnological tools if they have the capacity to transfer genetic material between bacteria. 
Finally, exploration of the native function of a S39006 phage receptor and its regulation will not 
only deepen insight into the function of bacterial surface components but also provide novel ways 
to manually control host susceptibility to phage, with potential biotechnological value.  
 
2. ΦCBH8 utilizes OmpW as S39006 receptor 
In order to identify the receptor that ΦCBH8 utilizes to infect S39006, ΦCBH8-resistant mutants 
of S39006 were generated and the mutated gene(s) was identified as a potential receptor gene(s). 
Mutagenesis using the transposon Tn-KRCPN1 was performed to generate S39006 mutants, as 
described in Section 4.2.5, Chapter 2 (33). Theoretically, Tn-KRCPN1 would randomly insert into 
the S39006 genome and mutants that had successfully acquired the transposon would contain 
kanamycin resistance. If Tn-KRCPN1 inserted into the phage receptor, then mutants would also 
be resistant to ΦCBH8. Therefore, in order to select for mutants with Tn-KRCPN1 insertion in 
receptor gene(s), cells subjected to mutagenesis were grown in the presence of kanamycin and 
high titer ΦCBH8 in a top lawn.  
 
After 48h incubation, four mutant colonies arose, three of which were found to be false positives 
after re-streaking and testing for ΦCBH8 susceptibility. One mutant, named S39006-R1, was truly 
resistant to ΦCBH8 as well as possessing kanamycin resistance (Figure 6.1a-b). An adsorption 
assay was carried out to compare ΦCBH8 adsorption to wild type S39006 (S39006-wt) and 
S39006-R1. As shown in Figure 6.2, at a MOI of 0.01, more than 90% of ΦCBH8 have adsorbed 
to S39006-wt within 20min (n=3), as reflected in the decreased abundance of free phage remaining 
in the culture. In contrast, no phage has adsorbed to S39006-R1, as in the phage-only control. This 










Figure 6.1: Spot test assay of ΦCBH8 infecting S39006-R1 with and without 
complementation of the putative receptor mutant. (a) ΦCBH8 forms clear spots on S39006-wt; 
the positive control. (b) ΦCBH8 does not form clear spots on S39006-R1; indicating resistance. (c) 
ΦCBH8 does not form clear spots on S39006-R1 carrying the ompW plasmid but without induction 
of expression. (d) ΦCBH8 forms clear spots on S39006-R1 complemented with ompW with 
induction, showing restoration of susceptibility 
  






Figure 6.2: Adsorption assay of ΦCBH8 infecting S39006-R1 with and without 
complementation of the putative receptor mutant. The adsorption assay was carried out as 
described in detail in Section 3.9, Chapter 2. The lower the amount of free phage in the culture, 
the higher the number of phages that have adsorbed to cells. The percentage of free phage is 
calculated by dividing the titer of the phage taken from the sample at any given time point by the 
titer of the phage in the sample at time point 0. Error bars represent standard deviation from 
triplicates. 
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Replicon cloning (33) was used to investigate which gene was disrupted by the transposon, details 
of the method is described in Section 4.2.6, Chapter 2. Genomic DNA from S39006-R1 was 
extracted and digested with the restriction enzyme EcoRV which does not cut within the 
transposon, followed by ligation which allowed the digested DNA fragments containing the 
transposon to circularize. Because Tn-KRCPN1 contains an origin of replication (oriR6K), the 
circularized DNA (replicon) could be propagated within pir+ strains and this allows for cloning, 
sequencing, and then identification of S39006 sequences adjacent to the transposon insertion site. 
Sequencing results showed that Tn-KRCPN1 was inserted into the ompW gene that encodes an 
outer membrane protein W (OmpW) containing 211 amino acids. Insertion of the transposon after 
the 155th amino acid disrupted translation of ompW, therefore preventing phage adsorption. This 
suggests that OmpW is the host membrane component recognized by ΦCBH8 during adsorption. 
 
To confirm that OmpW is the phage receptor, the ompW gene from S39006-wt (denoted 
ompWS39006) was first amplified by PCR and inserted into the multi-cloning site of an L-ara 
inducible pBAD33 plasmid. The recombinant plasmid was introduced into S39006-R1 by 
transformation and its infection by ΦCBH8 was assessed in a spot test. As shown in Figure 6.1c-
d, induction of ompW expression from the pBAD33::ompWS39006 plasmid with 0.05% L-ara 
restored S39006-R1’s susceptibility to ΦCBH8. Similarly, ΦCBH8 adsorption to S39006-R1 
(pBAD33::ompWS39006) was also restored to a level comparable to S39006-wt (Figure 6.2). The 
complementation result confirmed that OmpW is the receptor for ΦCBH8. 
 
Spot tests and adsorption assays with S39006-wt, S39006-R1 and S39006-R1 
(pBAD33::ompWS39006)  were also performed using ΦCHI14, ΦX20 and ΦCBH189. Similar to 
ΦCBH8, the other S39006 phages also failed to lyse or adsorb to OmpW-deficient mutant whereas 
complementation of ompW restored their ability to adsorb and infect (data not shown). This shows 
that the ToxINPa-sensitive S39006 phages characterized so far all utilize OmpW as the receptor in 
S39006. 
 
3. Expansion of ΦCBH8 host range 
BLASTp search for homologues of S39006 OmpW showed that OmpW is conserved among 
Gram-negative species. In particular, OmpW from several Dickeya, Yersinia and Pectobacterium 
species share high protein sequence identity (>70% identity with 100% coverage) with 
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OmpWS39006. Protein sequence alignment of OmpWS39006 with OmpW from some of these strains 
showed that conserved residues and residues with highly similar properties are dispersed 
throughout the protein sequence (Figure 6.3). Attempts were made to transform some of these 
strains and other commonly used laboratory strains (e.g. E.coli DH5α) with pBAD33::ompWS39006 
to test whether ΦCBH8 could then infect these otherwise non-susceptible hosts. As shown in Table 
6.1 and Figure 6.4, of the 16 strains tested, E.coli DH5α, D.solani MK10 and D.zeae NCPP 3532 
became susceptible to ΦCBH8 after ompWS39006 expression was induced. The role of OmpW as 
the phage receptor in these strains was further confirmed in an adsorption assay. As shown in 
Figure 6.5, at a M.O.I. of 0.01, within 20 min more than 98% of ΦCBH8 adsorbed to E.coli DH5α 
after induced expression of ompWS39006, comparable to ΦCBH8 adsorption to S39006-wt (Figure 
6.2). Similarly, in the presence OmpWS39006, ΦCBH8 adsorption to D.zeae NCPP 3532 was also 
rapid, with more than 94% of phages adsorbed within 20 min. In contrast, ΦCBH8 adsorption to 
D.solani MK10 expressing ompWS39006 was slower, with 80% of phages adsorbed within 20 min 
and 88% adsorbed after 25 min. The adsorption results provide important confirmation that 
expression of ompWS39006 in previously resistant bacterial strains could artificially expand the host 
range of ΦCBH8 by providing the appropriate receptor absent from those hosts. This shows that 
the only obstacle preventing ΦCBH8 from successfully infecting those alternative hosts is the lack 



















Figure 6.3: Protein sequence alignment of OmpW from S39006 and other strains. “*” 
(asterisk): positions that have a single, fully conserved residue. “:” (colon): conservation between 
groups of strongly similar properties. “.” (period): conservation between groups of weakly similar 
properties. 
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Sensitive to ΦCBH8? 
Pantoea agglomerans 9rz4 ✓ ✕ 
Serratia plymuthica A153 ✓ ✕ 
Serratia marcescens Sma12 ✓ ✕ 
Dickeya sp. NCPPB 3274 ✓ ✕ 
Dickeya paradisiaca ✓ ✕ 




E. coli DH5α ✓ ✓ 
Dickeya zeae NCPP 3532 ✓ ✓ 




Dickeya dianthicola ✕ ✕ 
Dickeya chrysanthemi 402 ✓ ✕ 








*Note: strains transformed with pBAD33::ompWS39006 were subjected to plasmid mini-prep and 
subsequent sequencing to ensure that pBAD33::ompWS39006 was obtained and that ompWS39006 did 
not mutate. In the absence of the appropriate antibody, it is unknown whether OmpWS39006 is 
expressed in each strain, therefore only the ones that became sensitive to ΦCBH8 were chosen for 
further characterization. 
  




Figure 6.4: Spot test of serially diluted ΦCBH8 infecting E.coli DH5α, D.solani MK10 and 
D.zeae NCPP 3532 transformed with pBAD33::ompWS39006, with and without L-arabinose 
induction. Without induction of ompWS39006 expression, the hosts remained resistant to ΦCBH8 
(top row). However, when induced with 0.05% L-ara, ΦCBH8 was able to form clear spots on the 
hosts (bottom row). 
 




Figure 6.5: (figure legend provided overleaf) 
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Figure 6.5: Adsorption of ΦCBH8 to (a) E.coli DH5α, (b) D.solani MK10 and (c) D.zeae 
NCPP 3532 transformed with pBAD33::ompWS39006, with and without L-ara induction. The 
adsorption assay was carried out as described in detail in Section 3.9, Chapter 2. The lower the 
amount of free phage in the culture, the higher the number of phages that have adsorbed to cells. 
The percentage of free phage is calculated by dividing the titer of the phage taken from the sample 
at any given time point by the titer of the phage in the sample at time point 0. Error bars represent 
standard deviation from triplicates. 
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4. ΦCBH8 does not activate ToxINPa-mediated Abi in E.coli DH5α 
With the expanded host range, it was possible to explore ToxINPa-mediated Abi activation by 
ΦCBH8 in bacteria other than S39006. Previous studies showed that ToxINPa encoded by pTA46 
is functional as an Abi system in E.coli DH5α (64), therefore DH5α was transformed with both 
pTA46 and pBAD33::ompWS39006.  As control, DH5α was transformed with both pTA47 (ToxINPa-
FS) and pBAD33::ompWS39006. The EOP of ΦCBH8 infecting DH5α containing ToxINPa or 
ToxINPa-FS was measured. With an EOP of 0.148 (n=3), it seemed that ΦCBH8 was not aborted 
by ToxINPa. Phage plaques that arose from the top lawn of DH5α containing ToxINPa were bulked 
up and plated out again on DH5α containing ToxINPa or ToxINPa-FS to rule out the possibility that 
they were high frequency escape mutants. Indeed, the EOP of escape “suspects” was still 10-1, 
indicating that they were not escape mutants. Therefore ΦCBH8 does not activate Abi in E.coli 
DH5α, suggesting that ToxINPa-sensitivity is host dependent for this phage. 
 
5. ΦCBH8 mediates plasmid transfer between hosts through transduction 
Some phages mediate the transfer of genetic material between bacteria through transduction and 
have been used as important biotechnological tools (Section 1.3.3, Chapter 1). Given the expanded 
host range of ΦCBH8, it was possible to test whether ΦCBH8 is a transducing phage in its native 
host and in new hosts. A transduction assay (described in detail in Section 3.8, Chapter 2) was first 
done to test whether ΦCBH8 could transduce the pBR322 plasmid (ApR, TcR) in S39006-wt. The 
donor strain was S39006-wt transformed with pBR322 and the recipient strain was S39006-wt 
without any plasmid. ΦOT8, a known high-efficiency transducer of S39006 was used as positive 
control and the recipient strain added with only phage buffer was used as negative control. 
Successful transductants were recognized by the ability to grow on LBA containing both ampicillin 
and tetracycline. The result from the transduction assay showed that ΦCBH8 is able to transduce 
pBR322 between S39006-wt, with the highest transduction efficiency of 4.4´10-8 (n=3) achieved 
at a MOI of 0.1. Next, the transduction of pBR322 in DH5α was tested. The donor strain was 
DH5α expressing ompWS39006 and containing the pBR322 plasmid. The recipient strain was DH5α 
expressing ompWS39006 but without any plasmid. DH5α containing the pBAD33::ompWS39006 
plasmid but without induction of expression was also used as a negative control recipient. 
Successful transductants were recognized by the ability to grow on LBA containing ampicillin, 
chloramphenicol and tetracycline. Results showed that ΦCBH8 is able to transduce pBR322 into 
DH5α, with the highest transduction efficiency of 5.0´10-9 (n=3) achieved at a MOI of 1. In all of 
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the transduction assays mentioned above, the receipt of the transduced plasmid was not only 
confirmed by the newly acquired antibiotic resistance of recipient cells, but also by the physical 
evidence of the acquired DNA visualized on agarose gel (Figure 6.6). For transduction of pBR322 
into S39006-wt, plasmid mini-prep of transductant followed by digestion with HindIII yielded a 
single DNA band of ~5-6kb in size, confirming the acquisition of pBR322. For transduction of 
pBR322 into DH5α (expressing ompWS39006), plasmid mini-prep of transductant followed by 
digestion with HindIII yielded two distinct DNA bands, one with ~5-6kb in size and the other with 
~4-5kb in size, indicative of the existence of both pBR322 and pBAD33::ompWS39006 in the 
recipient strain. To rule out the possibility of natural competence causing the acquisition of 
pBR322, additional negative controls were also used where phage lysates were treated with DNase 
and RNase to digest any genetic material in solution, as well as adding pBR322 DNA directly into 
the recipient cell culture. However, none of the negative controls yielded any positive results, 
proving that transduction by ΦCBH8 is indeed the reason for the observed plasmid transfer. 
 
To further substantiate these results, a second plasmid (pTRB30, KnR, modified from pQE80L) 
was used to test ΦCBH8 transduction. Similar to the case of pBR322, ΦCBH8 was also shown to 
mediate pTRB30 transfer in S39006-wt and in DH5α (expressing OmpWS39006). 
 
In contrast, ΦCBH8 was not able to transduce chromosomal markers. For both markers tested (Tn-
KRCPN1, KnR and mini-Tn5, Sm/SpR), no successful transductant was found while ΦOT8, the 
positive control, was able to transduce both chromosomal markers with high efficiency. These 


















Figure 6.6: Visualization of DNA transfer in (a) S39006-wt and (b) DH5α. In (a), the 
transduction of pBR322 between wild type S39006 strains was tested. Transductant that arose in 
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the selection plate was re-streaked at least twice and subjected to mini-prep. The resulting DNA 
was visualized on an agarose gel (lane 4) and exhibited the same pattern as the mini-prep product 
from the donor strain (lane 2). The mini-prep product from transductant was also digested with 
Hind III and showed a size between 4-5 kb on the agarose gel, consistent with the 4.3 kb size of 
pBR322. In (b), the transduction of pBR322 between DH5α was tested. Both the donor and 
recipient DH5α already contained the recombinant vector pBAD33::ompWS39006. Transductant that 
arose in the selection plate was re-streaked at least twice and subjected to mini-prep. The resulting 
DNA was visualized on the agarose gel (lane 3). The resulting DNA was also digested with Hind 
III and contained two bands with distinct sizes, one between 4-5 kb (consistent with the 4.3 kb size 
of pBR322) and another between 5-6 kb, consistent with the 5.4 kb size of pBAD33. 
 
 
6. The function of OmpWS39006 
As a highly conserved minor porin, the function of OmpW has only been elucidated in E.coli K-
12 as the receptor for colicin S4 (167). OmpW has also been connected with resistance to 
antibiotics, resistance to phagocytosis and the transition from aerobic to anaerobic growth 
conditions (168-170). However, the exact role of OmpW in relation to these phenotypes is unclear. 
The function of OmpW in S39006 has not been studied before, therefore it would be important to 
gain some insight into the role of OmpW other than as a phage receptor. This would enable us to 
exploit OmpW functionality to regulate phage infection. 
 
6.1 OmpWS39006 is not important for S39006 fitness and is non-toxic 
The viability of S39006-R1 (with transposon inserted into ompW) serves as proof that OmpW is 
not essential for S39006 survival. To further assess whether OmpW is involved in bacterial growth 
and affects bacterial fitness, a growth assay was carried out in LB medium comparing wild type 
S39006 versus an OmpW mutant S39006-R4, where 4/5 of the OmpW peptide has been truncated 
and therefore should be non-functional. Detailed method on the genesis of S39006-R4 is in Section 
7.1, Chapter 2. As shown in Figure 6.7a-b, no difference in growth has been observed under 
aerobic or anaerobic conditions between S39006-wt and S39006-R4 grown in LB. Phase contrast 
microscopy imaging of S39006-wt and S39006-R4 also showed no difference in cell morphology 
during growth (data not shown). This shows that OmpW does not affect cell growth and division 
under either aerobic or anaerobic conditions with rich medium.  




The toxicity of OmpWS39006 in a heterologous host was also investigated. In a growth assay of 
E.coli DH5α, cells containing pBAD33::ompWS39006 were induced to express OmpW after 2 hours 
of growth with 0.5% L-ara. As shown in Figure 6.7c, cells with induced OmpW expression 
exhibited a similar growth rate as cells containing the empty pBAD33 vector. In contrast, DH5α 
containing the empty pBAD33 vector but without L-ara induction reached a higher OD600, due to 
the toxic effect of L-ara on cells. Taken together, these results indicate that OmpW is not toxic 









Figure 6.7: Growth assay of cells without functional OmpWS39006 or over-expressing 
OmpWS39006. (a) Growth curve of S39006-wt versus S39006-R4 in aerobic conditions, with a 
starting OD of 0.05. (b) Growth curve of S39006-wt versus S39006-R4 in anaerobic conditions, 
with a starting OD of 0.05. (c) Growth curve of DH5α containing pBAD33 or 
pBAD33::ompWS39006, with or without 0.5% L-ara induction, with a starting OD of 0.1. 
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6.2 OmpW is not associated with common phenotypes of S39006 
S39006 is known for its phenotypes such as secretion of secondary metabolites, motility, and 
virulence. To investigate whether OmpW is involved in any of those phenotypes, a series of 
phenotypic assays were carried out to compare S39006-wt with S39006-R4, including secretion of 
Carbapenem, prodigiosin and N-butanoyl-L-homoserine lactone (BHL); ability to swim and 
swarm in agar; response to stress conditions such as the presence of ethanol, H2O2, SDS and NaCl; 
resistance to antibiotics; and virulence in potato and C. elegans. However, S39006-wt and S39006-
R4 showed no significant difference in any of the phenotypes tested, suggesting that OmpW is not 
involved in secondary metabolite secretion, motility, stress tolerance and virulence phenotypes 
mentioned above. Detailed description and results of the phenotypic assays are included in 
Appendix III. 
 
6.3 Genetic context and promoter analysis of ompWS39006 
In the absence of phenotypic differences between S39006-wt and S39006-R4, the genetic context 
of ompWS39006 was analyzed to gain more insight on its function. As shown in the schematic 
representation of ompW and neighboring genes in Figure 6.8a, ompW is not part of an operon. 
Genes located upstream of ompW (gene encoding cysteine cluster protein, gene encoding a 
hypothetical protein, the ycib gene that encodes intracellular separation protein A and gene 
encoding acetyl-CoA esterase) are also not part of an operon, nor are they obviously related to 
each other functionally. Genes located downstream of ompW are part of the tryptophan operon and 
encodes for tryptophan synthetase. However, it is unlikely that ompW is related to the Trp operon 
because of the distance between them and the different direction of transcription. 
 
In addition, sequences surrounding the promoter region of ompWS39006 are were analyzed by 
BPROM to look for potential binding sites for regulators. As shown in Figure 6.8b, the promoter 
region contains two near-perfect binding sites for FNR (Fumarate and Nitrate Reductase 
Regulatory) protein, which is required for the switch from aerobic to anaerobic metabolism. This 
is consistent with results by Xiao and colleagues showing that OmpW is involved in 
aerobic to anaerobic transition in E.coli K-12 (169). However, previous results (Figure 6.7a-b) did 
not support the view that OmpW plays a role in bacterial growth in different oxygen availability  
 





Figure 6.8: Genetic context and promoter analysis of ompWS39006. (a) Schematic diagram 
showing genes neighboring ompW in S39006. The direction of arrow head represents 5’®3’ 
direction of genes. (b) Putative regulator binding sites of ompW promoter region. Sequences in red 
color represent cognate consensus sequences for regulator binding. Arrow marks the presumed 
ompW transcription start site. 
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in S39006, at least in rich medium. The ompWS39006 promoter region also contains putative binding 
sites for CpxR and SoxS proteins that activate stress-combative genes and superoxide response 
regulon, respectively. However, previous results (Figure S2, Appendix III) also provide 
contradictory evidence as the OmpW-deficient mutant failed to exhibit any growth difference in 
the presence of various stress conditions. Finally, a predicted CRP (cAMP receptor protein) 
binding site is also found 5’ prior to the ompW transcription start site. Genes regulated by CRP are 
mostly involved in energy metabolism, such as the galactose, citrate, or PEP group translocation 
system (171), therefore OmpW could be involved in energy metabolism as a transporter. However 
due to the vast number of genes CRP regulates, it is not immediately clear what role OmpW might 
play. 
 
6.4 Conservation of residues important for OmpW function 
The structure of OmpWS39006 was investigated next in order to understand its function. Attempts 
were made to impose the tertiary structure of OmpWS39006 modelled by i-TASSER with structures 
of OmpW in E.coli K-12 and P. aeruginosa PAO1, the only two organisms whose OmpW structure 
has been elucidated by crystallography or NMR (172-174). However, such comparison has little 
meaning since i-TASSER relied on K-12 and PAO1 OmpWs to model the structure of OmpWS39006, 
therefore potential differences could have been omitted. In contrast, comparison of the primary 
sequence of OmpW in the said organisms could provide more insight. As shown in Figure 6.9a, 
OmpW protein sequences are extremely similar between the three species, with the exception of a 
few short stretches of dissimilar sequences that are mainly located in extracellular loop regions. 
Among the conserved residues, those that are found to embellish the hydrophobic lumen of OmpW 
in K-12 and PAO1 remained identical or similar in hydrophobicity at cognate positions in S39006 
(Figure 6.9b, red arrows). The hydrophobic lumen in K-12 and PAO1 were proposed to act as the 
channel for small hydrophobic molecules to pass through (172, 173), therefore the conservation of 
the hydrophobic lumen in S39006 implies a similar function. In addition, OmpW in PAO1 is 
believed to contain a Proline that forms a lateral opening in the transmembrane region of OmpW 
where the transported molecule would exit (173). Analysis of protein sequence alignment shows 
that this Proline (Figure 6.9b, green arrow) is conserved in S39006 as well, suggesting the existence 
of a lateral opening. Taken together, these similarities suggest that akin to the predicted function 
of OmpWK-12 and OmpWPAO1, OmpWS39006 could also function as a tunnel through which a small 
hydrophobic molecule passes through the outer membrane through lateral transport. However, 
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Figure 6.9: Protein sequence alignment of OmpW in S39006, E.coli K-12 and P. aeruginosa 
PAO1. Figure legend provided overleaf. 





Figure 6.9: Protein sequence alignment of OmpW in S39006, E.coli K-12 and P. aeruginosa 
PAO1. “*” (asterisk): positions that have a single, fully conserved residue. “:” (colon): 
conservation between groups of strongly similar properties. “.” (period): conservation between 
groups of weakly similar properties. (a) Prediction of the secondary structure of OmpWS39006 based 
on the crystal structures of OmpWK-12 and OmpWPAO1. Short stretches of dissimilar sequences are 
mainly located in extracellular loop regions and labeled with dashed dotted bi-directional arrows 
in red color. (b) Conservation of functionally important residues in OmpW of the three different 
species. Red arrow: residues that are highly conserved among the three species and are located in 
the lumen of OmpW, facing inward. Green arrow: conserved Proline located at the lateral opening 
of OmpW in PAO1. 
  




The outer membrane (OM) of Gram-negative bacteria serves as a barrier between the cell and its 
external surroundings. OM consists of phospholipids, LPS and proteins, with 50% of the OM mass 
contributed by proteins (175, 176). Some of these outer membrane proteins (OMPs), also known 
as porins, form transmembrane β-barrels that control the selective permeability of certain 
molecules across the OM. Depending on the size of the proteins, the porins can be categorized into 
major porins (12-22 β-strands, trimeric) and minor porins (8 or 10 β-strands, monomeric) (177). 
Aside from performing their physiological function, some OMPs are exploited by phages as 
receptors for adsorption. For example, OmpC (Outer membrane protein C) is recognized by phage 
T4 (165, 178), LamB (Maltoporin) is recognized by phage λ (179), and BtuB (Vitamin B12 
transporter) is recognized by some S. Typhimurium phages (22).  
 
OmpW is a minor porin widely distributed in Gram-negative bacteria. In 2014, Xu and colleagues 
reported that OmpW acts as the receptor for Vibrio cholerae O1 El Tor phage VP5, making it the 
first instance where OmpW is associated with phage recognition (180). In this study, we have 
found that OmpW also acts as the receptor for phages ΦCBH8, ΦCHI14, ΦX20 and ΦCBH189, 
the first instance for S39006 phages. Even though highly conserved homologues of OmpWS39006 
exist in different species (Figure 6.3), ΦCBH8 was found to be highly specific for OmpWS39006, 
failing to infect any other potential hosts tested. This is unsurprising because only one or a few 
key residues may be essential for phages recognition, therefore a slight difference in primary 
sequence could mean completely different interaction with the phage tail (181).  
 
Despite the restricted host range of ΦCBH8, it was shown that expression of plasmid-encoded 
OmpWS39006 protein enabled ΦCBH8 to infect a few otherwise non-susceptible hosts. Adsorption 
assays indicated, that upon induction of ompWS39006 expression, ΦCBH8 was able to adsorb to 
these hosts rapidly, implying that receptor specificity, instead of other post-adsorption defense 
mechanisms, was the main obstacle for successful infection. In contrast, 13 other hosts that have 
also acquired the ompWS39006-bearing plasmid failed to show susceptibility to ΦCBH8, the reason 
of which could be lack of ompWS39006 expression from the plasmid, improper folding or transport 
of the exogenous OmpWS39006 or the existence of other defense mechanisms. With the expanded 
host range of ΦCBH8, it was possible to test the phage for transduction across different species. 
ΦCBH8 transduced two plasmids with ColE1 origin in its original host and the new host, but failed 
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to transduce two chromosomal markers tested. The reason for this is unclear, but a possibility could 
be speculated from the requirement of headful packaging for generalized transduction. In order for 
a generalized transducing phage to “accidentally” package host DNA into its capsid, the size of 
the DNA fragment must be similar to the phage genome size (182, 183).  Therefore, for ΦCBH8 
to package S39006 DNA into its capsid, a chromosomal fragment bigger than 170 kb is required. 
Fragments of this size, equivalent to 3% of S39006 chromosome, might be non-existent by the 
time DNA packaging occurs since degradation of the host chromosome happens rapidly after 
initiation of infection. In contrast, studies have shown that plasmids are not necessarily degraded 
by phages during infection (184) and could therefore still be packaged into the phage capsid. The 
two plasmids tested in this study have a much smaller size than required for headful packaging, 
but studies have shown that ColE1-type plasmids such as pBR322 replicate via rolling circle 
replication and could form a concatemer large enough for headful packaging (185). Even though 
this explanation for ΦCBH8’s ability to transduce plasmid and inability to transduce chromosomal 
markers remains to be experimentally verified, ΦCBH8 could still act as a useful biotechnological 
tool to transfer plasmids between hosts. 
 
The discovery that OmpW acts as a phage receptor on the S39006 surface begged the question 
about the physiological function of OmpW. The answer to this question could help link S39006’s 
susceptibility to phage with its other biological phenotypes. Literature search showed that no 
experimental data exists on the function of OmpW in S39006 or other Serratia species. So far, the 
only well-established function of OmpW is that of colicin S4 receptor in E. coli K-12.  Other 
studies have proposed several functions for OmpW in different bacteria but are yet to be 
substantiated. For example, OmpW in Vibrio cholerae was proposed to transport carnitine (186), 
OmpW in Salmonella typhimurium was proposed to be an efflux pump of methyl viologen (187) 
and OmpW in Acinetobacter baumannii was found to transport iron (188). The transport function 
of OmpW is also predicted from structures of the protein in E.coli K-12 and P. aeruginosa PAO1 
where the inner tunnel of OmpW is lined with hydrophobic residues and contains an opening in 
the periplasmic domain of the porin, suggesting that OmpW is involved in lateral transport of a 
small hydrophobic molecule. The proposed transport function of OmpW seems to serve the 
purpose of stress tolerance and adaptation. In the examples mentioned above, carnitine is a 
compatible solute important for osmo-adaption in the presence of high NaCl concentration, methyl 
viologen is the inducer of reactive oxygen species, and iron homeostasis is important for bacterial 
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survival. Furthermore, previous studies have also shown that OmpW is involved in bacterial 
resistance to antibiotics such as tetracycline and kanamycin (168). Aside from stress response and 
adaptation, OmpW is also reported to be important in virulence. OmpW in E.coli K-12 was found 
to protect bacteria against host phagocytosis in mice infection assays (170) while OmpW in A. 
baumanni acted as a highly immunogenic marker in mice infection (189). 
 
The great variety of suggested functions for OmpW in different bacteria provided clues for its 
function in S39006, yet relevant assays carried out in this study comparing wild type S39006 and 
an OmpW mutant, looking at virulence, stress response and antibiotic resistance, did not yield any 
positive results. Furthermore, OmpWS39006 was also found to be non-essential for S39006 when 
grown in LB and non-toxic when over-expressed in E.coli DH5α. Even though the number of 
phenotypes assayed in this study is far from exhaustive, the current negative results, most of which 
were obtained from growth in rich medium and optimal growth conditions, could imply that the 
function of OmpW might only be clear in certain conditions, such as when grown in certain 
nutrient sources, oxygen availability or temperature. In fact, bioinformatics prediction of potential 
regulators that may act on the ompWS39006 promoter suggested that OmpW could be regulated by 
CRP, a global regulator involved in carbon metabolism, and FNR, a regulator involved in O2 
availability, consistent with data shown in E.coli K-12 (169). The ompW promoter also contains a 
SoxS binding site, consistent with data shown in S. typhimurium (190). Future work will focus on 
screening for regulators of ompWS39006 to find clues on its function and investigate how OmpW 
regulation is linked to S39006 susceptibility to phage. 
 
Finally, using the expanded host range of ΦCBH8, the host-dependency of ToxINPa-mediated Abi 
activation was tested, which was the original aim in this study that led to the discovery of OmpW 
as a phage receptor. Using E.coli DH5α as a second host background where ToxINPa is known to 
be functional as an Abi system, it has been shown that ΦCBH8 is not aborted by ToxINPa, in 
contrast to using S39006 as the host background. This host-dependency of Abi-activation by 
ΦCBH8 could imply that certain phage product(s) involved in ToxINPa-sensitivity in S39006 is 
not expressed adequately or assembled properly in the new host background or growth conditions. 
It could also imply that Abi-activation is not directly through a phage product(s) but could involve 
certain responses from host-specific pathways acting as a “middleman”. Nonetheless, the host-
dependency observed in this study suggests that activation of ToxINPa-mediated Abi is a very 
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specialized process that requires the correct combination of phage and host. This may be good 
news for phage therapy as a broad host range phage might not be “threatened” by Abi systems 
such as ToxINPa in one host even if it is aborted in another. 
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Chapter 7 – Final Discussion 
 
ToxINPa, the Type III TA system, was found on a cryptic plasmid in P.atrosepticum SCRI1039 
and protected bacteria from phage infection through Abi, in its native host and in other bacteria 
(64). Despite understanding of its structure and mode of action on bacterial cells (64, 70, 90-92), 
little is known about the interaction between ToxINPa and phages, and how phage infection triggers 
the activation of abortive infection (Abi) mediated by ToxINPa. This thesis describes work 
performed to characterize phages of S39006 that are sensitive to ToxINPa and their genetic loci 
that are involved in activating ToxINPa-mediated Abi. 
 
1. Summary of findings 
Two phages isolated on S39006, ΦCBH8 and ΦCBH189, were shown to be ToxINPa-sensitive. 
This is an addition to the ToxINPa-sensitive S39006 phages isolated from the natural environment 
that includes ΦCHI14 and ΦX20 (105, 106). All four phages belonged to the Myoviridae family 
and were T4-like phages. Bioinformatic analysis showed that the four S39006 phages were highly 
similar to each other and formed a new genus, the closest relative of which was E.coli phage EcS1. 
Despite their high level of sequence similarity, ΦCBH8, ΦCHI14 and ΦX20 were able to produce 
spontaneous “escape” mutants of ToxINPa while ΦCBH189 could not. Escape mutants of ΦCBH8 
were sequenced and their genomes compared to the wild type genome. ToxINPa escape loci of 
ΦCBH8 were characterized in detail and compared to those of ΦCHI14 and ΦX20. 
 
ΦCBH8 could escape ToxINPa through two independent routes. Some ΦCBH8 mutants that 
survived in the presence of ToxINPa lost a large region in their genomes (large deletion, or LD 
mutants). Some ΦCBH8 mutants acquired mutations in the asiA gene. ΦCHI14 mutants also had 
large deletion mutations or asiA mutations while all ΦX20 mutants were LD mutants. The repeated 
occurrences of these escape loci highlighted their importance in ToxINPa-sensitivity and the fact 
that these S39006 phages may possess a variety of modes of interaction with ToxINPa. 
 
The LD region lost in different LD mutants had different sizes and borders but shared a common 
core. The large size of the LD regions and the absence of these regions in other related phages 
suggested that the corresponding genes must be involved in some novel phage biology that called 
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for further characterization. The deletions probably occurred through recombination, based on the 
presence of direct repeats adjacent to the deletion borders. ΦCBH8o, the mutant with the smallest 
LD region of 6.5 kb, lost 13 orfs and 11 tRNAs. Despite exhaustive bioinformatics analysis, no 
predictable function could be assigned to any of the orfs. These orfs did not appear to be related to 
general phage fitness because ΦCBH8o showed no difference in adsorption efficiency or burst size 
compared to the wild type. Complementation assays of individual orfs deleted in ΦCBH8o showed 
that no orf expression could activate ToxINPa-mediated Abi on its own, suggesting the 
simultaneous involvement of at least 2 non-contiguous orfs. The orfs might be located some 
distance apart from each other, presumably at the borders of the deleted regions, which would 
explain the large size of the deleted regions. Among the orfs deleted in ΦCBH8o, orf10 and orf18 
were toxic to S39006 when expressed. orf10 induced filamentation of cells and orf18 could not be 
cloned without acquiring mutations. orf10 and orf18 were located at the borders of the common 
core deleted in all mutants, making them potential candidates responsible for Abi-activation. 
Furthermore, expression of orf16, orf17 and orf19 were also observed to partially reduce the titer 
of ΦCBH8o when expressed in the presence of ToxINPa, making them likely candidates involved 
in Abi-activation. 
 
Complementation with the wild type AsiA protein caused asiA mutant phages, previously 
insensitive to ToxINPa, to be aborted by ToxINPa again. This suggested that AsiA plays an 
important role in activating ToxINPa-mediated Abi. Most of the mutations occurred at the CTD of 
AsiA with the exception of a V13G mutant. Mutated AsiA protein was shown to have lost its 
function in inhibiting cell growth. Phages with mutated AsiA demonstrated decreased burst size 
and extended latent period. These results suggested that mutation of the AsiA protein affected its 
function in σ-appropriation, but enabled phages to escape ToxINPa, therefore implying that the 
mechanism through which AsiA activates Abi may be related to σ-appropriation. Experimental 
evidence supported this view because AsiA was found to decrease expression from the toxINPa 
promoter. 
 
OmpW was identified as the receptor for the ToxINPa-sensitive S39006 phages. Heterologous 
expression of S39006 OmpW in other hosts (E.coli DH5α, D.solani MK10 and D.zeae NCPP 3532) 
expanded the host range of ΦCBH8 and enabled assessment of  ΦCBH8 sensitivity to ToxINPa in 
DH5α. Even though ΦCBH8 was strongly aborted by ToxINPa in S39006, it was not aborted in 
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DH5α where ToxINPa (expressed from the same vector) was known to be functional as an Abi 
system (64). This suggested that host background plays a role in activation of ToxINPa-mediated 
Abi, at least in some strains. In addition to its sensitivity to ToxINPa, ΦCBH8 was also found to 
have the capacity for transduction as it enabled the transfer of two different ColE1-type plasmids 
in S39006. Expansion of ΦCBH8 host range also enabled it to act as a transducing phage in DH5α. 
Finally, bioinformatic analysis suggested that OmpW could be the outer membrane porin that acts 
as a transporter of a small hydrophobic molecule related to metabolism or stress response. 
 
2. Insights on the activation of ToxINPa-mediated Abi 
Given the results summarized above, two different models could be proposed for the activation of 
ToxINPa-mediated Abi by ΦCBH8 - the “AsiA model” and the “toxicity model”.  
 
In the AsiA model (Figure 7.1a), the in-coming phage produces AsiA proteins to take over host 
transcription machineries. Through σ-appropriation, AsiA reduces transcription of host genes, 
including the toxINPa genes carried on a plasmid. Reduced toxINPa transcription would lead to 
inbalance of ToxI and ToxN and degradation of the more labile ToxI, causing the dissociation of 
the ToxINPa complex, and thereby “activation” of Abi. In addition to experimental evidence 
described in this study, the AsiA model is supported by biochemical data from previous studies 
where the ToxINPa complex was shown to be highly dynamic – ToxN degraded the full length 
ToxI transcript constantly in vitro, even in the presence of excess single ToxI repeats (91, 92). This 
highlighted the importance of ToxI:ToxN stoichiometry for ToxINPa stability and showed the 
consequence of transcription disruption by AsiA at the toxINPa promoter, observed in this study. 
A similar mode of action was also proposed for phage T4 activating the phage exclusion function 
of the hok/sok system (88). 
 
To further substantiate the AsiA model, future work could focus on comparing the cellular level 
of toxINPa mRNA and comparing the ToxI:ToxN ratio in the presence or absence of AsiA. This 
could provide more solid proof that transcription disruption is the reason for Abi activation.  
 
In the toxicity model (Figure 7.1b), the in-coming phage produces at least two proteins that are 
toxic to the host. These proteins trigger the activation of certain host response pathways that, in 
turn, activates ToxINPa-mediated Abi through disruption of toxINPa transcription, translation, or 
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direct interaction with the ToxINPa complex. Compared to the AsiA model, this model is less 
robust because while the LD region deleted in ΦCBH8 mutants was involved in Abi-activation, it 
 
 
Figure 7.1: Two models proposed for how ΦCBH8 activates ToxINPa-mediated Abi.  
(a) The AsiA model. (b) The toxicity model. Figure legend is provided overleaf. 




Chapter 7 Final Discussion 
 
 149 
Figure 7.1: Two models proposed for how ΦCBH8 activates ToxINPa-mediated Abi. (a) The 
AsiA model. (b) The toxicity model. In the AsiA model, the in-coming phage produces AsiA 
proteins to take over host transcription machineries. Through σ-appropriation, AsiA reduces 
transcription of host genes, including the toxINPa genes carried on a plasmid. Reduced toxINPa 
transcription would lead to inbalance of ToxI and ToxN and degradation of the more labile ToxI, 
causing the dissociation of the ToxINPa complex, and thereby “activation” of Abi. In the toxicity 
model, the in-coming phage produces at least two proteins that are toxic to the host. These proteins 
trigger the activation of certain host response pathways that, in turn, activates ToxINPa-mediated 




























was not possible in this study to narrow down the target to specific orfs. The presumed involvement 
of the toxic hypothetical proteins ORF10 and ORF18 in Abi-activation was only theoretical. 
However, this model was still suggested because of two reasons. First, protein M1-23 from ΦM1 
infecting P. atrosepticum, a highly toxic protein, was involved in activating ToxINPa-mediated Abi 
(98). Therefore, an analogy might be drawn between M1-23 and ORF10/ORF18. Second, ΦCBH8 
was not aborted by ToxINPa in DH5α, highlighting the importance of host background, therefore 
suggesting that particular host pathways are involved. 
 
Clearly, more extensive work needs to be done to support the toxicity model. First, to pinpoint 
specific orfs within the LD region that are involved in Abi-activation, orfs in the phage genome 
could be knocked out sequentially until ΦCBH8 becomes insensitive to ToxINPa. Such targeted 
phage genome modification could be carried out with emerging techniques such CRISPR-Cas 
(191). Once target orfs are identified, the level and order of expression of these orfs could be 
tracked through transcriptomics, proteomics and metabolomics, through which additional phage 
orf(s) involved in the Abi-activation process could also be identified. This could be carried out in 
concert with monitoring the transcription, translation and stability of the ToxINPa complex to 
gather evidence on the interaction of phage orf(s) with ToxINPa. In the meantime, the transcriptome, 
proteome and metabolome of the host could also be analyzed to identify any potentially specific 
host pathways involved in ToxINPa-mediated Abi.  
 
In summary, through analysis of asiA mutants and LD mutants of ΦCBH8, two distinct models of 
ToxINPa-mediated Abi activation could be suggested. Of course, these two models might overlap 
since AsiA is also toxic to the cell. This reflects the flexibility of the ToxINPa system and its 
interaction with phage. The apparent flexibility and adaptability in ToxINPa system performance 
could also imply that ToxINPa has another unknown primary function(s) that responds to a wide 
variety of stimuli, and this may be one reason for the lack of an obvious, unified mechanism for 
the activation of ToxINPa. It may be important, however, to remember that the original ToxINPa 
system was discovered in a culture collection strain of Pectobacterium atrosepticum where it was 
carried on a natural, but cryptic, plasmid replicon. So, by definition, all subsequent analyses of 
ToxINPa system functionality have been based on artificially engineered derivatives in different 
bacterial hosts, including S39006. Still, the flexibility of the ToxINPa system discovered in this 
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study and in previous studies (regardless of host background) echoes with previous hypothesis put 
forward by  Wood and colleagues that aiding cellular response to a myriad of stresses is the primary 
function of TA systems (86). Indeed, ToxINPa system could be a good example of this hypothesis 
– it is readily activated by wide range of stimuli and signals. The activation by phages could be a 
by-product of this response system as some phage orfs could mimic the effect of signals related to 
stress and survival. 
 
 
3. Other future work 
Aside from the extensive work needed on phage escape loci and ToxINPa described above, research 
could also be carried out on other interesting aspects of phage biology uncovered as a result of this 
study. For example, aside from its role in Abi-activation, the orfs in the LD region of ΦCBH8 
could be investigated in depth to explain their biological function, the reason for their existence in 
the phage genome and their evolutionary origin. If cellular elongation caused by ORF10 is due to 
its real function rather than an artifact caused by overexpression, then ORF10 could be exploited 
biotechnologically because of its potential ability to prevent septation in the cell. 
 
Furthermore, the discovery that OmpW is exploited by various phages as a receptor to enter the 
host begs investigation of its natural physiological function. If the function and regulation of 
OmpW is understood, it would be possible to control S39006 susceptibility to phages by up- or 
down-regulating OmpW expression. Theoretically, this information may even prove useful in 
phage therapy studies and for biotechnological exploitation. Future work could focus on 
discovering the natural function of the OmpW porin through two different approaches. On one 
hand, more phenotypical assays could be carried out, especially testing equivalent phenotypes 
related to the presumed roles of OmpW in other bacteria. On the other hand, screening of ompW 
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Predicted gene product 
reverse 1 2169 1 2169 722 rIIA - protector from prophage-induced early lysis 
reverse 2 2383 2180 204 67 hypothetical protein 
reverse 3 2705 2370 336 111 hypothetical protein 
reverse 4 2924 2772 153 50 hypothetical protein 
reverse 5 4806 2968 1839 612 DNA topoisomerase II large subunit 
reverse 6 5120 4872 249 82 conserved hypothetical protein 
reverse 7 5299 5120 180 59 fmdD - family putative regulatory protein 
reverse 8 5624 5286 339 112 hypothetical protein 
reverse 9 5964 5614 351 116 hypothetical protein 
reverse 10 6404 6048 357 118 hypothetical protein 
reverse 11 6631 6404 228 75 cef - modifier of suppressor tRNAs 
reverse 12 7099 6701 399 132 hypothetical protein 
reverse 13 7773 7117 657 218 phage-associated homing endonuclease 
reverse 14 8453 7770 684 227 dexA exonuclease A 
reverse 15 8679 8446 234 77 hypothetical protein 
reverse 16 10012 8687 1326 441 RecD-like DNA helicase 
reverse 17 10308 10012 297 98 conserved hypothetical protein 
reverse 18 11003 10308 696 231 putative anti-sigma factor 
reverse 19 11698 11090 609 202 ADP-ribosylase 
reverse 20 11935 11753 183 60 hypothetical protein 
reverse 21 12060 11935 126 41 hypothetical protein 
reverse 22 12160 12032 129 42 hypothetical protein 
reverse 23 12527 12225 303 100 hypothetical protein 
reverse 24 12848 12600 249 82  small outer capsid protein 
reverse 25 13409 12888 522 173 dCTPase 
reverse 26 13754 13419 336 111 hypothetical protein 
reverse 27 14084 13800 285 94 hypothetical protein 
reverse 28 14428 14081 348 115 hypothetical protein 
reverse 29 15437 14415 1023 340 DNA primase subunit   




reverse 31 16256 15969 288 95 spackle periplasmic protein 
reverse 32 17744 16314 1431 476 DNA primase-helicase subunit   
reverse 33 18101 17757 345 114 head vertex assembly chaperone 
reverse 34 19269 18103 1167 388 recA- like recombination protein 
reverse 35 19547 19380 168 55 hypothetical protein 
reverse 36 20140 19592 549 182 hypothetical protein 
reverse 37 21039 20128 912 303 hypothetical protein 
reverse 38 21737 21039 699 232 putative thymidylate synthase 
reverse 39 22078 21734 345 114 hypothetical protein 
reverse 40 23244 22075 1170 389 hypothetical protein 
reverse 41 23884 23246 639 212 segB - putative endonuclease 
reverse 42 24246 23881 366 121 cpb - capsule biosynthesis protein 
reverse 43 25924 24230 1695 564 hypothetical protein 
reverse 44 26106 25963 144 47 hypothetical protein 
reverse 45 26732 26103 630 209 D-arabinose 5-phosphate isomerase 
reverse 46 27142 26729 414 137 hypothetical protein 
reverse 47 29911 27203 2709 902 DNA polymerase 
reverse 48 30352 29990 363 120 regA - translational repressor protein 
reverse 49 30929 30354 576 191 clamp loader small subunit   
reverse 50 31876 30920 957 318 DNA polymerase clamp loader subunit    
reverse 51 32637 31948 690 229 sliding clamp DNA polymerase accessory   
reverse 52 33054 32683 372 123 rpbA - RNA polymerase binding protein 
reverse 53 33254 33063 192 63 hypothetical protein 
reverse 54 34894 33254 1641 546 endonuclease subunit 
reverse 55 35952 34933 1020 339 recombination endonuclease subunit 
reverse 56 36092 35949 144 47 hypothetical predicted membrane protein 
reverse 57 36225 36157 69 22 hypothetical protein 
reverse 58 36583 36398 186 61 hypothetical protein 
reverse 59 36765 36568 198 65 hypothetical protein 
reverse 60 37093 36743 351 116 hypothetical protein 
reverse 61 37323 37096 228 75 hypothetical protein 
reverse 62 37843 37307 537 178 sigma factor for late transcription 
reverse 63 38173 37910 264 87 hypothetical protein 
reverse 64 38403 38173 231 76 hypothetical protein 
reverse 65 38753 38412 342 113 hypothetical protein 
reverse 66 39074 38814 261 86 hypothetical protein 
reverse 67 39456 39145 312 103 nrdH - glutaredoxin 




reverse 69 39953 39711 243 80 hypothetical protein 
reverse 70 40552 40079 474 157 nrdG - anaerobic NTP reductase, small subunit 
reverse 71 42362 40539 1824 607 nrdD - anaerobic NTP reductase, large subunit 
reverse 72 42832 42359 474 157 recombinase endonuclease VII 
reverse 73 43169 42867 303 100 hypothetical protein 
reverse 74 43620 43156 465 154 pinA - inhibitor of host Lon protease 
reverse 75 44025 43723 303 100 conserved hypothetical protein 
reverse 76 44212 44018 195 64 hypothetical protein 
reverse 77 44365 44213 153 50 hypothetical protein 
reverse 78 44662 44366 297 98 conserved hypothetical protein 
reverse 79 44822 44655 168 55 hypothetical protein 
reverse 80 44979 44815 165 54 hypothetical protein 
reverse 81 45220 44945 276 91 thioredoxin 
reverse 82 45437 45183 255 84 hypothetical protein 
reverse 83 45795 45466 330 109 hypothetical protein 
reverse 84 46300 45785 516 171 hypothetical protein 
reverse 85 46527 46303 225 74 hypothetical protein 
reverse 86 46760 46524 237 78 hypothetical protein 
reverse 87 47793 46753 1041 346 hypothetical protein 
reverse 88 48667 47894 774 257 hypothetical protein 
reverse 89 48913 48725 189 62 hypothetical protein 
reverse 90 49281 48913 369 122 hypothetical protein 
reverse 91 49451 49281 171 56 hypothetical protein 
reverse 92 49914 49444 471 156 hypothetical protein 
reverse 93 50408 49914 495 164 hypothetical protein 
reverse 94 50635 50405 231 76 hypothetical protein 
reverse 95 51679 50699 981 326 hypothetical protein 
reverse 96 52034 51798 237 78 hypothetical protein 
reverse 97 52225 52031 195 64 hypothetical protein 
reverse 98 53243 52230 1014 337 thioredoxin 
reverse 99 53683 53240 444 147 hypothetical protein 
reverse 100 53816 53652 165 54 hypothetical protein 
reverse 101 54402 53884 519 172 hypothetical protein 
reverse 102 54926 54441 486 161 hypothetical protein 
reverse 103 55191 54928 264 87 hypothetical protein 
reverse 104 55476 55249 228 75 hypothetical protein 
reverse 105 56149 55478 672 223 hypothetical protein 




reverse 107 56548 56441 108 35 hypothetical protein 
reverse 108 57051 56605 447 148 hypothetical protein 
reverse 109 57540 57154 387 128 hypothetical protein 
reverse 110 57820 57527 294 97 rI - lysis inhibition regulator membrane protein 
reverse 111 58042 57830 213 70 hypothetical protein 
reverse 112 58488 58105 384 127 hypothetical protein 
reverse 113 58720 58550 171 56 hypothetical protein 
reverse 114 59297 58710 588 195 tk - thymidine kinase 
reverse 115 59481 59299 183 60 tk - thymidine kinase 
reverse 116 59948 59478 471 156 hypothetical protein 
reverse 117 60301 59945 357 118 vs - valyl-tRNA synthetase modifier 
reverse 118 60849 60301 549 182 hypothetical protein 
reverse 119 61316 60861 456 151 regB - site-specific RNA endonuclease 
reverse 120 61666 61376 291 96 hypothetical protein 
reverse 121 61898 61656 243 80 hypothetical protein 
reverse 122 62139 61873 267 88 hypothetical protein 
reverse 123 62669 62136 534 177 hypothetical protein 
reverse 124 63301 62885 417 138 
denV - endonuclease V, N-glycosylase UV repair 
enzyme 
reverse 125 63643 63356 288 95 hypothetical protein 
reverse 126 64128 63643 486 161 lysozyme murein hydrolase 
reverse 127 64635 64162 474 157 nudE - nudix hydrolase 
reverse 128 64864 64628 237 78 hypothetical protein 
reverse 129 65204 64875 330 109 hypothetical protein 
reverse 130 65740 65201 540 179 hypothetical protein 
reverse 131 66672 65740 933 310 hypothetical protein 
reverse 132 66963 66739 225 74 hypothetical protein 
reverse 133 67298 67005 294 97 hypothetical protein 
reverse 134 67672 67298 375 124 hypothetical protein 
reverse 135 68486 67665 822 273 hypothetical protein 
reverse 136 69129 68524 606 201 hypothetical protein 
reverse 137 69612 69217 396 131 hypothetical protein 
reverse 138 70303 69698 606 201 hypothetical protein 
reverse 139 70841 70497 345 114 hypothetical protein 
reverse 140 71033 70949 85 NA tRNA-Leu (TAA) 
reverse 141 71115 71039 77 NA tRNA-Arg (TCT) 
reverse 142 71708 71259 450 149 hypothetical protein 




reverse 144 72180 71929 252 83 hypothetical protein 
reverse 145 72275 72200 76 NA tRNA-Met (CAT) 
reverse 146 72560 72333 228 114 hypothetical protein 
reverse 147 72736 72662 75 NA tRNA-Gly (TCC) 
reverse 148 72811 72738 74 NA tRNA-Trp (CCA) 
reverse 149 72892 72818 74 NA tRNA-Phe (GAA) 
reverse 150 73055 72980 76 NA tRNA-Ile (GAT) 
reverse 151 73137 73060 78 NA tRNA-Pro (TGG) 
reverse 152 73384 73139 246 81 hypothetical protein 
reverse 153 73503 73410 94 NA tRNA-Ser (TGA) 
reverse 154 73583 73508 76 NA tRNA-His (GTG) 
reverse 155 73755 73680 76 NA tRNA-Gln (TTG) 
reverse 156 74139 73762 378 125 hypothetical protein 
reverse 157 74272 74196 77 NA tRNA-Met (CAT) 
reverse 158 74481 74398 84 NA tRNA-Asn (GTT) 
reverse 159 74565 74489 77 NA tRNA-Lys (TTT) 
reverse 160 74645 74571 75 NA tRNA-Glu (TTC) 
reverse 161 74725 74650 76 NA tRNA-Asp (GTC) 
reverse 162 74820 74732 89 NA tRNA-Tyr (GTA) 
reverse 163 75112 74924 189 62 hypothetical protein 
reverse 164 75308 75105 204 67 hypothetical protein 
reverse 165 75480 75295 186 61 hypothetical protein 
reverse 166 75875 75543 333 110 hypothetical protein 
reverse 167 76327 75872 456 151 hypothetical protein 
reverse 168 77288 76596 693 230 dNMP kinase 
reverse 169 77877 77290 588 195 tail completion and sheath stabilizer protein 
reverse 170 78797 77967 831 276 DNA end protector protein 
reverse 171 79246 78797 450 149 head completion protein 
forward 172 79294 79869 576 191 baseplate wedge subunit 
forward 173 79878 81596 1719 572 baseplate hub + tail lysozyme 
forward 174 81596 82102 507 168 hypothetical protein 
forward 175 82395 84347 1953 650 baseplate wedge subunit 
forward 176 84344 87430 3087 1028 phage baseplate wedge initiator 
forward 177 87430 88434 1005 334 phage baseplate wedge subunit 
forward 178 88499 89371 873 290 baseplate wedge tail fiber connector 
forward 179 89368 91197 1830 609 baseplate wedge subunit and tail pin 
forward 180 91197 91880 684 227 baseplate wedge subunit and tail pin 




forward 182 93434 95188 1755 584 wac - fibritin neck whisker protein 
forward 183 95248 96186 939 312 neck protein 
forward 184 96188 96964 777 258 neck protein 
forward 185 97007 97840 834 277 tail sheath stabilizer and completion protein 
forward 186 97837 98337 501 166 terminase DNA packaging enzyme, small subunit 
forward 187 98321 100156 1836 611 terminase DNA packaging enzyme, large subunit 
forward 188 100192 102174 1983 660 hypothetical protein 
forward 189 102275 102958 684 227 hypothetical protein 
forward 190 102962 103453 492 163 tail tube protein 
forward 191 103571 105139 1569 522 portal vertex protein of head 
forward 192 105139 105390 252 83 prohead core protein 
forward 193 105391 105816 426 141 prohead core protein 
forward 194 105816 106463 648 215 
prohead assembly (scaffolding) protein and 
protease 
forward 195 106496 107311 816 271 prohead core scaffold protein 
forward 196 107333 108892 1560 519 major capsid protein 
forward 197 108981 110234 1254 417 phage capsid vertex 
reverse 198 110813 110262 552 183 hypothetical protein 
reverse 199 111820 110813 1008 335 rn1B - RNA ligase 2 
reverse 200 112217 111924 294 97 conserved hypothetical protein 
reverse 201 112441 112214 228 75 hypothetical protein 
reverse 202 113058 112519 540 179 hoc - head outer capsid protein 
reverse 203 113799 113089 711 236 inh - inhibitor of prohead protease 
forward 204 114081 115358 1278 425 
uvsW - RNA-DNA and DNA-DNA helicase, 
ATPase 
forward 205 115355 115582 228 75 uvsW.1 - RNA-DNA and DNA-DNA helicase 
reverse 206 115810 115646 165 54 hypothetical protein 
reverse 207 116280 115846 435 144 
uvsY - recombination repair and ssDNA binding 
protein 
reverse 208 116732 116337 396 131 baseplate wedge subunit 
reverse 209 117361 116732 630 209 baseplate hub subunit 
forward 210 117413 118165 753 250 baseplate hub assembly catalyst 
forward 211 118162 119382 1221 406 baseplate hub subunit 
forward 212 119282 119821 540 179 baseplate hub distal subunit 
forward 213 119805 121562 1758 585 base plate hub subunit, tail length determinator 
forward 214 121571 122671 1101 366 phage baseplate tail tube cap 
forward 215 122671 123636 966 321 baseplate subunit 




reverse 217 126141 124039 2103 700 alt - RNA polymerase ADP-ribosylase 
reverse 218 126389 126207 183 60 hypothetical protein 
reverse 219 127882 126386 1497 498 DNA ligase 
reverse 220 128157 127891 267 88 hypothetical protein 
reverse 221 128899 128159 741 246 hypothetical protein 
reverse 222 129053 128874 180 59 hypothetical protein 
reverse 223 129244 129050 195 64 hypothetical protein 
reverse 224 129589 129422 168 55 hypothetical protein 
reverse 225 130035 129589 447 148 hypothetical protein 
reverse 226 130425 130069 357 118 hypothetical protein 
reverse 227 131008 130484 525 174 hypothetical protein 
reverse 228 131486 131016 471 156 hypothetical protein 
reverse 229 131891 131523 369 122 hypothetical protein 
reverse 230 132173 131997 177 58 hypothetical protein 
reverse 231 132582 132334 249 82 rIII - lysis inhibition accessory protein 
reverse 232 133004 132681 324 107 head assembly co-chaperone 
reverse 233 133385 133062 324 107 hypothetical protein 
reverse 234 133949 133386 564 187 cd - dCMP deaminase 
reverse 235 134290 133949 342 113 hypothetical protein 
reverse 236 135287 134271 1017 338 phospho-2-dehydro-3-deoxyheptonate aldolase 
reverse 237 135517 135287 231 76 hypothetical protein 
reverse 238 135785 135519 267 88 hypothetical protein 
reverse 239 136684 135785 900 299 polynucleotide kinase 
reverse 240 136899 136681 219 72 hypothetical protein 
reverse 241 137378 136896 483 160 hypothetical protein 
reverse 242 137817 137518 300 99 phage outer membrane lipoprotein 
reverse 243 138170 137814 357 118 putative membrane protein 
reverse 244 138658 138158 501 166 alc - inhibitor of host transcription 
reverse 245 139891 138719 1173 390 rnIA - RNA ligase 1 and tail fiber attachment 
reverse 246 140301 139888 414 137 denA - endonuclease II 
reverse 247 141512 140334 1179 392 nrdB - aerobic NDP reductase, small subunit 
reverse 248 141706 141509 198 65 hypothetical protein 
reverse 249 144000 141745 2256 751 nrdA - aerobic NDP reductase, large subunit 
reverse 250 144296 143991 306 101 hypothetical protein 
reverse 251 145153 144293 861 286 thyA - dTMP thymidylate synthase 
reverse 252 145524 145150 375 124 hypothetical protein 
reverse 253 145846 145505 342 113 hypothetical protein 




reverse 255 146650 146426 225 74 hypothetical protein 
reverse 256 147020 146742 279 92 hypothetical protein 
reverse 257 147432 147076 357 118 hypothetical protein 
reverse 258 147750 147517 234 77 hypothetical protein 
reverse 259 147971 147747 225 74 hypothetical protein 
reverse 260 148287 148036 252 83 hypothetical protein 
reverse 261 149317 148430 888 295 single-stranded DNA binding protein 
reverse 262 150053 149400 654 217 loader of gp41 DNA helicase 
reverse 263 150636 150028 609 202 segD - homing endonuclease 
reverse 264 150944 150633 312 103 late promoter transcription accessory protein 
reverse 265 151206 150919 288 95 dsbA - dsDNA binding protein, late transcription 
reverse 266 152155 151214 942 313 rnh - RNaseH ribonuclease 
forward 267 152261 156031 3771 1256 long tail fiber, proximal subunit 
forward 268 156040 157191 1152 383 
hinge connector of long tail fiber, proximal 
connector 
forward 269 157253 157912 660 219 hinge connector 
forward 270 157921 160665 2745 914 long tail fiber, distal subunit 
forward 271 160697 161212 516 171 distal long tail fiber assembly catalyst 
forward 272 161393 161899 507 168 receptor-recognizing protein 
forward 273 161927 162583 657 218 holin lysis mediator 
reverse 274 162870 162601 270 89 asiA - anti-sigma 70 protein 
reverse 275 163262 162924 339 112 hypothetical protein 
reverse 276 163377 163246 132 43 hypothetical protein 
reverse 277 163570 163352 219 72 hypothetical protein 
reverse 278 163847 163542 306 101 hypothetical protein 
reverse 279 164281 163847 435 144 hypothetical protein 
reverse 280 164622 164278 345 114 hypothetical protein 
reverse 281 165272 164637 636 211 
motA - transcriptional regulator of middle 
promoters 
reverse 282 166040 165369 672 223 hypothetical protein 
reverse 283 166349 166209 141 46 hypothetical protein 
reverse 284 167713 166349 1365 454 topoisomerase II medium subunit 
reverse 285 167873 167718 156 51 hypothetical protein 
reverse 286 168623 168195 429 142 ndd - nucleoid disruption protein 
reverse 287 168909 168709 201 66 hypothetical protein 
reverse 288 169039 168917 123 40 hypothetical protein 
reverse 289 169724 169077 648 215 endonuclease IV 




reverse 291 170178 169978 201 66 hypothetical protein 



















Predicted gene product 
reverse 1 2169 1 2169 722 rIIA - protector from phage-induced early lysis  
reverse 2 2383 2180 204 67 hypothetical protein   
reverse 3 2741 2370 372 123 hypothetical protein   
reverse 4 2951 2772 180 59 hypothetical protein   
reverse 5 4806 2968 1839 612 DNA topoisomerase II large subunit   
reverse 6 5340 5092 249 82 hypothetical protein    
reverse 7 5519 5340 180 59 conserved putative regulatory protein, fmdB family  
reverse 8 5844 5506 339 112 hypothetical protein   
reverse 9 6268 5834 435 144 hypothetical protein    
reverse 10 6624 6268 357 118 hypothetical protein    
reverse 11 6842 6624 219 72 cef - modifier of suppressor tRNAs   
reverse 12 7328 6930 399 132 hypothetical protein   
reverse 13 8022 7339 684 227 exonuclease A    
reverse 14 8248 8015 234 77 hypothetical protein    
reverse 15 9581 8256 1326 441 RecD-like DNA helicase 
reverse 16 9877 9581 297 98 hypothetical protein    
reverse 17 10572 9877 696 231 putative anti-sigma factor   
reverse 18 11267 10659 609 202 ADP-ribosylase    
reverse 19 11505 11323 183 60 hypothetical protein   
reverse 20 11850 11602 249 82 hypothetical protein  
reverse 21 12418 12170 249 82 small outer capsid protein   
reverse 22 12979 12458 522 173 dCTPase   
reverse 23 13324 12989 336 111 hypothetical protein    
reverse 24 13654 13370 285 94 hypothetical protein    
reverse 25 13784 13665 120 39 hypothetical protein    
reverse 26 14793 13771 1023 340 DNA primase subunit   
reverse 27 15306 14839 468 155 hypothetical protein   
reverse 28 15612 15325 288 95 spackle periplasmic protein   




reverse 30 17457 17113 345 114 head vertex assembly chaperone   
reverse 31 18625 17459 1167 388 recA-like recombination protein   
reverse 32 19496 18948 549 182 hypothetical protein   
reverse 33 20395 19484 912 303 hypothetical protein   
reverse 34 21093 20395 699 232 putative thymidylate synthase   
reverse 35 21458 21090 369 122 hypothetical protein 
reverse 36 22627 21458 1170 389 peptidase  
reverse 37 23267 22629 639 212 homing endonuclease  
reverse 38 23629 23264 366 121 hypothetical protein 
reverse 39 25307 23613 1695 564 hypothetical protein   
reverse 40 25489 25346 144 47 hypothetical protein   
reverse 41 26115 25486 630 209 D-arabinose 5-phosphate isomerase   
reverse 42 26531 26112 420 139 hypothetical protein    
reverse 43 29294 26586 2709 902 DNA polymerase   
reverse 44 29735 29373 363 120 regA - translational repressor protein   
reverse 45 30312 29737 576 191 clamp loader small subunit   
reverse 46 31274 30303 972 323 DNA polymerase clamp loader subunit    
reverse 47 32020 31331 690 229 sliding clamp DNA polymerase accessory   
reverse 48 32437 32066 372 123 rpbA - RNA polymerase binding protein 
reverse 49 32637 32446 192 63 hypothetical protein   
reverse 50 34319 32637 1683 560 recombination endonuclease subunit    
reverse 51 34531 34316 216 71 hypothetical protein  
reverse 52 35543 34524 1020 339 recombination endonuclease subunit   
reverse 53 35971 35816 156 51 hypothetical protein   
reverse 54 36174 35989 186 61 hypothetical protein   
reverse 55 36356 36159 198 65 hypothetical protein   
reverse 56 36684 36334 351 116 hypothetical protein   
reverse 57 36914 36687 228 75 hypothetical protein   
reverse 58 37434 36898 537 178 sigma factor for late transcription   
reverse 59 37764 37501 264 87 hypothetical protein   
reverse 60 37994 37764 231 76 hypothetical protein   
reverse 61 38380 38003 378 125 hypothetical protein   
reverse 62 38665 38405 261 86 hypothetical protein 
reverse 63 39038 38736 303 100 glutaredoxin   
reverse 64 39300 39028 273 90 hypothetical protein   
reverse 65 39544 39302 243 80 hypothetical protein   




reverse 67 41953 40130 1824 607 anaerobic NTP reductase large subunit   
reverse 68 42423 41950 474 157 recombinase endonuclease VII   
reverse 69 42760 42458 303 100 hypothetical protein   
reverse 70 43184 42747 438 145 inhibitor of host Lon protease   
reverse 71 43329 43165 165 54 hypothetical protein  
reverse 72 43616 43314 303 100 hypothetical protein   
reverse 73 43803 43609 195 64 hypothetical protein    
reverse 74 43956 43804 153 50 hypothetical protein   
reverse 75 44253 43957 297 98 hypothetical protein    
reverse 76 44413 44246 168 55 hypothetical protein   
reverse 77 44811 44536 276 91 thioredoxin   
reverse 78 45076 44774 303 100 hypothetical protein   
reverse 79 45386 45057 330 109 hypothetical protein   
reverse 80 45891 45376 516 171 hypothetical protein   
reverse 81 46118 45894 225 74 hypothetical protein   
reverse 82 46351 46115 237 78 hypothetical protein   
reverse 83 47384 46344 1041 346 hypothetical protein   
reverse 84 48288 47485 804 267 hypothetical protein   
reverse 85 48504 48316 189 62 hypothetical protein   
reverse 86 48872 48504 369 122 hypothetical protein    
reverse 87 49042 48872 171 56 hypothetical protein   
reverse 88 49505 49035 471 156 hypothetical protein    
reverse 89 49999 49505 495 164 hypothetical protein   
reverse 90 50262 49996 267 88 hypothetical protein   
reverse 91 51339 50290 1050 349 thioredoxin  
reverse 92 51628 51392 237 78 hypothetical protein   
reverse 93 52641 51625 1017 338 thioredoxin    
reverse 94 53060 52638 423 140 hypothetical protein    
reverse 95 53289 53050 240 79 hypothetical protein    
reverse 96 53794 53282 513 170 hypothetical protein    
reverse 97 54318 53833 486 161 hypothetical protein    
reverse 98 54542 54318 225 74 hypothetical protein    
reverse 99 55516 54830 687 228 hypothetical protein    
reverse 100 55793 55527 267 88 putative C4-type zinc finger protein    
reverse 101 56413 55952 462 153 hypothetical protein    
reverse 102 56903 56517 387 128 hypothetical protein    




reverse 104 57405 57193 213 70 hypothetical protein   
reverse 105 57851 57468 384 127 hypothetical protein   
reverse 106 58083 57913 171 56 hypothetical protein   
reverse 107 58660 58073 588 195 thymidine kinase    
reverse 108 58871 58662 210 69 hypothetical protein  
reverse 109 59047 58871 177 58 hypothetical protein   
reverse 110 59510 59040 471 156 hypothetical protein   
reverse 111 59866 59507 360 119 valyl-tRNA synthetase modifier   
reverse 112 60408 59863 546 181 hypothetical protein   
reverse 113 60875 60420 456 151 site-specific RNA endonuclease   
reverse 114 61212 60937 276 91 hypothetical protein  
reverse 115 61444 61202 243 80 hypothetical protein   
reverse 116 61685 61419 267 88 hypothetical protein   
reverse 117 62350 61682 669 222 hypothetical protein   
reverse 118 62696 62397 300 99 putative internal head protein  
reverse 119 63157 62741 417 138 pyrimidine dimer DNA glycosylase 
reverse 120 63499 63212 288 95 hypothetical protein   
reverse 121 63984 63499 486 161 T4-like lysozyme  
reverse 122 64491 64018 474 157 hypothetical protein    
reverse 123 64720 64484 237 78 hypothetical protein    
reverse 124 65060 64731 330 109 hypothetical protein    
reverse 125 65371 65057 315 104 hypothetical protein    
reverse 126 65840 65361 480 159 hypothetical protein   
reverse 127 66842 65910 933 310 hypothetical protein   
reverse 128 67175 66909 267 88 hypothetical protein  
reverse 129 67468 67175 294 97 hypothetical protein   
reverse 130 67842 67468 375 124 hypothetical protein   
reverse 131 68656 67835 822 273 hypothetical protein   
reverse 132 69299 68694 606 201 hypothetical protein   
reverse 133 69584 69384 201 66 hypothetical protein  
reverse 134 70051 69656 396 131 hypothetical protein   
reverse 135 70699 70136 564 187 hypothetical protein    
reverse 136 71188 70799 390 129 hypothetical protein   
reverse 137 71265 71181 85 NA tRNA-Leu (TAA) 
reverse 138 71346 71271 76 NA tRNA-Arg (TCT) 
reverse 139 71939 71490 450 149 hypothetical protein   




reverse 141 72495 72160 336 111 hypothetical protein    
reverse 142 72509 72434 76 NA tRNA-Met (CAT) 
reverse 143 72956 72567 390 129 hypothetical protein    
reverse 144 72970 72896 75 24 tRNA-Gly (TCC) 
reverse 145 73051 72978 74 NA tRNA-Trp (CCA) 
reverse 146 73279 73205 75 24 tRNA-Phe (GAA) 
reverse 147 73441 73366 76 NA tRNA-Ile (GAT) 
reverse 148 73523 73446 78 25 tRNA-Pro (TGG) 
reverse 149 73770 73525 246 81 hypothetical protein   
reverse 150 73887 73796 92 NA tRNA-Ser (TGA) 
reverse 151 73967 73892 76 NA tRNA-His (GTG) 
reverse 152 74139 74064 76 NA tRNA-Gln (TTG) 
reverse 153 74555 74148 408 135 adhesin  
reverse 154 74657 74581 77 NA tRNA-Met (CAT) 
reverse 155 74860 74784 77 NA tRNA-Asn (GTT) 
reverse 156 75088 75013 76 NA tRNA-Asp (GTC) 
reverse 157 75273 75079 195 64 hypothetical protein   
reverse 158 75183 75095 89 NA tRNA-Tyr (GTA) 
reverse 159 75485 75291 195 64 hypothetical protein   
reverse 160 75654 75475 180 59 hypothetical protein   
reverse 161 75851 75651 201 66 hypothetical protein    
reverse 162 76246 75914 333 110 hypothetical protein   
reverse 163 76698 76243 456 151 hypothetical protein   
reverse 164 76967 76698 270 89 chaperone for long tail fiber formation    
reverse 165 77659 76967 693 230 dNMP kinase   
reverse 166 78248 77661 588 195 tail completion and sheath stabilizer protein   
reverse 167 79168 78338 831 276 DNA end protector protein   
reverse 168 79617 79168 450 149 head completion protein   
forward 169 79665 80240 576 191 baseplate wedge subunit   
forward 170 80240 81967 1728 575 baseplate hub subunit and tail lysozyme   
forward 171 81967 82473 507 168 hypothetical protein    
forward 172 82473 82766 294 97 hypothetical protein    
forward 173 82766 84718 1953 650 baseplate wedge subunit    
forward 174 84715 87801 3087 1028 baseplate wedge initiator    
forward 175 87801 88805 1005 334 baseplate wedge subunit   
forward 176 88870 89742 873 290 baseplate wedge tail fiber connector   




forward 178 91568 92251 684 227 baseplate wedge subunit and tail pin   
forward 179 92251 93795 1545 514 short tail fiber protein    
forward 180 93805 95559 1755 584 fibritin neck whisker protein   
forward 181 95619 96557 939 312 neck protein    
forward 182 96559 97335 777 258 tail sheath stabilizer and completion protein   
forward 183 97426 98211 786 261 terminase DNA packaging enzyme small subunit   
forward 184 98208 98708 501 166 terminase DNA packaging enzyme large subunit   
forward 185 98692 100527 1836 611 tail sheath protein  
forward 186 100563 102545 1983 660 hypothetical protein   
forward 187 102646 103329 684 227 tail tube protein   
forward 188 103333 103824 492 163 portal vertex protein of head    
forward 189 103942 105510 1569 522 prohead core protein    
forward 190 105510 105779 270 89 prohead core protein   
forward 191 105780 106205 426 141 prohead assembly (scaffolding) protein and 
protease   
forward 192 106205 106852 648 215 prohead core scaffold protein   
forward 193 106885 107700 816 271 major capsid protein   
forward 194 107722 109281 1560 519 capsid vertex protein    
forward 195 109371 110624 1254 417 hypothetical protein    
reverse 196 111203 110652 552 183 RNA ligase 2    
reverse 197 112210 111203 1008 335 hypothetical protein    
reverse 198 112577 112314 264 87 hypothetical protein    
reverse 199 112807 112574 234 77 hypothetical protein    
reverse 200 113424 112885 540 179 head outer capsid protein    
reverse 201 114166 113456 711 236 inhibitor of prohead protease    
forward 202 114223 115725 1503 500 RNA-DNA and DNA-DNA helicase, ATPase    
forward 203 115722 115949 228 75 RNA-DNA and DNA-DNA helicase   
reverse 204 116647 116213 435 144 recombination repair and ssDNA binding protein   
reverse 205 117099 116704 396 131 baseplate wedge subunit   
reverse 206 117728 117099 630 209 baseplate hub subunit   
forward 207 117780 118532 753 250 baseplate hub assembly catalyst   
forward 208 118529 119749 1221 406 baseplate hub subunit   
forward 209 119784 120188 405 134 baseplate hub distal subunit    
forward 210 120172 121917 1746 581 baseplate hub subunit tail length determinator    
forward 211 121926 123026 1101 366 baseplate tail tube cap    
forward 212 123026 123991 966 321 gp54 baseplate tail tube initiator   




reverse 214 126495 124393 2103 700 RNA polymerase ADP-ribosylase   
reverse 215 126743 126561 183 60 hypothetical protein   
reverse 216 128236 126740 1497 498 DNA ligase   
reverse 217 128523 128245 279 92 hypothetical protein   
reverse 218 129253 128513 741 246 hypothetical protein   
reverse 219 129410 129228 183 60 hypothetical protein   
reverse 220 129598 129407 192 63 hypothetical protein   
reverse 221 129779 129573 207 68 hypothetical protein    
reverse 222 129943 129776 168 55 hypothetical protein   
reverse 223 130395 129943 453 150 hypothetical protein   
reverse 224 130801 130436 366 121 hypothetical protein    
reverse 225 131384 130860 525 174 hypothetical protein    
reverse 226 131862 131392 471 156 hypothetical protein    
reverse 227 132253 131900 354 117 hypothetical protein    
reverse 228 132529 132359 171 56 hypothetical protein    
reverse 229 132892 132644 249 82 rIII lysis inhibition accessory protein   
reverse 230 133314 132991 324 107 head assembly co-chaperone   
reverse 231 133695 133372 324 107 tail fiber protein  
reverse 232 134259 133696 564 187 dCMP deaminase  
reverse 233 134600 134259 342 113 hypothetical protein   
reverse 234 135597 134581 1017 338 phospho-2-dehydro-deoxyheptonate aldolase    
reverse 235 135827 135597 231 76 hypothetical protein    
reverse 236 136095 135829 267 88 hypothetical protein   
reverse 237 136295 136092 204 67 hypothetical protein  
reverse 238 137040 136327 714 237 Seg-like homing endonuclease  
reverse 239 137995 137096 900 299 polynucleotide kinase   
reverse 240 138231 137992 240 79 hypothetical protein  
reverse 241 138796 138311 486 161 hypothetical protein    
reverse 242 139235 138936 300 99 outer membrane lipoprotein   
reverse 243 139588 139232 357 118 putative membrane protein    
reverse 244 140070 139576 495 164 inhibitor of host transcription    
reverse 245 141303 140131 1173 390 RNA ligase 1 and tail fiber attachment catalyst    
reverse 246 141713 141300 414 137 DenA endonuclease II   
reverse 247 143005 141746 1260 419 NrdB aerobic NDP reductase, small subunit  
reverse 248 145217 142962 2256 751 NrdA aerobic NDP reductase, large subunit  
reverse 249 145513 145208 306 101 hypothetical protein   




reverse 251 146555 145695 861 286 hypothetical protein    
reverse 252 146926 146555 372 123 hypothetical protein    
reverse 253 147248 146907 342 113 dihydrofolate reductase    
reverse 254 147831 147229 603 200 hypothetical protein    
reverse 255 148097 147831 267 88 hypothetical protein    
reverse 256 148482 148168 315 104 hypothetical protein    
reverse 257 148924 148502 423 140 hypothetical protein    
reverse 258 149177 148944 234 77 hypothetical protein    
reverse 259 149398 149174 225 74 hypothetical protein   
reverse 260 149798 149460 339 112 hypothetical protein   
reverse 261 150866 149979 888 295 single-stranded DNA binding protein    
reverse 262 151603 150950 654 217 loader of DNA helicase    
reverse 263 151908 151600 309 102 late promoter transcription accessory protein    
reverse 264 152188 151883 306 101 dsDNA binding protein    
reverse 265 153119 152178 942 313 RNase H  
forward 266 153225 156995 3771 1256 long tail fiber proximal subunit   
forward 267 157004 158155 1152 383 hinge connector of long tail fiber, proximal 
connector   
forward 268 158217 158876 660 219 hinge connector of long tail fiber, distal connector  
forward 269 158885 161638 2754 917 long tail fiber distal subunit    
forward 270 161670 162185 516 171 distal long tail fiber assembly catalyst   
forward 271 162355 162999 645 214 hypothetical protein  
forward 272 163027 163683 657 218 holin lysis mediator   
reverse 273 163970 163701 270 89 asiA-anti-sigma 70 protein   
reverse 274 164362 164024 339 112 hypothetical protein   
reverse 275 164477 164346 132 43 hypothetical protein   
reverse 276 164947 164651 297 98 anti-restriction nuclease 
reverse 277 165381 164947 435 144 anti-restriction nuclease  
reverse 278 165725 165378 348 115 anti-restriction nuclease 
reverse 279 166372 165737 636 211 motA-transcriptional regulator of middle promoters   
reverse 280 167182 166466 717 238 hypothetical protein    
forward 281 167181 167453 273 90 hypothetical protein    
reverse 282 168810 167446 1365 454 topoisomerase II medium subunit   
reverse 283 168940 168815 126 41 hypothetical protein    
forward 284 168956 169126 171 56 hypothetical protein    
reverse 285 169292 169119 174 57 hypothetical protein    




reverse 287 169988 169797 192 63 hypothetical protein    
reverse 288 170118 169996 123 40 hypothetical protein    
reverse 289 170797 170156 642 213 denB endonuclease IV   
reverse 290 171251 171051 201 66 hypothetical protein   




Appendix III - Phenotypic comparison of 
S39006-wt and S39006-R4 
 
Secondary metabolite production 
To investigate whether OmpW is involved in the secretion of the Carbapenem, a β-lactam 
antibiotic with broad-spectrum activity (102), overnight cultures of S39006-wt and S39006-R4 
were spotted side by side on a top lawn of E.coli ESS to compare their ability to produce a halo 
from killing ESS. As shown in Figure S1a, no obvious different was observed between S39006-
wt and S39006-R4, indicating that the lack of OmpW does not affect ability to produce or 
transport the Carbapenem. 
 
The role of OmpW in the production or excretion of prodigiosin, the red pigment molecule 
with antimalarial, antifungal and antibiotic function, was also investigated by comparing the 
amount of prodigiosin secreted by S39006-wt and S39006-R4 in exponential phase (116). As 
shown in Figure S1b, no significant difference in prodigiosin secretion was found between 
S39006-wt and S39006-R4, indicating that OmpW is not involved in prodigiosin production 
or secretion. 
 
Furthermore, the effect of OmpW on the production of N-butanoyl-L-homoserine lactone 
(BHL) was also investigated. BHL is a quorum sensing molecule that mediates the control of 
secondary metabolite production in S39006. However, OmpW was not involved in BHL 




S39006 is able to facilitate its own motility through swimming, swarming and flotation. To 
investigate whether OmpW deficiency affects any of the motility mechanisms, S39006-wt and 




Eiken agar and float in LB. However, no significant differences were observed in any of the 
assays (data not shown), indicating that OmpW is not involved in motility of S39006. 
 
Stress response 
The role of OmpW in stress response was investigated by comparing the growth of   S39006-
wt and S39006-R4 on solid agar containing 2.5% ethanol, 3% H2O2, 0.1% SDS and 2.5% NaCl, 
respectively. As shown in Figure S1c, no obvious difference was observed under these stress 
conditions between S39006-wt and S39006-R4, indicating that OmpW is not involved in the 







Figure S1: Secondary metabolite secretion and stress response in S39006-wt and S39006-
R4. (a) Comparison of Carbapenem production in S39006-wt and S39006-R4. The halo 
surrounding spotted bacterial culture is formed from Carbapenem inhibition of E.coli ESS 
growth in the top lawn, therefore the size of the halo is reflective of Carbapenem concentration. 
The result shown is representative of triplicates. (b) Comparison of relative prodigiosin 
concentration in S39006-wt and S39006-R4. Error bars represent standard deviation from 
triplicates. (c) Comparison of S39006-wt and S39006-R4 growth response to 2.5% ethanol, 3% 
H2O2, 0.1% SDS and 2.5% NaCl. For ethanol, SDS and NaCl, overnight cultures of cells were 
serially diluted and spotted on LBA containing cognate stress agents. For H2O2, filter paper 
containing 3% H2O2 was placed on a top lawn containing S39006-wt or S39006-R4. The 
smaller the size of the clearing around the filter paper, the higher the level of bacterial tolerance 





Previous research has shown that OmpW is related to antibiotic resistance in other species 
(168). To investigate whether the same is true for S39006, an assay was performed comparing 
the zone of clearing formed by different antibiotic disks on the top lawns of S39006-wt and 
S39006-R4. The inhibition ratio was calculated by dividing the clearance diameter formed on 
S39006-wt by the clearance diameter formed on S39006-R4. As shown in Figure S2a, of the 
25 antibiotics tested, only three of them had no growth inhibition effect on either S39006-wt 
or S39006-R4. However, for those active against S39006-wt, no difference in action was 
observed for the OmpW-mutant as all of their inhibition ratio are close to 1. This suggests that 
OmpW is not involved in the cell’s susceptibility to the antibiotics tested, either as an influx 
route or efflux pump. 
 
Virulence 
Previous studies have also shown that OmpW is involved in antigenic response from the host 
during bacterial infection (170). This prompted the interest to test whether OmpW is involved 
in S39006 virulence during infection of its hosts, such as C. elegans and potato. In a C.elegans 
virulence assay, S39006-wt and S39006-R4 were used to feed C. elegans DH26 and virulence 
was reflected by the speed of DH26 dying. As shown in Figure S2b, when DH26 was fed with 
E.coli OP50 (negative control), the number of live worms decreased gradually until after ~ 14 
days when no surviving worm was left. In comparison, worms fed on S39006-wt and the 
OmpW-mutant died rapidly with no worms alive after 4-5 days. However, the rate of decrease 
only had marginal differences with or without OmpW, suggesting that OmpW is not related to 
S39006 virulence in C. elegans DH26. 
 
Similarly, in a potato virulence assay, S39006-wt and S39006-R4 were compared for their 
ability to cause soft rot. The same amount (1×106 cfu) of S39006-wt and the OmpW-mutant 
were inoculated to the same potato and the resulting soft rot was weighed every 24 hours. As 
shown in Figure S2c, no obvious difference in rot weight was observed during the infection 
process between S39006-wt and S39006-R4, indicating that OmpW is not involved in S39006 







Figure S2: Antibiotic susceptibility and virulence of S39006-wt and S39006-R4.  
(a) Antibiotic susceptibility of S39006-wt versus S39006-R4. The inhibition ratio is calculated by 
dividing the diameter of clearance formed around an antibiotic disk on S39006-wt by the diameter 
of clearance formed on S39006-R4. Where inhibition ratio is “0”, it means the antibiotic was not 
able to inhibit growth on either S39006-wt or S39006-R4. Error bars represent standard deviation 
from triplicates. Abbreviation and concentration of antibiotics: CAZ – Ceftazidime 30µg/µl; CFU 
– Ceftiofur 20µg/µl; Pol – Polymyxin 100 IU; OXT – Oxytetracycline 30µg/µl; ENO – 
Enrofloxacin 5µg/µl; AMX – Amoxycillin 30µg/µl; PIP – Pipericillin 75µg/µl; IMP – Imipenem 
10µg/µl; AMK – Amikacin 30µg/µl; M – Marbofloxacin 5µg/µl; AMP – Ampicillin 10µg/µl; Fra 
– Framycetin 100µg/µl; FUS - Fusidic Acid 10µg/µl; CLX – Cephalexin 30µg/µl; TOB – 
Tobramycin 10µg/µl; NEO – Neomycin 10µg/µl; CRX – Cefuroxime 30µg/µl; AUG – Augmentin 




MTZ – Metronidazole 5µg/µl; COT – Cotrimoxazole 25µg/µl; CAR – Carbenicillin 100µg/µl; KN 
– Kanamycin 5µg/µl 
(b) Virulence comparison of S39006-wt and S39006-R4 infecting C. elegans DH26. The ratio of 
worms alive is calculated by dividing the number of live worms each day by the number of live 
worms on day 1. E.coli OP50 is used as negative control. The result shown is representative of 
triplicates. (c) Virulence comparison of S39006-wt and S39006-R4 infecting potato. The weight 
of soft rot was compared at day 2-4 post inoculation to reflect the level of virulence. Error bars 
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Bacteriophages Evolve to Escape
Abortive Infection via Multiple Routes
in a Bacterial Host Employing
“Altruistic Suicide” through Type III
Toxin-Antitoxin Systems
Bihe Chen, Chidiebere Akusobi †, Xinzhe Fang and George P. C. Salmond*
Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom
Abortive infection is an anti-phage mechanism employed by a bacterium to initiate
its own death upon phage infection. This reduces, or eliminates, production of viral
progeny and protects clonal siblings in the bacterial population by an act akin to an
“altruistic suicide.” Abortive infection can be mediated by a Type III toxin-antitoxin system
called ToxINPa consisting of an endoribonuclease toxin and RNA antitoxin. ToxINPa is a
heterohexameric quaternary complex in which pseudoknotted RNA inhibits the toxicity
of the toxin until infection by certain phages causes destabilization of ToxINPa, leading
to bacteriostasis and, eventually, lethality. However, it is still unknown why only certain
phages are able to activate ToxINPa. To try to address this issue we first introduced
ToxINPa into the Gram-negative enterobacterium, Serratia sp. ATCC 39006 (S 39006)
and then isolated new environmental S 39006 phages that were scored for activation
of ToxINPa and abortive infection capacity. We isolated three T4-like phages from a
sewage treatment outflow point into the River Cam, each phage being isolated at least
a year apart. These phages were susceptible to ToxINPa-mediated abortive infection but
produced spontaneous “escape” mutants that were insensitive to ToxINPa. Analysis of
these resistant mutants revealed three different routes of escaping ToxINPa, namely by
mutating asiA (the product of which is a phage transcriptional co-activator); by mutating
a conserved, yet functionally unknown, orf84; or by deleting a 6.5–10 kb region of the
phage genome. Analysis of these evolved escape mutants may help uncover the nature
of the corresponding phage product(s) involved in activation of ToxINPa.
Keywords: abortive infection, toxin-antitoxin, bacteriophage, Serratia, T4-family phage
INTRODUCTION
Bacteria are susceptible to viral (bacteriophage) predation but have evolved several strategies to
resist viral infection. One strategy is abortive infection (Abi) in which an infected bacterial cell
dies precociously and thereby concomitantly blocks the production of mature phage progeny
(Chopin et al., 2005). This protects clonal siblings in the bacterial population and therefore is akin
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to an “altruistic suicide.” Abi can be mediated through toxin-
antitoxin (TA) systems, which are widespread in prokaryotes.
Genetically, TA systems are usually composed of two genes
transcribed from a single promoter. The upstream gene
encodes an antitoxin that neutralizes the toxin product of
the downstream gene. Functionally, TA systems impact on
several biological processes such as the formation of persister
cells, responses to environmental stress, plasmid stabilization,
and phage exclusion through abortive infection (Gerdes et al.,
2005).
Some Type III TA systems are bifunctional in that they
also confer an Abi phenotype on their bacterial hosts. These
TA systems are comprised of a proteinaceous toxin and an
RNA antitoxin (Fineran et al., 2009). The first Type III
TA system identified (ToxINPa) was encoded by a cryptic
plasmid (pECA1039) in Pectobacterium atrosepticum. ToxINPa
was originally identified because ToxN shared 31% amino acid
sequence identity with the AbiQ protein, which was involved in
an abortive infection system in Lactococcus lactis (Emond et al.,
1998; Fineran et al., 2009). Recent mutational analysis of the
antitoxin and structural characterization of the toxin of the AbiQ
system revealed that it is also a member of the Type III TA
systems (Samson et al., 2013; Bélanger andMoineau, 2015). Since
the discovery of ToxNPa, numerous other Type III TA systems
have been identified bioinformatically in diverse bacterial genera
and they can be chromosomally, plasmid, or phage-encoded
(Blower et al., 2012). Type III TA systems have been classified
into ToxIN, CptIN, and TenpIN families. The toxic proteins of
these families are homologous to ToxNPa, while the antitoxin
primary DNA sequences vary in length and number of tandem
repeats. Interestingly, while ToxINPa exhibited a strong Abi
phenotype, ToxINBt from Bacillus thuringiensis did not exhibit
an Abi phenotype when challengedwith over 100 different phages
(Blower et al., 2012).
ToxINPa is composed of an RNA antitoxin, ToxI, which
binds to and suppresses the toxic endoribonuclease protein,
ToxN. Crystallographic evidence revealed that ToxINPa forms
a triangular heterohexameric structure with 3 ToxN proteins
in complex with 3 ToxI RNA pseudoknots (Blower et al.,
2011). The complex is held in an inactive state under normal
cellular conditions. However, during infection with specific
phages, the complex is activated by an unknown mechanism,
allowing the endoribonuclease to degrade host RNAs, leading
to bacteriostasis and subsequent cell death. This phenomenon
has features of a prokaryotic apoptosis that manifests itself
in precocious death of the virally-infected bacterial host and,
consequently, also inhibits progeny phage production. As
this outcome restricts or terminates further phage invasion
of the clonal bacterial population, the abortive infection
process can be viewed as an altruistic suicide (Fineran et al.,
2009).
Some phages aborted by ToxINPa have the capacity to
evolve spontaneous resistant mutants at low frequency that can
circumvent the Abi system. The ToxINPa resistant mutants of
8TE, a P. atrosepticum phage, were found to overcome abortive
infection by an RNA-based molecular mimicry of the ToxI
antitoxin. The 8TE escape phage had expanded a “pseudo-ToxI”
region in the viral genome that was similar, but not identical,
to the ToxI sequence. This expanded “pseudo-ToxI” region was
expressed during phage infection and actively suppressed ToxN,
thus allowing the 8TE mutants to evade abortive infection
(Blower et al., 2011). Recently, AbiQ-resistant mutations of
four phages were sequenced revealing multiple loci involved in
resistance, but how these genes conferred resistance to AbiQ
remained elusive (Samson et al., 2013).
To date, 8TE remains the only phage whose ToxINPa-escape
mechanism is understood. Thus, the primary aim of this study
was to characterize additional resistance mutations of new
ToxINPa-sensitive phages and, by their study, perhaps add to
the repertoire of known escape loci. Depending on the nature of
the relevant mutation(s), the escape locus might provide insight
into how phage infection leads to activation of the ToxINPa
complex.
In this study, we isolated and characterized Serratia sp. ATCC
39006 (S 39006)-specific phages, 8CHI14, 8X20, and 8CBH8.
Comparison of the genomic sequences of spontaneous ToxINPa-
escape mutants and their wild type progenitors revealed three
different routes of escape: (1) mutation of asiA, encoding a
predicted phage transcriptional co-activator in 8CHI14 and
8CBH8; (2) mutation of an unknown gene (orf84) in a
8CHI14 mutant; (3) deletion of a large region (6.5–10 kb)
of the phage genome in most mutants of all three T4-family
phages.
MATERIALS AND METHODS
Bacterial Strains, Bacteriophages, and
Growth Conditions
Bacterial hosts and phages used in this study are listed in Table 1.
All experiments were performed with S 39006. Bacteria were
cultured at 30◦C in Luria-Broth (LB) (10 g liter−1 tryptone, 5 g





Serratia sp. ATCC 39006
LacA (wt)
Laboratory strain, referred to
as wild type (wt) in text, Lac−
derivative of S 39006,
carbapenem+, prodigiosin+
PLASMIDS*
pTA46 toxIPa, ToxNPa Fineran et al., 2009
pTA47 toxIPa, ToxNPa-frameshift (FS) Fineran et al., 2009
pFR2 tenpIPl, tenpNPl Blower et al., 2012
pFR8 tenpIPl, tenpNPl-FS Blower et al., 2012
BACTERIOPHAGES
8CHI14 Environmentally isolated phage This study
8X20 Environmentally isolated phage This study
8CBH8 Environmentally isolated phage This study
*All plasmids containing Type III TA loci are in a pBR322 vector with ampicillin resistance
for selection. The TA complexes are expressed from their native promoter.
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liter−1 yeast extract, 5 g liter−1 NaCl) or on LB agar (LBA)
containing 1.5% w v−1 or 0.35% w v−1 agar to make LBA or
top-LBA plates respectively. Bacterial growth was monitored by
measuring optical density at 600 nm (OD600) using a Thermo
Scientific Helios Zeta spectrophotometer. Where required,
media were supplemented with ampicillin at 100µg mL−1.
Bacteriophages 8CHI14, 8X20, and 8CBH8 were isolated from
treated effluent collected from a sewage treatment plant in
Cambridge, United Kingdom. The bacteriophages were selected
from a library of S 39006-specific phages isolated using an
enrichment procedure detailed previously (Evans et al., 2010).
Phage lysates were generated as described previously (Petty et al.,
2006). Spot tests were performed as described previously (Evans
et al., 2010). Phages were stored at 4◦C in phage buffer containing
10mM MgSO4, 10mM Tris-HCl, 0.01% w v
−1 gelatin and a few
drops of chloroform. Efficiency of Plating (E.O.P.) was calculated
after incubating serial dilutions of phage lysates overnight on
bacterial lawns on LBA and dividing the titer of the phage on the
test host by the titer of the phage on the control host (Kutter,
2009).
Isolation of Phage Escape Mutants
Plaques of rare spontaneous phage mutants were isolated on
lawns of S 39006 cells expressing ToxINPa infected with wild
type 8CHI14, 8X20, or 8CBH8. Individual plaques were then
purified at least twice on a lawn of S 39006 expressing ToxINPa.
Final lysates of escape mutant phages were then prepared from
near-confluent lawns until a final titer of >109 plaque forming
units (p.f.u.) mL−1 was obtained.
Electron Microscopy
Transmission ElectronMicrograph (TEM) images of phages were
taken at the Multi-Imaging Center, University of Cambridge
using a Tecnai G2 series transmission electron microscope.
Samples were prepared by adsorbing 10µl of phage lysate
(>108 p.f.u. mL−1) onto a charged copper grid for 3 min.
The grids were then washed with water twice before being
stained with 2% phosphotungstic acid (PTA) neutralized with
potassium hydroxide (KOH). The accelerating voltage was
120.0 kV and the direct magnification used to image phages was
25,000x.
Phage Genome Sequencing
Phage DNA was extracted using a standard phenol-chloroform
protocol (Sambrook, 1989). In a phase-lock gel (PLG) tube (5′
Prime), 450µL of high titer phage lysate was incubated with
4.5µL of 1mg/mL DNase I and 2.5µL of 10mg/mL RNase A
and incubated at 37◦C for 30 min. The mixture was then added
to 11.5µL of 20% SDS and 4.5µL of 10mg/mL Proteinase K
and incubated for another 30min. DNA was extracted by adding
500µL of a Phenol:Chloroform:Isoamyl Alcohol 25:24:1 mix
and centrifuged at 1,500 × g for 5min. The supernatant was
transferred to a new PLG tube and the previous step repeated. In
a new PLG tube, the supernatant was supplemented with 500µL
of Chloroform:Isoamyl Alcohol 24:1 and centrifuged at 1,500× g
for 5min. The aqueous phase at the top was then incubated with
45µL sodium acetate (3mol/L, pH 5.2) and 500µL of 100%
Isopropanol at room temperature for 15min. The mixture was
then subjected to centrifugation at 12,000 × g for 20min, after
which the pellet was washed at least twice with 70% ethanol and
then re-suspended in dH2O.
The genomes of wild type phages and selected escape mutants
were sequenced using the Junior Roche 454 Genome Sequencer
FLX pyrosequencer at the Department of Biochemistry,
University of Cambridge or using the Illumina MiSeq, and HiSeq
2500 platforms at MicrobesNG. The resulting contigs were
assembled using Genomic Sequencer de novo assembler (Roche)
or SPAdes. The wild type sequences had coverage ranging from
57x to 100x of the full genome while the escape phage sequences
had coverage ranging from 45x to 150x.
Genome Annotation and Bioinformatics
Phage genome open reading frames (ORFs) were defined
using the gene prediction tools GeneMark.hmm (Lukashin
and Borodovsky, 1998) and Glimmer (Delcher et al., 1999).
Homologs of predicted proteins were identified using PSI-
BLASTp searches or i-TASSER (Roy et al., 2010). The program
tRNAScan-SE (Lowe and Eddy, 1997) was used to identify phage
tRNA genes and ARAGORN (Laslett and Canback, 2004) was
used to predict host tRNA genes. The genomic sequences of
wild type and escape phages were compared using Geneious 6.1
(Biomatters Ltd) and Artemis (Rutherford et al., 2000). Protein
alignments were conducted using the EMBOSS “ClustalW”
program. Final alignment images were generated using the
ESPript 2.2 program. All the above analysis were used at default
settings.
DNA Manipulations
The asiA locus of additional 8CHI14 and 8CBH8 mutants was
probed by PCR amplification using primers oBH3 (5′- CTGTGA
CTTCGAGCTTAAATCTCC-3′) and oBH4 (5′- CGCTATATG
TCAACAGGCCG-3′). Subsequent amplicons were subjected to
Sanger sequencing.
Phage Burst Size
Phage burst size assays were performed as described previously
(Petty et al., 2007). In brief, an overnight S 39006 culture was used
to inoculate LB in a 250mL conical flask and incubated at 30◦C
to OD600 = 0.5. Phage samples were then added at a multiplicity
of infection (M.O.I.) of 0.001 and the culture incubated with
shaking at 150 rpm at 30◦C. Samples were taken at different time
points and chloroform-treated before titrating to determine the
number of p.f.u. The one-step growth curve describes phages per
initial infection center, over time.
Phage Adsorption
An overnight culture of S 39006 was adjusted to OD600 = 1 with
LB in a 250mL conical flask and infected with phages at anM.O.I.
of 0.001. The 10mL infected culture was placed in a shaking water
bath at 30◦C with shaking at 150 rpm. One hundred microliters
samples were taken at different time points and added to 900µL
of chilled LB. The samples were chloroform-treated immediately
and then titrated. The final adsorption curve was plotted by
calculating the percentage of free phages in the culture against
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time. An LB-only sample was infected with phages as a negative
control.
RESULTS
Three ToxINPa-Sensitive S 39006 Phages
Were Isolated
Since 2013, three phages that could be aborted by ToxINPa were
isolated fromwater from treated sewage effluent in samples taken
at least a year apart from each other. The phages were initially
isolated after enrichment on the S 39006 host expressing ToxINPa
with a frameshift mutation in the toxN gene. Abi sensitivity
of these three phages, named 8CHI14, 8X20, and 8CBH8 in
chronological order, were examined initially by comparing titers
from spot tests on S 39006 lawns expressing ToxINPa or with the
frameshifted version of the ToxINPa locus as negative control.
E.O.P. measurements showed that the three phages were strongly
aborted by ToxINPa: the E.O.P.s of 8CHI14, 8X20, and 8CBH8
were 2.0 × 10−7, 2.8 × 10−8, and 8.0 × 10−6 respectively.
Therefore, all three phages could produce “spontaneous escape”
mutants that became insensitive to ToxINPa at low frequencies.
Interestingly, all three phages were also aborted by another Type
III TA system (TenpINPl) (Blower et al., 2012) but without
producing any detectable spontaneous escape mutants (E.O.P.
<10−9). None of the phages showed sensitivity to other Type III
TA systems tested.
8CHI14, 8X20, and 8CBH8 Are T4-Like
Phages of the Myoviridae Family
TEM images revealed that all three phages had isometric,
icosahedral heads, contractile tails and tail fibers (Figure 1). This
classified them in the Caudovirales order and Myoviridae family
(Ackermann, 2009). Whole genome sequencing results revealed
that 8CHI14, 8X20, and 8CBH8 were very similar to each
other at the DNA sequence level. 8CHI14 and 8CBH8 both
have a size of 171,151 bp and contain 275 predicted open reading
frames (ORFs). 8CHI14 and 8CBH8 are almost identical
genomically, except for 19 point mutations, 11 of which are
in ORFs and cause non-synonymous mutations. tRNAscan-SE
identified 16 tRNA genes encoded by 8CHI14 and 8CBH8.
Similarly 8X20 has a genome of 172,450 bp with 279 ORFs
plus 17 predicted tRNA genes and it shared 93.8% homology
with the genomes of 8CHI14 and 8CBH8. Interestingly all
three phages encode almost twice the number of tRNAs as other
related phages, such as T4 and CC31. Further, all three phages
also have a GC content of ∼38%, much lower than the host
GC content of 49.24%. The genomes of all three phages were
deposited in GenBank with the following accession numbers:
8CHI14 (MF036690), 8CBH8 (MF036691), and 8X20
(MF036692).
8CHI14 was used as a representative of the new isolates to
compare with related phages (Figure 2): 8CHI14 shares 55.0,
57.5, 55.3, 54.3, 57.4, and 60.1% DNA sequence identity with
phages T4, CC31, 8R1-RT, 8S16, PG7, and PEi20 respectively—
all of the above being T4-like phages.
ToxINPa-Sensitive S 39006 Phages Harbor
at Least Three Distinct ToxINPa Escape
Loci
Although ToxINPa aborted T4-like S 39006 phages efficiently,
rare phage plaques appeared at low frequencies. We presumed
that these rare plaques arose due to viral mutations enabling
phages to “escape” or circumvent the effects of ToxINPa.
Therefore, we expected that definition of the corresponding
mutations would enable identification of the phage genes
encoding products responsible for “activation” of the ToxINPa
system.
In total, 24 “escape” mutants of these S 39006 phages were
subject to whole genome sequencing; 5 of 8CHI14 mutants, 11
of 8X20 mutants and 8 of 8CBH8 mutants. Mutations were
FIGURE 1 | TEM images of (A) 8CHI14, (B) 8X20, and (C) 8CBH8. 8CHI14 and 8CBH8 have extended tails while 8X20 captured in the images shows a
contracted tail.
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FIGURE 2 | Whole genome alignment of wild type 8CHI14 with other T4-like phages. DNA homologies are displayed in red. The degree of similarity is proportional to
the intensity of red. Similar linear organization of the genome is observed between the aligned phages: (A) Comparison with 8CBH8 and 8X20. (B) Comparison with
T4 and CC31. (C) Comparison with phage 8R1-RT and PEi20. (D) Comparison with PG7 and 8S16.
mapped to the corresponding wild type genomes to identify the
putative ToxINPa resistance loci. Interestingly, the mutations did
not all map to single locations in the corresponding genomes.
Instead, three distinct mutational types were identified in the
genomes of the 24 escape phages (Table 2): 21 mutants harbored
a large deletion (size ranging from 6.5 to 10 kb) in their genomes;
2 mutants carried a nonsense mutation or deletion in the asiA
gene; and 1 mutant had a missense mutation in an orf encoding
a hypothetical protein, ORF84.
Asia is Involved in the Activation of ToxINPa
Two sequenced escape mutants of 8CHI14 (8CHI14b and
8CHI14f) had mutations in the asiA gene (Table 2). After
defining these mutant asiA variants, the asiA locus in additional
8CHI14 and 8CBH8 “escape” mutants were probed by PCR
and Sanger sequencing and 6 further independent asiA mutants
were identified. The asiA locus encodes the protein AsiA, the
homolog of which in 8T4 is involved in σ70-appropriation
(Hinton et al., 2005). Most of the mutations affect the C-terminal
domain (CTD) of AsiA, including: (1) truncation of the CTD
via a point mutation leading to a premature stop codon; (2)
extension of the CTD via insertion or deletion of nucleotides
leading to frameshift mutations that eliminated the natural stop
codon. Only one mutant had a V13Gmutation in the N-terminal
domain of the protein (Figure 3).
ORF84 May Be Involved in the Activation of
ToxINPa
One mutant (8CHI14e) had a single nucleotide substitution
in the gene, orf84. The A to C substitution caused an
E66D change in the encoded ORF84 protein. Homologs of
ORF84 have been found in 11 other phages, the most similar
homolog belonging to enterobacterial phage, CC31. However, no
functional information exists currently for any of the homologs
from both sequenced-based predictions and structure-based
predictions.
The “Large Deletion” is the Most Prevalent
Mutational Route through Which These S
39006 Phages Escape ToxINPa
The majority (21 out of 24) of the sequenced “escape” mutants
of S 39006 phages became insensitive to ToxINPa by a similar
type of mutation—through a large deletion of a specific viral
genome locus (Table 2). This was the only common mutational
route through which all three S 39006 phages could escape
ToxINPa. In particular, all 11 of the 8X20 mutants isolated
arose through this “large deletion” mutation. The corresponding
deletions overlapped across a common core and varied from
6,521 bp (8CBH8o) to 10,094 bp (8CHI14c). The largest
deleted region contains 19 ORFs and 13 tRNA genes, whereas
the smallest contains 13 ORFs and 10 tRNA genes (Figure 4).
Although the precise 5′ and 3′ borders of most deletion
mutations were variable, closer inspection revealed the presence
of direct repeats flanking the deleted region in every mutant
(Table 3). The repeat length and sequence was unique in each
mutant and most of the repeats appeared numerous times in
the wild type genome, some are also represented within the
deleted region. The presence of the direct repeats may suggest
slipped mispairing during replication, or inter/intra-molecular
misalignment during recombination, as possible mechanisms
driving the deletion mutations (Singer and Westlye, 1988; Pierce
and Masker, 1989).
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Mutation type Gene(s) affected Effect of mutation
8CHI14a large deletion (7,647
bp)
14 ORFs elimination of
affected genes12 tRNA genes
8CHI14b nonsense mutation asiA E71: stop codon
8CHI14c large deletion
(10,094 bp)
19 ORFs elimination of
affected genes13 tRNA genes
8CHI14e missense mutation orf84 E66D




19 ORFs elimination of
affected genes11 tRNA genes
8CBH8l large deletion (7,802
bp)
15 ORFs elimination of
affected genes11 tRNA genes
8CBH8m large deletion (8,575
bp)
17 ORFs elimination of
affected genes6 tRNA genes
8CBH8o large deletion (6,521
bp)
14 ORFs elimination of
affected genes10 tRNA genes
8CBH8p large deletion (8,368
bp)
16 ORFs elimination of
affected genes10 tRNA genes
8CBH8t large deletion (7,328
bp)
15 ORFs elimination of
affected genes9 tRNA genes
8CBH8u large deletion (8,158
bp)
17 ORFs elimination of
affected genes4 tRNA genes
8CBH8x large deletion (7,731
bp)
14 ORFs elimination of
affected genes10 tRNA genes
8X20b large deletion (9,533
bp)
19 ORFs elimination of
affected genes11 tRNA genes
8X20d large deletion (9,479
bp)
19 ORFs elimination of
affected genes8 tRNA genes
8X20f large deletion (9,473
bp)
19 ORFs elimination of
affected genes8 tRNA genes
8X20g large deletion (9,533
bp)
19 ORFs elimination of
affected genes11 tRNA genes
8X20h large deletion (9533
bp)
19 ORFs elimination of
affected genes11 tRNA genes
8X20j large deletion (9,533
bp)
19 ORFs elimination of
affected genes11 tRNA genes
8X20k large deletion (9,533
bp)
19 ORFs elimination of
affected genes11 tRNA genes
8X20l large deletion (9,533
bp)
19 ORFs elimination of
affected genes11 tRNA genes
8X20m large deletion (9,533
bp)
19 ORFs elimination of
affected genes11 tRNA genes
8X20n large deletion (9,533
bp)
19 ORFs elimination of
affected genes11 tRNA genes
8X20o large deletion (9,533
bp)
19 ORFs elimination of
affected genes11 tRNA genes
Deleted Regions Contain Mostly Unknown ORFs
The ability of “large deletion” mutants to escape ToxINPa
infers that the 6.5–10 kb deleted region contains genetic
elements directly or indirectly responsible for activating
ToxINPa. In our limited pool of spontaneous “large
deletion” mutants, 6.5 kb was the most compact deletion
and therefore detailed inspection of the ORFs and tRNAs in
this region was undertaken. Every individual predicted ORF
was investigated by searching for DNA homologies using
nucleotide BLAST; amino acid sequence homology using
protein BLAST; and finally i-TASSER for predicted structural
homologs.
Of the 13 predicted ORFs within the smallest deletion region
found in 8CBH8o, 6 encode hypothetical proteins with no
sequence, or structural, homologs, while 7 of the ORFs encode
homologs in other T4-like phages. However, no functional
information is available about any of these homologs—except for
one hypothetical protein encoded by the 3′ end of the deletion
region. This hypothetical protein, (ORF145), shows some
similarity to the membrane anchor domain of an agglutinating
adhesin (YadA) in both protein BLAST and i-TASSER structural
predictions.
The absence of any functional information for individual
ORFs in the “large deletion” locus prompted an analysis of
whether the region is present in other related phages or is unique
to the T4-family S 39006 phages reported in this study. Therefore,
the 6.5 kb smallest deletion region from 8CBH8o was aligned
with the genomes of the related phages that show high homology
with the entire genomes of these environmental T4-like S 39006
phages. ACT alignment showed only very limited identity of the
6.5 kb region with phages T4, CC31, 8R1-RT, 8S16, PG7, and
PEi20 (Figure 5).
The presence of multiple tRNA genes within the deleted
regions may also suggest that these tRNAs play a role in
susceptibility to ToxINPa. Among all the “large deletion”
mutants, 8CBH8u showed deletion of the smallest number
of tRNAs: Gly with the TTC anticodon, Met with the CAT
anticodon, Arg with the TCT anticodon and Leu with the
TAA anticodon. tRNAs genes with the same anticodons for
the above mentioned amino acids appear 3 times and 6 times
for the first two and only once for the last two in the host
genome. The presence of these tRNA genes in the host genome
suggests it may be unlikely that they are the direct activators
of ToxINPa. However, the low frequency of Arg (TCT) and
Leu (TAA) in the host genome suggests the possibility that
their deletion from the phage genome might lead to inefficient
translation of some viral transcripts encoding products that
activate ToxINPa.
Loss of the Large Deletion Locus Affects the Fitness
of Mutant Phages
Given the extent of the viral genome deletions and absence
of any functional information on most of the deleted gene
products, we decided to investigate the impact of the deletions
on phage fitness, represented by adsorption efficiency and
burst size. The burst size of wild type 8CBH8 and 8CBH8o
infecting exponential phase S 39006 with an M.O.I. of 0.001
was measured by one-step growth (n = 5). Both wild type
8CBH8 and 8CBH8o showed a latent period of 25 min and
a rise period of about 35 min. The average burst size was
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FIGURE 3 | Alignment of the primary sequence of AsiA encoded in 8CHI14 and 8CBH8 wild type and escape phages. Blue highlight indicates identical sequences
while yellow highlight shows variations in the primary sequence of AsiA in escape mutants.
FIGURE 4 | Diagram of the deleted regions in 8CHI14, 8CBH8, and 8X20 mutants. (A) Mapping of “large deletion” regions onto 8CHI14 and 8CBH8 genomes
shows the start and end of each deletion. The same presentations of the deleted regions are used for 8CHI14 and 8CBH8 due to their high similarity. (B) Mapping of
“large deletion” regions onto the 8X20 genome shows the start and end of each deletion.
approximately 22 phage particles per initial infection center for
wild type 8CBH8 and 28 for 8CBH8o (Figure 6A). However,
the adsorption efficiency of 8CBH8o was lower than that of
wild type 8CBH8 (Figure 6A), suggesting a fitness defect. To
investigate if the difference in adsorption was phage-dependent
or host-dependent, we carried out a second adsorption assay
(n = 3) using stationary phase S 39006 instead of exponential
phase host but retaining the same M.O.I. As shown in Figure 6B,
no obvious difference in binding to host cells was observed—
both phages achieving >95% adsorption in 20min. These results
may suggest that the “large deletion” mutation causes decrease
in adsorption efficiency only when infecting exponential phase
host cultures, but causes no significant difference in burst
size. However, due to the variable nature of the fitness assays,
further experiments should be carried out in the future to
verify the differences in adsorption seen in 8CBH8 and the
8CBH8o mutant, especially in the exponential phase of bacterial
growth.
DISCUSSION
In this study we isolated three highly homologous T4-family
environmental phages of S 39006 that are sensitive to ToxINPa-
mediated Abi. Rare spontaneous mutants of these phages
were able to circumvent ToxINPa via multiple escape routes.
The independent isolation of 8CHI14, 8X20, and 8CBH8
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8CHI14a TCAGCCA 40 3
8CHI14c GGATTA >100 4
8CBH8f GAACTGC 22 3
8CBH8l TTGAGTAG 7 0
8CBH8m GTCCCTG 11 0
8CBH8o CCGAAGC 15 1
8CBH8p GTTCAC 94 4
8CBH8t AGCCATCC 5 0
8CBH8u GGAAGCC 22 1
8CBH8x ATCTG >100 11
8X20b, g, h,
j, k, l, m, n, o
AACTGCTACA 2 0
8X20d GGGAAAC 6 0
8X20f CTTCGCC 21 1
The repeat length varies from 5 to 10 nucleotides and the sequences are different in each
mutant of unique deletion size. Most of the repeats appear numerous times in the wild
type genome and some of them appear also within the deleted region.
is interesting since pairwise alignment of their genomes with
other T4-like phages showed that they are mosaics of one
another—whole-genome alignments consist of varying-length
stretches of high homology interspersed with stretches of
no homology (Nolan et al., 2006; Petrov et al., 2006). This
kind of similarity and diversity is typical among T4-like
phages (Petrov et al., 2010) yet the relatively low overall
sequence similarities indicate that 8CHI14, 8X20, and 8CBH8
may represent a new type of T4-like genome configuration.
Furthermore, the isolation of only 3 ToxINPa-sensitive, and
very similar phages (despite multiple environmental enrichments
yielding more than 300 phages over a 3-year span) suggests
a relatively rare incidence of ToxINPa-sensitive viruses among
environmental phages of S 39006. However, this rarity may
not be surprising because wild type S 39006 does not
carry ToxINPa naturally. Furthermore, it is possible that
these new phages arose in the environment by propagation
on alternative native hosts taxonomically unrelated to S
39006.
We showed recently that a single phage gene product from
phage 8M1 was responsible for activating the ToxINPa system
in the natural host, P. atrosepticum (Blower et al., 2017). A
phage product might interact with ToxI and degrade it or
sequester it away from ToxN to liberate the toxin. Alternatively,
a phage product could interact with ToxN, reducing the affinity
between ToxN and ToxI. Interactions of the phage product(s)
with both ToxI and ToxN are also formally possible. Based
on our recent observations with the evolution of 8M1 to
ToxINPa resistance in P. atrosepticum, we expected to find
mutations in a single locus in “escape” mutants of 8CHI14,
8X20, and 8CBH8. However, our characterization of the
FIGURE 5 | DNA sequence comparisons of the smallest deleted region in
8CBH8o (6.5 kb) with other T4-like phages, using ACT. (A) Comparison with
phage T4. (B) Comparison with CC31. (C) Comparison with 8R1-RT. (D)
Comparison with 8S16. (E) Comparison with PG7. (F) Comparison with
PEi20.
latter “escape” mutants has now suggested a more complicated
landscape for potential activation mechanisms operating on
ToxINPa.
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FIGURE 6 | Fitness comparison of 8CBH8wt and 8CBH8o. (A) One-step
growth curve of 8CBH8wt and 8CBH8o. (B) Adsorption of 8CBH8wt and
8CBH8o to wild type S 39006. 8CBH8wt and 8CBH8o with LB-only was
used as a negative control for adsorption.
One “escape” locus found in both 8CHI14 and 8CBH8
mutants is asiA, which encodes AsiA, a highly-conserved
protein in T4-like phages (Figure 7). In T4, AsiA is an anti-
sigma factor that represses host transcription through a process
known as σ-appropriation, and, together withMotA, co-activates
transcription of phage middle genes (Hinton et al., 2005). AsiA
monomers bind tightly to regions 4.1 and 4.2 of σ70 and abolish
the sigma factor’s ability to bind to the−35 promoter sequence of
host genes (Hinton, 2010). As a result, AsiA inhibits transcription
of bacterial genes with a −10/−35 promoter. In addition, AsiA-
bound σ70 adopts an altered conformation that allows the T4
transcriptional activator, MotA, to bind σ70 and the MotA box
present in the promoter region of T4 middle-expressed genes.
Thus, the AsiA-σ70-MotA complex disrupts the ability of RNA-
polymerase (RNAP) to recognize and transcribe host genes but
reconfigures the enzyme to transcribe phage middle-expressed
genes (Ouhammouch et al., 1995; Lambert et al., 2004). Most
of the 6 escape mutants of 8CHI14 and 8CBH8 produce an
AsiA with either an extended or truncated CTD, while only one
mutant has a V13G substitution in the NTD. In AsiA the role
of the CTD is controversial and not fully understood, with some
studies showing that mutations in the CTD of AsiA affected
its function in σ-appropriation and MotA binding (Yuan and
Hochschild, 2009; Yuan et al., 2009) while other studies showed
no compromise in σ-appropriation of AsiA with a mutated CTD
(Pal et al., 2003). As for the V13G mutation in the NTD, the
mutated amino acid is homologous to V14 in T4, which was
defined as an essential residue for AsiA-AsiA homodimer and
AsiA-σ70 interactions (Gilmore et al., 2010). Future research
will investigate whether AsiA plays a direct role in ToxINPa
activation as a phage product or as a part of the AsiA-RNAP-
MotA complex, or whether AsiA indirectly activates ToxINPa
by disturbing ToxI:ToxN stoichiometry or phage middle gene
transcription.
The most frequently found escape locus among the S 39006
phage mutants was the deletion of a substantial region of the
phage genomes. The size of the deletion represented 3.8–5.8%
of the total genome size. These deletant mutants remained
viable on S 39006 indicating that the deleted region is not
essential for phage replication, at least under the laboratory
conditions used. How the deletion mutations confer resistance is
not immediately obvious, given the number of genes affected. As
no missense mutations were isolated that mapped to this locus,
we presume that two or more genes have to be mutated in this
locus simultaneously for phages to escape, and presumably, these
genes might be located toward the two ends of the deletion,
hence the large deletion size. An interesting hypothesis here
would be that the entire deletion region might contain genes
that wild type phages acquired by recombinogenic lateral gene
transfer (Petrov et al., 2010) in the natural environment (perhaps
during mixed viral infections) and these genes, in concert,
could be responsible for activating ToxINPa in bacterial hosts.
The possibility that the deleted region was acquired through
lateral gene transfer is supported by two pieces of evidence:
(1) attempts to align the large deletion locus with several
other T4-like phages (T4, CC31, 8R1-RT, 8S16, PG7, and
PEi20) showed very little homology (Figure 5); and (2) most
of the 5’ borders of the large deletion mutations lie within
tRNA genes (Figure 4), whose conserved sequences are readily
recombinogenic. It could be argued that this has echoes of
the descriptions of Pathogenicity Islands in bacteria (Karaolis
et al., 1999; Schmidt and Hensel, 2004) and therefore could even
suggest that the large deletion region is a potentially mobile viral
genome unit.
The only clue to possible functions of ORFs in the deleted
regions comes from ORF145, which is a YadA homolog. YadA
was first found in Yersinia species and serves as a virulence
factor that mediates Yersinia adherence to epithelial tissue
(Hoiczyk et al., 2000). YadA cognate genes have also been
found in other phages but it is unknown if they might be
transferred to their bacterial hosts to enhance virulence (Moreno
Switt et al., 2013). Future work will involve investigating the
impact of ORF145 in allowing phage “escape.” Finally, given
the important physiological roles for phage-encoded tRNAs in
viral morphogenesis, future research into the role that the tRNAs
encoded within the deleted regions may play in phage “escape”
requires investigation.
In summary, this study has discovered a distinct group of
T4-family S 39006 phages that could activate the ToxINPa-
mediated abortive infection system. The data on the “escape”
mutants of these environmental phages suggest that either
ToxINPa can be activated by more than one phage product,
or that production of the ToxINPa- activating product involves
multiple biological processes and that defects in several could
enable phages to circumvent Abi. Future investigations will
Frontiers in Microbiology | www.frontiersin.org 9 May 2017 | Volume 8 | Article 1006
Chen et al. Type III TA Escape Phage
FIGURE 7 | Alignment of AsiA from 8CHI14 and related phages. The N-terminal region of AsiA is highly conserved among phages while the C-terminal region is more
varied. The protein secondary structure prediction is overlaid on the alignment.
involve further characterization of the products from the escape
loci of these phages, and experiments to try to dissect their
physiological roles during the process of abortive infection—and
its circumvention.
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Abstract: Toxin-antitoxin (TA) systems are small genetic modules that encode a toxin (that targets
an essential cellular process) and an antitoxin that neutralises or suppresses the deleterious effect
of the toxin. Based on the molecular nature of the toxin and antitoxin components, TA systems are
categorised into different types. Type III TA systems, the focus of this review, are composed of a
toxic endoribonuclease neutralised by a non-coding RNA antitoxin in a pseudoknotted configuration.
Bioinformatic analysis shows that the Type III systems can be classified into subtypes. These TA
systems were originally discovered through a phage resistance phenotype arising due to a process
akin to an altruistic suicide; the phenomenon of abortive infection. Some Type III TA systems are
bifunctional and can stabilise plasmids during vegetative growth and sporulation. Features particular
to Type III systems are explored here, emphasising some of the characteristics of the RNA antitoxin
and how these may affect the co-evolutionary relationship between toxins and cognate antitoxins in
their quaternary structures. Finally, an updated analysis of the distribution and diversity of these
systems are presented and discussed.
Keywords: abortive infection; altruistic suicide; type III toxin-antitoxin; bacteriophages; quaternary
structures; co-evolution; pseudoknotted RNA; endoribonuclease
1. Introduction
Toxin-antitoxin (TA) systems are composed of a bacteriostatic or bactericidal toxin and a cognate
antidote which is referred to as the antitoxin. In most cases, the antitoxin directly interacts with
either the proteinaceous toxin or its mRNA and thus antagonises the deleterious effect of the toxin.
In addition to their physical interdependence, they are linked at the genetic level and are often
encoded in bicistronic operons with a promoter-proximal antitoxin gene. Save for a few Type I systems,
all TA systems are encoded in operons wherein the antitoxin gene is usually found upstream of the
toxin-encoding ORF. Nonetheless a few Type II systems such as HigBA and HicAB are exceptions and
have a reverse genetic organisation [1]. This transcriptional organisation favours an excess of antitoxin
in homeostatic conditions where the toxin is inhibited. The harmful activities of the toxins are due to
their interference with essential cellular processes including DNA replication, translation, cell wall
synthesis, and maintenance of membrane integrity [2–6].
The active toxin always interacts with its targets as a protein while the nature of the potent
antitoxin is either RNA or protein. In addition, antitoxins neutralise their cognate toxins at several
levels and act via distinct mechanisms. The nature of the antitoxin and its mode of action underpin
the classification of TA systems into five Types (I–V) [7–9]. RNA antitoxins of Type I and III interact
with the toxin transcripts (RNA-RNA interactions) or with the toxic protein (RNA-protein interactions)
respectively. Most Type I antitoxin RNAs bind the toxin transcript in its 5'UTR region. Formation of
this RNA-RNA duplex has two main effects [10]. Firstly, translation of the mRNA into the toxic protein
Toxins 2016, 8, 282; doi:10.3390/toxins8100282 www.mdpi.com/journal/toxins
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is hindered as the antitoxin RNA is usually complementary to the region containing the ribosome
binding site (RBS) of the toxin transcript or directly competes with ribosomes. In addition to blocking
translation initiation, the antitoxin/toxin RNA duplexes are the targets of cellular RNases and thus
antitoxin binding ultimately leads to degradation of the toxin transcripts [6]. Aside from Type I TA
systems, inhibition of toxin translation is also used by the only Type V system identified so far [7].
In this case, toxin production is turned off directly by the antitoxin which is an RNase that degrades
toxin mRNAs and thus directly regulates toxin transcript levels [7]. In Type II, III, and IV systems,
translation of the toxin is not directly affected. Type II systems use direct protein-protein interactions
where antitoxins either mask the toxin active site or sterically hinder the toxins from reaching their
target [1–3]. Type IV antitoxins also prevent toxin-target interactions but achieve this by competing
with the toxins for their target, without direct contacts with their cognate toxins [8,9]. Finally, Type III
TA systems fall into the category of RNA-protein interactions in which the toxin active site is occluded
by the antitoxin RNA [11–14].
TA systems were originally discovered in the late 80s [15,16] and, for a long period, were defined in
only two types (Type I and II) which have been extensively studied. In contrast, the archetypal Type III
TA system and, subsequently, the Type IV and V systems, were discovered only recently. While data
are still comparatively limited for the newer Type IV and V systems, a more holistic image is beginning
to emerge regarding Type III systems, with accumulating biochemical, structural, and functional
data. This review covers these systems, describing their diversity and toxin-antitoxin/abortive
infection bifunctionality and discusses their impact on bacteria-phage co-evolution, given their
anti-phage activity.
2. Type III TA Systems Are Split into Three Families Which Share the Same Genetic Organisation
The novelty of Type III TA systems involves the nature of RNA-protein interactions between
their components [11,12]. These interactions are unusual as the toxin is involved in processing the
antitoxin into its active form. More precisely, the antitoxin, a small non-coding RNA (sRNA) composed
of several repeats of short nucleotide sequences, is processed into monomers of these repeats by the
toxin. The heteromeric complexes adopted by Type III systems during homeostatic conditions are
composed of alternating interactions between antitoxin and toxin monomers [12–14]. As for other
Types of TA systems, the antitoxin has a shorter half-life than the toxin [11] but the specific details of
antitoxin degradation are not yet completely clear.
At the genetic level, Type III TA systems are organised in characteristic bicistronic operons
transcribed from a single promoter. The downstream toxin gene is preceded by a Rho-independent
terminator that separates it from the upstream short repetitive nucleotide sequences that encode the
antitoxin sRNA (Figure 1) [11,17]. Presumably, organisation in operons ensures a higher synthesis of
the antitoxin compared to the toxin and thus avoids physiologically precocious, and potentially lethal,
toxin activity. Unique to Type III systems toxin expression is further modulated by the presence of
the inter-gene Rho-independent terminator. A final regulatory fail-safe may reside in the fact that one
antitoxin sRNA will be processed into several monomers that could neutralise two or three toxins,
thus further ensuring an appropriately regulated antitoxin:toxin stoichiometry.
Although all Type III TA systems share the same genetic arrangement, they can be further
differentiated into three families which are classified according to the amino acid sequence similarities
that they share [18]. The subfamilies are called ToxIN, CptIN, and TenpIN where the “I” and
“N” represent the antitoxin and toxin components respectively. Thus, for the ToxIN system of
Pectobacterium atrosepticum the antitoxin is referred to as ToxIPa, the toxin as ToxNPa and both
components as ToxINPa [18]. CptIN was named after the Coprococcus catus GD/7 system (CoPrococcus
Type III Inhibitor/toxiN) and the third family, TenpIN for Type III ENdogenous to Photorhabdus
Inhibitor/toxIN [18]. While the toxin sequence directly influences the subgroup to which a particular
system belongs, it is also interesting to note how their cognate antitoxins differ between and within
the subgroups.
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3. Antitoxin Length Is Important for Type III System Functions
ntitoxin repeats are a key feature of Type III syste s. The nu ber of repeats varies bet een
syste s and they have been sho n to be crucial for antitoxin activity. For instance, the antitoxins of
the ToxI a, ToxI Bt, and AbiQ systems that belong to the ToxIN family, all diverge at the pri ary
sequence level and nu ber of repeats, hile the length of the ono ers is quite conserved. ToxI a,
ToxI , and antiQ sRNAs are composed of, respectively, 36 nucleotides repeated 5.5 times, 34 nucleotides
repeated 2.9 times, and 35 nucleotides repeated 2.8 times (Figure 1). In vitro, the antitoxin activity
can be retained despite increasing or decreasing repeat numbers. However, the range of repeats in
which each antitoxin remains functional varies. For instance, 2.5 repeats from 5.5 were necessary and
sufficient for ToxIPa antitoxin to inhibit its toxin [19] while at least 1.8 repeats from 2.8 were essential for
the antitoxin activity of antiQ [17]. antiQ mutants containing 1.8 and 3.8 repeats were readily obtained
hile clones with only 0.8 of a basic repeat were inviable, suggesting that an incomplete repeat
sequence is insufficient to avoid toxicity of AbiQ [17]. In addition to its TA function, the AbiQ system
also acts as an abortive infection system against some phages (See below, Section 6.1). This activity is
also affected by the number of antiQ repeats however the anti-phage activity of the system is altered
independently of its toxin neutralising activity. For instance, deletion or addition of one repeat to
antiQ decreased the phage resistance provided by the AbiQ system, indicating that the length of the
wild-type antiQ is critical for optimal anti-phage activity. Similarly, mutations in key residues for
antitoxin processing led to significant loss of anti-phage activity while a point mutation that affects
pseudoknot structure increased anti-phage activity, but did not affect bacterial fitness [17].
4. Assembly of the Toxin-Antitoxin Complexes
When the paradigmatic ToxINPa system was first discovered, the activity of the toxin component
was unknown and mining structural databases with the predicted structure of ToxNPa gave no
meaningful results [11]. Insight into its activity was gained later with the resolution of its crystal
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structure and the discovery of the triangular architecture adopted by the three toxin-antitoxin
monomers [12]. Resolution of the quaternary structures of further Type III systems showed that
this interesting feature of Type III TAs exhibits some variations on a theme where toxin and antitoxin
monomers alternate (in hexameric or tetrameric complexes) in which only RNA-protein interactions
occur. A hallmark shared by all the structures is that it is the antitoxin processing that leads to the
inactive, stable TA complex [12–14]. So far, the core architecture of Type III systems seems to be
subfamily specific and likely depends on the length and fold of the antitoxin monomers.
4.1. The ToxIN Systems Form Triangular Heterohexamers
Most of the structural data currently available concerns the ToxIN subfamily. The quaternary
structure of the ToxINPa and ToxINBt systems has been resolved (Figure 2A,B) and bioinformatic
analyses predict that the AbiQ system shares the same quaternary architecture [12,13,20]. These crystal
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Figure 2. Crystal structures of Type III TA systems. (A) ToxINPa (PDB ID: 2XDD) and (B) ToxINBt
(PDB ID: 4ATO) form heterohexameric complexes [12,13]; (C) CptINEr (PDB ID: 4RMO) assembles into
a heterotetrameric complex [14].
Both the ToxINPa and ToxINBt systems assemble into heterohexameric complexes (Figure 2A,B)
that adopt a triangular architecture where toxins occupy the apices and are held together by processed
antitoxin monomers [12,13]. In the complexes, each pseudoknotted ToxI RNA is bound head to
tail to two separate ToxN monomers and occludes their active sites. Since ToxNPa and ToxNBt are
both endoribonucleases, cleavage of cognate tandem RNAs into single repeats and assembly into the
ToxIN complexes is likely associated with the inhibition of toxicity. Experimental data show that,
while ToxNPa is neutralized by both the processed and precursor forms of ToxIPa, the precursor ToxIPa
is the preferred substrate, indicating the involvement of the antitoxin processing in toxin inhibition [13].
Additionally, the pseudocontinuous arrangement of ToxI units in these structures and the 2′-3′ cyclic
phosphates at the 3′ end of the processed antitoxins support this mechanism [12,13]. Finally, ToxINPa
complexes can self-assemble in vitro from ToxNPa combined either with processed or precursor ToxIPa
RNAs indicating that the self-assembly of these structures is largely mediated by the antitoxin RNAs
and does not require any cellular factors or exogenous energy [13].
Both ToxIPa and ToxIBt antitoxin monomers fold into a classic H-type pseudoknot structure
flanked by two single-stranded tails. These ends and the adjacent areas of the pseudoknot interact
with their respective toxins to stabilise the trimeric structure (Figure 2A,B) [12,13]. Analysis of the
crystal structure of ToxINPa showed that each ToxIPa tail interacts with a different ToxNPa monomer
via electropositive grooves where hydrogen bonds occur between the protein and the RNA bases.
The antitoxin 3′ end tail containing the 2′-3′ cyclic phosphate is held in place in this groove by five
side chains, Tyr29, Lys33, Thr52, Ser53, and Lys55, that form the ToxNPa active site [12]. Similarly,
key areas of ToxIBt that interact with ToxNBt are the single stranded tails, where C19 and G20 interact
with Lys148 of the toxin, and the 5′ tail of ToxIBt and U10 interact with a hydrophobic pocket of the
ToxNBt interacting with the 3′ end [13].
Toxins 2016, 8, 282 5 of 14
4.2. CptINEr Assembles into Heterotetramers
In contrast to the ToxIN systems, CptINEr—currently the only other Type III TA system with
a solved crystal structure—assembles into tetramers (Figure 2C). Its quaternary structure is composed
of two toxin monomers joined by two antitoxin RNAs [14]. The CptI monomers are longer than the
corresponding examples in the ToxI repeats and the fold they adopt probably accounts for the difference
in quaternary structures—with the nature of the pseudoknotted RNA perhaps driving the evolution of
the toxin-antitoxin complexes.
4.3. Type III Antitoxins Form Pseudoknots
All the antitoxins crystallised so far adopt a pseudoknotted fold in their TA complexes.
Pseudoknots are a recurrent RNA structural motif in which a loop forms interactions with distal bases
outside the loop to form triple stranded structures. Usually the third nucleotide is an adenine enabling
A-minor interactions [21]. In the quaternary structures of the TA systems, the antitoxin pseudoknots
exhibit three distinct regions that interact with each other through duplex and triplex hydrogen bonds
(Figure 3) [12,13]. An important feature is the core of the pseudoknot which contains three internal
base triplexes. One of these internal base triplexes (triplex 3, GUU) separates the two based-paired
stems of the pseudoknot with interdigitation of a guanine (Figure 3A,B). While key components are
conserved in both ToxI pseudoknots, this curious structural aspect was not predicted due to the
low sequence homology between the antitoxins. Despite overall similar structures, the RNA-protein
interfaces show substantial differences as highlighted by the selective inhibition displayed by both
antitoxins and the absence of functional cross-talk between antitoxins and toxins of the Pectobacterium
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Figure 3. Pseudoknot arrange ts of Type III antitoxins. (A) ToxIPa; (B) ToxIBt; and (C) CptIEr.
Base-base hydrogen bonds are shown by black lines. Nucleotides involved in loops are indicated in
brown. Corresponding areas for each antitoxin are highlighted by similar colors.
In contrast, CptIEr monomers fold into an H-type pseudoknot distinctly different from the fold of
the antitoxins of the ToxIN family. Firstly, CptIEr has two coaxial stems assembled entirely from duplex
base pairing (Figure 3C) as opposed to the triplex base pairing seen in the other two antitoxins [14].
Even among RNA pseudoknots, the loops of the CptIEr pseudoknots are unusual. Indeed, loop 1
(L1) interacts with stem 2 (S2) while loop 2 (L2) interacts with stem 1 (S1), a configuration that leads
often to triplex base pairing [21]. These canonical pseudoknot interactions are found in the ToxI RNAs
where two triplex b se pairs occur from the interaction of L2 with S1, alth ugh there is no triplex
pairing with L1 and S2 (Figure 3A,B) [12,13]. The CptIEr ps ud knot is more atypical as L1 is extremely
short and only consists of a single base that does not interact with S2 and is instead eld in place by
interactions with the 3′ end of L2 (Figure 3C) [14]. L2 of CptIEr is adenine rich and longer than in the
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other antitoxins and forms a novel counter-clockwise A-minor twist motif [14]. This conformation
appears to be necessary for its antitoxin activity, as suggested by experiments on substitution and
deletion mutations that disrupted key features of this twist [14]. As with the ToxI-type antitoxins,
functional cross inhibition experiments have confirmed that CptI antitoxins also show high toxin
specificity [14].
5. Type III Toxins Share a Common Fold and Activity
To date, the structures of four Type III toxins have been solved; three of which belong to members
of the ToxIN family (ToxINPa, ToxINBt and AbiQ) and, more recently, a member of the CptIN family.
All toxins share a globular β core surrounded by α-helices and loops. While the core structure is
conserved, most variations are found on the surface. These variations are thought to account for
cleavage and antitoxin specificity of the toxins. All Type III toxins tested so far for their mechanistic
action have been shown to be endoRNases that cleave mRNAs in adenine-rich regions but with
slightly different substrate specificities: ToxNPa AA/AU, ToxNBt A/AAAA, and AbiQ A/AAA [13,20].
As for other toxins that inhibit translation, Type III toxins initially have a bacteriostatic effect on
growth [3,11,20] that ultimately leads to lethality.
5.1. The ToxN Family
ToxNPa and ToxNBt have the same highly twisted core of six anti-parallel β-sheets and five main
variable loop regions (Figure 4A,B) [12,13]. Four of these loops, especially the long kinked helix H3,
act as the major sites of interaction between the toxins and their respective antitoxins while the fifth
encompasses the active site. In line with the structural data, bioinformatics analysis of the sequences
of the other members of the ToxN family showed that the core fold is conserved while most sequence
variability clusters in regions corresponding to these five loops [12]. The structure of AbiQ also
encompasses a core of six-stranded anti-parallel β-sheets surrounded by 6 α-helices (Figure 4C) [20].
Surprisingly, the RNase activity of AbiQ was only eliminated by one site-directed mutation in Ser51Leu
which is thought to make the nucleophilic attack during the cleavage [20]. The RNase activity of AbiQ
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Toxins 2016, 8, 282 7 of 14
5.2. The CptN Family
CptNEr shares the same core fold found in the other toxins despite its lower primary sequence
identity with members of the ToxN family (Figure 4E). In CptNEr, the highly twisted anti-parallel
β-sheets that form the core are surrounded by four α-helices that make extensive interactions with
the cognate antitoxin sRNA [14]. Compared to the ToxN family, in which ToxNPa, ToxNBt, and AbiQ
have a kink in helix three [12,13,20] the equivalent helix in CptNEr, helix H4, is much shorter [14].
However many of the hydrogen bonding networks in the RNase active site are also conserved
suggesting that this toxin is also an endoRNase.
5.3. Type III Toxins Share Homology with Type II Toxins
Unexpectedly, the structure of Type III toxins shows significant homology with toxins from the
Type II MazF/Kid/CcdB family (Figure 4). Members of this Type II family share a similar fold despite
low sequence similarity and different mechanisms of action. For instance, Kid and MazF toxins inhibit
translation by acting as endoRNases while CcdB toxins interact with DNA gyrase and affect DNA
replication [23–25]. Type II and Type III toxins share very low sequence similarity, e.g., only 11%
identity between ToxNPa and Kid, but their respective structures encompass a similar β core fold
region surrounded by helices and loops. Interestingly, despite sharing the same overall structure and
the same molecular activity i.e., endoRNases, the active sites of ToxN and Kid do not match well [11,25].
Less surprisingly, differences are also found in the regions that interact with their respective antitoxins.
For instance, the helix 3 region of ToxNPa overlays with the Kid structure but is greatly extended in the
N-terminal section of the ToxNPa, the main site of ToxI recognition. The equivalent helix in CptNEr,
helix H4, is much shorter and, as such, resembles more closely to the Kid toxin (Figure 4A,D,E).
6. Functions of Type III TA System
Two functions have been ascribed to Type III TA systems so far. Historically, the first function was
their abortive infection (Abi) activity that protects bacterial populations from invading bacteriophages.
Their second known function involves their role in stabilisation of plasmids.
6.1. Abortive Infection
Some Type III systems are active protagonists in the “molecular arms race” that occurs between
bacteria and phages. As these outnumber bacteria 10-fold in some environments, the prokaryotic hosts
are potentially subject to constant viral predation [26]. In response to this acute selective pressure on
microbial communities, bacteria have evolved a large array of defense mechanisms to circumvent the
lethal impact of viral infections [27,28].
At least some of these Type III systems are bifunctional and can act as abortive infection (Abi)
systems in addition to their TA functionality. This bifunctionality is possible as both activities require
the involvement of a self-poisoning protein. Abi mechanisms rely on a toxic protein that can be
viewed, from an evolutionary perspective, as inducing the altruistic suicide of infected cells to
prevent phage propagation in bacterial populations. Even though 23 different Abi systems have
been reported, mostly carried on lactococcal plasmids, there is still a paucity of information on the
molecular mechanisms involved in their function, with the exception of TA/Abi systems for which
some insight has been acquired recently [29]. Abi systems have been shown to act at different steps of
the phage replication cycle i.e., from DNA replication to the lysis step—but ultimately they all lead to
the death of the infected bacteria [29]. TA/Abi bifunctionality is not restricted to Type III systems as
TA systems from Type I to IV have been shown to protect bacteria from bacteriophages [8,11,30–32].
While molecular details are still elusive in most cases, a working model is that—following toxin
activation by the infecting phage—dissemination of phage progeny in the bacterial population is
restricted. Toxin activation could rely on the differential stability of the antitoxin and toxin products.
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Post-infection, this characteristic of TA systems could favour a state of free toxins upon the depletion
of the shorter lived antitoxins.
The ToxINPa system of P. atrosepticum was identified originally through its phage resistance
capacity encoded by a cryptic plasmid. Subcloning of different plasmid fragments eventually
narrowed the anti-phage activity down to the ToxIN system genetic module [11]. ToxINPa can
inhibit a spectrum of phages infecting multiple Gram-negative enterobacteria such as P. atrosepticum,
Escherichia coli, and Serratia spp. ([10] and unpublished data). This dual Abi and TA functionality
was shown later to be shared by some other Type III TA systems. The chromosomal tenpIN locus
from Photorhabdus luminescens, effectively aborts environmental coliphages when expressed from
a plasmid in E. coli [11,18,33] and, likewise, AbiQ is effective, in Gram-positive Lactococcus lactis,
against members of the common 936 and c2 phage groups as well as rarer lactococcal phages. When
expressed in E. coli, AbiQ also protects this Gram-negative host from some coliphages [33]. Therefore,
the protective effect against phages appears to be independent of the organism in which the systems
are present [11,18,33]. Phage resistance may be also independent of the original genetic location as
both plasmid and chromosomal systems can effectively inhibit phage replication [11,18]. Similarly,
no correlation between the Type III TA systems families and Abi activity can be drawn currently.
For instance, despite proficient anti-phage activity of the ToxINPa and AbiQ systems, no anti-phage
activity could be shown for the closely related ToxINBt system in its native host [13] and while both
phenotypes have been observed for members of the ToxIN family, no anti-phage activity has yet been
observed for the two tested CptIN systems from Eubacterium rectale and Ruminococcus torque [14,18].
A further aspect of anti-phage activity of Type III systems is the specificity these systems show
against subgroups of sensitive phages [11,18]. No correlation has been found between phage families
(Myoviridae, Siphoviridae, and Podoviridae) and abortive infection [33,34]. It is not known whether
phages that are not aborted by the TA/Abi systems have naturally and actively evolved resistance
mechanisms against these systems in the perpetual arms race that occurs between them and their
bacterial hosts, or whether they “simply” do not activate the toxin of these systems. Some examples
of mechanisms selected by phages to avoid Abi systems in general (as well as TA/Abi systems)
are known in the literature [34]. For instance, point mutations in key phage products have been
identified as the basis of escape mechanisms. More recently it was shown that phage T4 has an ADP
ribosyltransferase that chemically modifies the Type II MazF toxin to downregulate its activity and
thus avoid this TA/Abi system [32]. Another phage escape mechanism includes two examples where
the phages evolved mimics of the toxin’s substrates. In the case of the Type II RnlAB/LsoAB systems
of E. coli and phage T4, the phage uses the Dmd protein which acts like a Type II antitoxin and directly
interacts with the toxins. In contrast to the canonical antitoxins of RnlA and LsoA, Dmd is able to
cross-neutralise several toxins. Recent crystallographic studies showed that Dmd is thought to have a
different inhibition mechanism and directly interacts with the toxin active site by mimicking the toxin
substrates [35].
In the Type III systems, the ToxIN-sensitive phage TE was shown to produce low frequency
spontaneous mutants that escaped the ToxINPa system [36]. Analysis of the escape mutants revealed
that the majority of the mutants had extended a short viral sequence similar to the repeats of the ToxI
sRNA into a ‘pseudo-ToxI’ which functionally suppressed the toxin. In one case, recombination had
allowed the phage escape mutant to obtain natural ToxI repeats from the original plasmid antitoxin
sequences. Both scenarios allowed phage replication unaffected by the Abi/TA system [36].
The precise molecular mechanisms of these bifunctional TA/Abi systems are still under
investigation. In agreement with the current model, the toxin endoRNase activity and the Abi
phenotype have been shown to be linked [19]. However, this may not be a universal situation
because mutagenesis of key toxin residues can lead to the loss of the Abi phenotype despite retained
RNase activity [20] indicating that the details of the toxin activation are more subtle. This leads to
the question as to how Type III TA/Abi systems are actually activated and the molecular basis of the
differential sensitivity of different phages. Phage products that are involved in the activation of Type III
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TA/Abi systems might directly interact with the toxin, the antitoxin, or both, to prevent assembly of the
TA heterocomplexes, or to disrupt them. Alternatively, a phage product might interrupt transcription
of the TA operon or affect antitoxin RNA stability, thus causing imbalance in the TA components.
Both scenarios would lead to an excess of free toxin, which could inhibit mRNA translation, leading to
cell growth arrest and thereby ultimately prevent the release of phage progeny. The nature of the phage
products involved and the way they interact (directly or indirectly) with the TA system is unknown.
Experimental data for the ToxINPa and the AbiQ systems showed that toxin levels are not affected
during phage infections nor is transcription of the TA systems increased [19,20]. However transcripts
of the AbiQ system, expressed constitutively before infection, decrease during the infection, possibly as
part of a general infection phenomenon [20]. Based on experimental data, it is thought that the TA
systems are activated at late steps of phage replication, at least in the AbiQ system. It has been shown
that phage DNA is replicated in infected cells in the presence of the AbiQ system, as indicated by the
accumulation of concatemeric viral DNA [37].
6.2. Plasmid Inheritance through Addiction
Another function known for Type III systems is plasmid addiction. In contrast to the Abi
phenomenon where TA systems protect bacteria from invading DNA, when acting as “addiction”
modules they ensure the stable inheritance of plasmids in bacterial populations.
This feature of TA systems also relies on the antagonism of the self-poisoning essence of the
toxin and the labile nature of the antitoxin [11]. It supposes a continuous synthesis of the antitoxin
in order to keep the toxin in an inhibited state and thus renders the cell ‘addicted’ to the TA
system. Consequently, when present on mobile genetic elements such as plasmids, these “addiction”
modules promote the maintenance of the DNA molecule encoding the TA system and ensure the
continued presence of plasmids in bacterial populations via killing of plasmid-free segregant cells
by the toxins [15,38]. Historically, this mechanism has also been named post-segregational killing
(PSK) as lethality arises when plasmids are not segregated into both daughter cells during cell
division [38]. Alternatively, given the initially bacteriostatic—rather than bactericidal—nature of
Type III toxins [11,20], mis-segregation could lead to a transitory growth inhibition. Bacteria that
retained the plasmid would then be able to outgrow those that “lost” it, thus ensuring plasmid
maintenance at the population level.
Plasmid addiction is a function found in many TA systems of Type I and II and has also been
shown for some Type III TA systems. For example, ToxINPa and CptINEr increased plasmid retention
in E. coli W3110 to 100%, compared to 50% loss of the control vector [13,14]. Notably, the fact that
CptINEr is located on the chromosome of the original host, yet could promote plasmid maintenance
when cloned, suggests that CptINEr can promote its own retention and might be disseminated through
horizontal gene transfer [14].
In addition to the post-segregational killing during the exponential growth phase, one Type III
system has been show to ensure plasmid maintenance in stress conditions leading to sporulation
of Bacillus subtilis. During sporulation, bacteria differentiate into spores, a metabolically dormant
cell-type that can survive adverse environments and switch back to vegetative growth in favorable
conditions. The frequency of plasmid loss during sporulation is higher than in vegetative growth [39]
and the rate of plasmid loss can vary from 5% to 95% in Bacillus [40]. The B. subtilis ToxINBt system
favours plasmid retention in this specific context by decreasing plasmid loss around 10-fold (from 58%
for the control plasmid to 6% when the TA system was present) [39]. This was achieved by reducing
the proportion of cells that form mature spores—probably by the action of the toxin in plasmid-free
forespores. Only forespores that inherited a plasmid copy were able to mature and so this mechanism
ensures plasmid maintenance throughout the environmental stress that precipitated sporulation. It is
formally possible that other types of TA systems might affect plasmid retention by similar routes
during sporulation [39].
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7. New Bioinformatic Analysis Reveals a Significant Increase in Potential Novel Systems
Mining databases for ORFs and subsequent analysis of the proteins encoded by them can be
a powerful tool to gain evolutionary insight into genes encoding TA systems [41,42]. Investigating
the occurrence of Type III systems was initially complicated as bioinformatic analysis of non-coding
RNAs is still problematic. Solving the structure of ToxN made it possible to identify new members
of the Type III TA family by performing de novo structure-based homology searches [18]. A set of
criteria was used to determine which ToxN structural homologues found by FUGUE [43], a program
for sequence-structure comparison, are truly from Type III TA systems. The logic of the definition
was as follows: the ToxN homologues should be preceded by a palindromic repeat acting as
a Rho-independent terminator, which in turn should be preceded by sequences with a similar
organization to toxI—composed of a tandem array of nucleotide repeats. Subsequently, samples from
each family were taken and exhaustive BLASTp searches were performed, yielding a final list of
125 putative type III TA systems. The majority of hits were found on bacterial chromosomes and
plasmids of Firmicutes, Fusobacteria, and Proteobacteria as well as Archaea. One toxIN locus was
also encoded on a prophage [18]. Using these criteria, 37 putative Type III loci were identified
and were divided into three independent families according to their protein sequences as described
previously [18].
Given the near exponential increase of sequenced genomes available in databases during the
last few years, we did a new BLASTp search. Using the amino acid sequences of the characterized
ToxNPa, ToxNBt, AbiQ, TenpNPl, and CptNEr toxins as input, we did an initial BLASTp search against
the Bacteria and Viruses databases of Uniprot. We identified 603 potential Type III toxins with an
E-value <0.001. A selection of these predicted toxins were further analysed following the previously
established criteria. After validation as members of putative Type III TA systems, these toxins were
used for a further round of BLASTp. The new round of BLASTp searches with the selected toxin
homologues gave a few new putative toxins indicating that the search is exhaustive. The different
toxin groups seem to cluster to particular phylogenetic groups. For instance, the ToxN family is
primarily found in Firmicutes, Fusobacteria and occasionally other species. Systems from this group
also seem associated with the mobilome as they can be found on plasmid and chromosomal locations,
sometimes in the close vicinity of transposase elements. Despite the increased number of predicted
systems, Type III TA systems appear largely restricted to a limited group of phyla as only 8 out of
the currently estimated 74–76 bacterial phyla have at least one potential system [44]. Whether Type
III TA systems are indeed only confined to a restricted number of bacteria, or whether the current
distribution pattern is biased by the limited phylogenetic breadth of genome sequencing, is unknown.
It is intriguing that Type III TA systems seem to be confined to a few phylogenetic groups. As the
toxin mode of action, i.e., cleaving RNAs, is a general one that does not require any known external
factors, and given that they are found on plasmids, one might expect them to be spread through more
phylogenetic groups, in a similar way to the Type II systems where the majority of toxins are also
RNases [41,42,45].
Advances in technologies such as single-cell genomics and metagenomics will enable the
sequencing of uncultivated organisms from diverse habitats [44,46] and might affect the picture
of TA system distribution as the current “tree of life” expands and culturing-associated biases are
overcome [43,47]. When placing the consensus antitoxin repeats next to a phylogenetic tree based on
the protein toxin sequences, it becomes clear that the antitoxins of closely related toxins are conserved
as well (Figure 5). This consistency provided evidence for the notion of co-evolution of toxin and
antitoxin components. The length and the primary sequence of the consensus repeats are usually quite
conserved within the different toxin groups. On the other hand, the number of repeats is prone to
slight variations.
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Figure 5. Phylogenetic tree based on representative toxins of putative Type III TA systems associated
with the consensus repeats of the antitoxins: adenine (grey), guanine (white), cytosine (yellow),
and uracil (orange). Toxin protein sequences were aligned using MUSCLE [48]. The tree has been
constructed using PhyML and nearest neighbour interchange [49,50] and the figure has been made
using Ete3 [51].
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8. Conclusions
Work in recent years has increased our understanding of bacterial Type III TA systems. However,
it is abundantly clear that our understanding of the molecular mechanisms involved in Type III systems
and their activation is still rudimentary. These TA systems provide valuable reagents for fundamental
biochemical studies on protein:RNA interactions and the study of quaternary nucleoprotein complex
assemblies. The ecological and fitness implications of bacterial carriage of Type III TA systems
have yet to be investigated. Furthermore, the role of Type III systems in the evolution, replication,
and physiology of both bacteria and their viral parasites warrants deeper consideration.
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